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Physical loading is a potent regulator of bone anabolism, yet the cellular mechanisms 
by which this occurs are poorly understood. Due to the finite lifespan of bone 
forming osteoblasts, it is hypothesized that these cells must be replenished from a 
bone marrow stem cell (MSC) population in response to loading, as is seen in 
response to injury. It is hypothesized that the application of a mechanical stimulus 
may directly stimulate MSCs within the marrow to undergo osteogenic 
differentiation, as has been shown in vitro. However, how MSCs may sense this 
loading or whether loading actually regulates MSC differentiation in vivo is 
unknown.  
In this thesis, we first demonstrate that MSCs utilize cAMP as a 2nd 
messenger in mechanotransduction, that is required for flow mediated increases in 
osteogenic gene expression. Furthermore, we demonstrate that this 
mechanosignalling is dependent on the primary cilium and the ciliary localised 
adenylyl cyclase 6. Lastly, in this initial study we also demonstrate that this 
mechanotransduction mechanism can be targeted therapeutically to enhance cAMP 
concentrations and early osteogenic signalling, mimicking the beneficial effect of 
physical loading.  
In the second study of this thesis, we demonstrate that Gpr161 is a 
mechanoresponsive G-Protein Couple Receptor (GPCR), that localises to the cilium, 
and is required for fluid shear induced increases in cAMP and osteogenesis. This 
Gpr161 mediated mechanotransduction is dependent on the primary cilium but acts 
upstream of cilia localised adenylyl cyclase 6 (AC6), suggesting that Gpr161 may 
act through AC6 to regulate cAMP and MSC osteogenesis. Moreover, we 
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demonstrate that Hedgehog (Hh) signalling is positively correlated with osteogenesis 
and demonstrate that Hh signalling is mechanically regulated and required for 
loading-induced MSC osteogenesis through a primary cilium-Gpr161-AC6-cAMP 
mechanism. Taking the first two studies together, we have delineated a molecular 
mechanism of MSC mechanotransduction which occurs at the primary cilium and 
can be targeted therapeutically, demonstrating a potential mechanotherapeutic for 
bone loss diseases such as osteoporosis.  
Finally, we utilized Leptin Receptor to identify and trace the contribution of 
bone marrow stem cells to bone mechanoadaptation in vivo. Lepr-Cre; tdTomato+ 
mice were subjected to compressive tibia loading and histological analysis revealed 
that Lepr-Cre; tdTomato+ stem cells arise perinatally around blood vessels and 
increase within the marrow following tibial compressive loading. Mechanical 
loading induces an increase in bone formation parameters yet loading does not result 
in an increase in Lepr-Cre; tdTomato+ osteoblasts or osteocytes. Moreover, mice 
with a LepR specific deletion of AC6 have an attenuated response to compressive 
tibia loading, nor is there a change in the percentage of Lepr-Cre; tdTomato+ cells. 
This therefore demonstrates that LepR+ cells on the bone surface directly contribute 
to bone formation and that adenylyl cyclase 6 is required for activation of these cells 
in response to loading, highlighting an activation of the resident bone lining cells via 
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1.1 Osteoporosis and current treatments  
Osteoporosis is a systemic skeletal disorder characterized by low bone mass and 
micro-architectural deterioration that results in increased fracture risk, particularly of 
the vertebral body, distal forearm and proximal femur of postmenopausal women 
(Rachner et al., 2011, Drake et al., 2015). Bone mineral density (BMD), is a more 
practical definition of osteoporosis and can be assessed with dual x-ray 
absorptiometry (DXA). The difference in BMD of an older person and someone of 
the same gender at age 30 in standard deviation is known as the ‘T-score’. If the T-
score is equal or less than -2.5, i.e. more than 2.5 standard deviations below the 
average young adult, osteoporosis can be diagnosed (Rachner et al., 2011, Drake et 
al., 2015). Osteoporosis is predicted to result in fractures in 1 in 3 women and 1 in 5 
men over 50, with corresponding detrimental effects on the quality of life with a loss 
of mobility and autonomy. Therefore, osteoporosis has become a global economic 
health burden, and the incidences of these fractures are only set to rise with the aging 
population (Feng and McDonald, 2011). Furthermore, osteoporotic fractures of the 
hip and spine carry a 12-month excess mortality of up to 20%, due to hospitalisation 
and increased risk of other complications such as pneumonia or thromboembolic 
disease (Rachner et al., 2011).  
The characteristic of weakened bone microarchitecture results from altered 
activity of the bone resorbing cells, osteoclasts, and the bone forming cells, 
osteoblasts. The accelerated activity of the osteoclasts can overpower the 
compensatory bone formation (Drake et al., 2015, Feng and McDonald, 2011). 
Therefore, current therapeutics for osteoporosis primarily target the function and 
activity of osteoclasts in an aim to prevent further loss of BMD, however, these fail 
to recover bone mass and architecture (Rachner et al., 2011, Drake et al., 2015). 
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Current antiresorptive treatments such as oestrogen and bisphosphonates have been 
reported to have side effects such as heart disease, jaw osteonecrosis and cancer to 
name but a few (Drake et al., 2015, Rachner et al., 2011). A shift in the treatment 
approach for osteoporosis is emerging, resulting in anabolic therapies targeting 
osteocytes, osteoblasts and osteoprogenitors/skeletal stem cells. Most notably, 
parathyroid hormone (PTH) is one the first agents to be prescribed to treat 
osteoporosis by targeting osteoblast activity. PTH can be injected subcutaneously 
daily, where it increases both bone formation and resorption, with formation 
outweighing resorption particularly in the initial 6 to 12 months of therapy, therefore 
leading to increases in bone mass (Drake et al., 2015). However, treatment is 
currently limited to 24 months due to complications with osteosarcoma formation. 
Recently, Romosozumab, a monoclonal antibody that targets sclerostin derived from 
osteocytes has been shown to increase bone formation and decrease risk of fracture 
in clinical trials(Minisola, 2014, Padhi et al., 2014, Canalis, 2018). Mesenchymal 
stem cells (MSCs), as the precursor to the bone forming osteoblast are an obvious 
target due to their involvement in disease progression and treatment but have yet to 
be fully explored as a therapeutic target. MSCs reside within the bone marrow where 
they play a pivotal role in bone anabolism, and interestingly, osteoporosis presents 
with a decrease in MSC population and their ability to undergo osteogenic lineage 
commitment (Chen et al., 2016, Tewari et al., 2015). This reduction in the MSC 
population results in a deleterious effect on sustaining bone anabolism and thereby 
leading to increased risk of fracture, hence MSCs represent an exciting potential 
therapeutic target for the treatment of bone loss diseases such as osteoporosis which 
has yet to be explored.  
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1.2 Stem cell mechanobiology 
Bone has long been established as a mechanosensitive organ, which can adapt 
its structure to meet the demands of its mechanical environment, maintaining an 
optimal strength to weight ratio (Robling and Turner, 2002, Frost, 1963). The 
modulation of bone integrity has been observed in humans where bone mass is 
increased in athletes following sustained physical activity, while bone loss is 
observed in bed ridden patients and astronauts due to lack of mechanical loading. 
The mechanosensory capabilities of the osteocyte has highlighted this cell type as 
being the key player in bone mechanoadaptation (Schaffler et al., 2014, Bonewald, 
2011), however, recent studies have shown that mechanically driven adaptation can 
occur without the presence of osteocytes, suggestive of a direct mechano-activation 
of bone forming cells or their progenitors, mesenchymal stem cells (MSCs)(Chen 
and Jacobs, 2013, Kwon et al., 2012, Robling et al., 2006, Curtis et al., 2018). An 
elegant study employing an inducible osteocyte depletion model demonstrated that 
loading induced osteogenesis can occur independently of osteocyte activity. In this 
study, through modulating intramedullary pressure they found that structural 
adaptation to pressure-driven fluid flow proceed unimpeded following a significant 
depletion in osteocytes, consistent with the potential existence of a non-osteocytic 
bone cell population that senses the fluid flow (Kwon et al., 2012). Moreover, a 
vibration explant model resulted in no alteration of osteocyte expression of sclerostin 
protein and mechano-regulatory genes, however, c-Fos was upregulated in the 
marrow cells of mechanically stimulated explants (Curtis et al., 2018). Despite 
identification of applied forces that affect self-maintenance, proliferation, and 
differentiation of MSCs, mechanisms underlying the integration of mechanically 
induced signalling cascades and interpretation of mechanical signals by MSCs 
remain elusive.  
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MSCs are promising candidates for cell-based therapies in diverse conditions 
including skeletal disease. MSCs are multipotent cells capable of differentiation into 
multiple lineages of the musculoskeletal system, however, the identification of 
accurate and reliable MSC markers is an area of intense study. MSCs are often 
perivascular in vivo, where mouse MSCs are characterized by their lack of 
expression of hematopoietic and erythropoietic markers (CD45- and TER-119-), and 
positive expression of Platelet Derived Growth Factor receptor alpha (PDGFRα) 
(Morikawa et al., 2009, Nakao et al., 2010, Zhou et al., 2014). Furthermore, MSCs 
were identified as plastic-adherent, colony forming, non-hematopoietic cells, which 
can differentiate into chondrogenic, adipogenic and osteogenic progeny (Zhou et al., 
2014, Bianco et al., 2008). Developments in transgenics has allowed for the 
development of multiple MSC mouse models, where reporters and cre recombinase 
expression, under the control of regulatory elements of genes known to be essential 
in the regulation of skeletal and mesenchymal lineages have been developed (Kfoury 
and Scadden, 2015). Leptin Receptor (LepR) has recently been identified as being 
perivascular, a major source of the Stem cell fraction (Scf) within bone marrow and 
as a key player in adult bone formation (Zhou et al., 2014, Ding and Morrison, 2013, 
Ding et al., 2012). Additionally, LepR+ cells were shown to be functional, in that 
they were the main source of new osteoblasts and adipocytes in adult bone marrow 
and could form bony ossicles that support haematopoiesis in vivo (Zhou et al., 2014). 
While these studies show that LepR plays a role in bone formation, the question to 
its function in loading induced bone formation remains. The advancement of 
therapies relies on the ability to identify, isolate, manipulate, deliver MSCs in a safe 
and effective manner and to direct MSCs toward specific cell phenotypes (Castillo 
and Jacobs, 2010, Hao et al., 2015).  
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Loading-induced deformation of bone creates a complex mechanical 
microenvironment within the stem cell niche consisting of strain, pressure and fluid 
flow (Gurkan and Akkus, 2008). A large body of work has demonstrated that 
physiological OFS is a potent regulator of bone homeostasis, triggering an 
osteogenic response in osteoblasts, osteocytes and stem cells (Malone et al., 2007, 
Vezeridis et al., 2006, Klein-Nulend et al., 1995, Yourek et al., 2010, Stavenschi et 
al., 2017). In particular, a systematic study investigating the effect of oscillatory fluid 
shear (OFS) on MSCs demonstrated that OFS triggers an increase in Cyclo-
oxygenase 2 (Cox2), Osteopontin (Opn) and Runt related transcription factor 2 
(Runx2) expression at early time points, that resulted in enhanced collagen and 
mineral deposition over 21 days (Stavenschi et al., 2017). Despite the known 
contribution of mechanical loading to MSC osteogenic differentiation and bone 
formation, the mechanism by which these cells transduce mechanical stimuli into 
cellular activity, mechanotransduction, remains poorly understood. Deciphering 
these mechanisms would greatly aid in the development of mechanotherapies to 
prevent bone loss and promote regeneration in skeletal diseases such as osteoporosis 
(Rando and Ambrosio, 2018). 
1.3 Stem cell mechanotransduction  
Bone adaptation to the mechanical environment through the translation of 
mechanical cues to organ, tissue, and cell is known as mechanotransduction. Despite 
the known contribution of mechanical loading to MSC osteogenic differentiation and 
bone formation as discussed above, the mechanism by which mechanical stimuli are 
sensed and converted into cellular activity, remains elusive. 
Secondary messengers are one of the initiating biochemical components of 
intracellular signalling cascades triggered by a biophysical stimulus. Various second 
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messengers such as intracellular calcium (Ca2+), cyclic adenosine monophosphate 
(cAMP), cyclic guanosine monophosphate (cGMP), inositol trisphosphate (IP3) and 
diacylglycerol (DAG) initiate a plethora of downstream signalling cascades, 
however, Ca2+ has been the predominate 2nd messenger studied in response to fluid 
shear. Studies have shown that rapid fluxes in intracellular Ca2+ following OFS 
result in downstream transcriptional activity in bone cells (Hung et al., 1995, Lewis 
et al., 2017, Lyons et al., 2017). Moreover, human mesenchymal stem cells have 
demonstrated intracellular calcium increases following fluid shear that are required 
for downstream osteogenic gene expression (Liu et al., 2015, Corrigan et al., 2018).  
Conversely, osteocytes have been shown to undergo mechanosensing in a 
calcium-independent manner, where cAMP levels rapidly decreased following 2 
mins fluid flow (Kwon et al., 2010). Cyclic AMP is an ubiquitous second messenger 
that has been shown to be an important mediator in determining the response of a 
cell to external stimuli, whose main function is to activate the cAMP-dependent 
protein kinase A (PKA) (Yang et al., 2008, Kamenetsky et al., 2006, Bauman et al., 
2006). Low fluid shear has been shown to induce an increase in cAMP production 
over time and increasing shear rates in rat calvarial osteoblasts, indicating that cAMP 
is mechanoresponsive (Reich et al., 1990). A recent study using an ectopic bone 
formation model in immune-deficient mice, resulted in N6,2’-O-dibutyryladenosine-
3’,5’-cyclic monophosphate (db-cAMP) augmented bone-formation of hMSCs 
(Siddappa et al., 2008), indicating that MSCs may too utilize cAMP as a signalling 
mechanism. 
Cyclic AMP is universally generated by adenylyl cyclases (ACs), a family of 
enzymes that catalyze the cyclization of adenosine triphosphate (ATP) into cAMP 
(Kamenetsky et al., 2006, Hanoune and Defer, 2001). Adenylyl cyclase’s comprise a 
8 
 
family of nine distinct transmembrane isoforms (AC1-AC9), where each of the 
transmembrane ACs has individual regulatory properties, and the nine subtypes are 
expressed in only a limited number of tissues (Hanoune and Defer, 2001, Defer et 
al., 2000). Specifically, adenylyl cyclase 6 (AC6) has been shown to be expressed in 
mature bone cells and is required for loading-induced bone formation in vivo (Lee et 
al., 2014). Interestingly, skeletally mature mice, with a global deletion of AC6, did 
not present with a skeletal phenotype but formed significantly less bone than control 
mice following ulnar loading, demonstrating that AC6 is involved specifically in 
mechanotransduction leading to functional bone mechanoadaptation (Lee et al., 
2014). Additional in vitro studies have demonstrated a role for AC6 in osteocyte 
mechanotransduction (Kwon et al., 2010), but the potential role of AC6 in MSCs 
remains unknown. 
1.4 The Primary Cilium    
Primary cilia are solitary, immotile microtubule-based organelles, that protrude 
from the membrane in various cell types (Wheatley et al., 1996), including bone 
(Hoey et al., 2012) and have recently emerged as a nexus of intra- and extra-cellular 
signalling (Lee and Gleeson, 2010, Singla and Reiter, 2006a, Chen et al., 2016, Lee 
et al., 2015). Extending into the extracellular milieu, the primary cilium is ideally 
positioned to relay both biochemical (Hedgehog (Singla and Reiter, 2006), 
transforming growth factor beta (TGFβ) (Clement et al., 2013, Labour et al., 2016), 
BMP (Monnich et al., 2018)) and biophysical (fluid shear (Hoey et al., 2012b), 
compression (Wann et al., 2012), pressure (Luo et al., 2014)) cues. Furthermore, 
primary cilia are required to maintain tissue homeostasis, with defects in the cilium 
leading to several diseases known as ciliopathies (Hildebrandt et al., 2011). 
Specifically, in bone, the depletion of primary cilia in mature bone cells or their 
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progenitors results in an inhibition of the osteogenic response to fluid shear (Malone 
et al., 2007, Hoey et al., 2011, Hoey et al., 2012b), with these findings verified using 
in vivo models (Temiyasathit et al., 2012, Chen et al., 2016), demonstrating the 
important role of the cilium in bone mechanobiology.  
To identify new anabolic therapeutics, recent efforts have attempted to decipher 
the molecular mechanism of cilia-mediated mechanotransduction with contrasting 
results. Cilia-mediated mechanotransduction is predominately believed to be 
propagated by calcium signalling with initial studies by Praetorius and Spring 
(Praetorius and Spring, 2001) being verified by advanced cilia localised genetically 
encoded calcium indicators (Jin et al., 2014, Lee et al., 2015). Interestingly, work has 
recently emerged suggesting that primary cilia are not calcium-responsive 
mechanosensors as previously thought (Delling et al., 2016). Although these 
discrepancies may be associated to differences in calcium sensors utilized, it has 
raised the possibility of alternative second messengers in cilia mechanotransduction, 
namely cAMP. Previous work has demonstrated that that ciliary cAMP levels are 
fivefold higher than cytosolic cAMP in mouse embryonic fibroblasts and murine 
inner medullary collecting duct cells (IMDC3) and that this compartmentalized 
cAMP is regulated by ACs which localizes to the ciliary microdomain (Moore et al., 
2016). Moreover, AC6 was shown to localize to the primary cilium of 
cholangiocytes and osteocytes and was required for fluid shear induced cAMP 
signalling (Masyuk et al., 2006, Mick et al., 2015, Kwon et al., 2010), indicating that 
cilium may also be a cAMP-responsive mechanosensor and that molecular 
mechanisms may be cell type dependent. However, despite the progress in cilia-
mediated mechanotransduction in mature bone cells, the molecular mechanism of 




Figure 1.1: Outline of main objectives of thesis. The molecular mechanism of primary cilia mediated 
mechanotransduction in MSCs in vitro and the contribution of stem cells to loading induced bone 
formation in vivo were investigated.  
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Thesis objective  
The primary objective of this thesis is to investigate the molecular mechanisms 
employed in MSC mechanotransduction both in vitro and in vivo, with the aim of 
identifying new targets for mechanotherapeutic intervention. This thesis is broken 
down into three experimental chapters where their specific aims were:  
1. To determine if the primary cilium is a cAMP mechanosensor in 
mesenchymal stem cells and to delineate the AC responsible for this action.  
2. To identify the upstream mechano-activator of ACs within the primary cilium 
mediating cAMP dependent MSC mechanotransduction and osteogenesis. 
3. To identify the contribution of LepR+ MSCs and their progeny to loading-
















2.1 Skeletal physiology  
The adult human skeleton comprises of 206 bones, each serving the variety of 
functions (Clarke, 2008). The skeleton functions to provide structural support for the 
rest of the body, permit locomotion by providing levers for muscles, protect vital 
internal organs and structures, provide maintenance of mineral homeostasis and acid-
base balance, serve as a reservoir of growth factors and cytokines, and provide the 
environment for haematopoiesis within the marrow spaces (Clarke, 2008). The 
architectural arrangement of bone is complex at tissue, cell, matrix and molecular 
level. At the tissue scale, bone is organized as 80% cortical bone and 20% trabecular 
or cancellous bone (Clarke, 2008). Different bones and even skeletal sites within 
bones have varying ratios of cortical and trabecular bone, for instance vertebrae are 
composed of 25:75 cortical to trabecular bone, while the radial diaphysis is 95:5 
cortical to trabecular bone (Clarke, 2008).  
Cortical and trabecular bone differ in that cortical bone is dense and encloses the 
marrow cavity, whereas trabecular bone is light, porous bone enclosing numerous 
large spaces that give a spongy appearance (Clarke, 2008). Trabecular bone matrix is 
organized into a three-dimensional latticework of bony processes, called trabeculae, 
arranged along lines of stress (Clarke, 2008). Cortical osteons are cylindrical 
structures, which are made up of smaller and more complex networks, the lacunar-
canalicular system, where lineage committed osteocytes reside and connect, allowing 
for osteocyte signalling networks throughout the tissue (Ren et al., 2015). 
McNamara et al. (2009) revealed that the pericellular spaces between osteocytes and 
the lacunar-canalicular wall are filled with interstitial fluid and pericellular matrix, 
which is a gel-like fiber matrix thought to be composed of proteoglycans and other 
matrix molecules (McNamara et al., 2009). The bone matrix onto which cellular 
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components reside is composed of organic matter synthesized by bone depositing 
osteoblast cells such as collagen and other bone related proteins, inorganic matter- 
hydroxyapatite, and water (Ren et al., 2015) (Figure 2.1). 
The outermost surface of bone, apart from the joint area, is surrounded by a 
fibrous connective tissue sheath called the periosteum (Clarke, 2008). The 
periosteum contains blood vessels, nerve fibres, osteoblasts and osteoclasts. The 
innermost surface of bone is covered by a vascular membranous structure known as 
the endosteum. The location of the endosteum means it is in contact with the marrow 
space, blood vessels, bone lining cells, osteoblasts and osteoclasts (Clarke, 2008).  
Osseous medullary cavities are filled with soft marrow, one of the largest organs 
accounting for 5% of total body weight (Moulopoulos and Koutoulidis, 2015). Bone 
marrow is characterised by two types, the red haematopoietically active marrow, and 
the yellow fatty inactive marrow. Red marrow regresses post-natally, while yellow 
marrow is the fat cells which replace these hematopoietic cells over time 
(Moulopoulos and Koutoulidis, 2015). Arterial supply to the bone marrow is derived 
mainly from the nutrient artery. The marrow is served by numerous blood vessels, 
where near the bone arterioles open and anastomose with a plexus of venous sinuses. 
Nutrient artery derived capillaries extend into the Haversian canals and return back 
into the marrow cavity, where they too open into vinous sinuses, thereby resulting in 
circular blood flow from the centre of the marrow cavity toward the periphery 
(Travlos, 2006b). Red and yellow marrow also differ in their blood supply. Red 
marrow has a rich vascular supply with a dense sinusoidal network, while during the 
transition from red to yellow marrow yellow marrow, vascularisation decreases in 
size and the dense network of sinusoids is replaced by sparse capillaries 
(Moulopoulos and Koutoulidis, 2015). The cellular content of bone marrow is again 
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characterised by two sub groups, the hematopoietic cells and the stromal cells, the 
latter which are not directly involved in haematopoiesis such as osteoblasts, 
mesenchymal stem cells (MSC), reticular cells, endothelial cells and adipocytes.  
Figure 2.1: Structural organization of bone (Vectorstock.com). 
 
Bone marrow is a major hematopoietic organ and is important as both a primary 
and secondary lymphoid organ responsible for the production of blood cells 
(Travlos, 2006b, Travlos, 2006a). In addition to blood production, bone marrow 
plays a critical role in tissue repair, bone modelling and re-modelling and in the 
maintenance of bone homeostasis (Travlos, 2006b). The functionality of bone 
marrow relies heavily on the hematopoietic microenvironment which is able to 
recognize and retain stem cells and provide factors to support proliferation, 





2.1.1 Bone cells 
Skeletal homeostasis is orchestrated and controlled by the interaction of bone 
cell types mediating deposition and resorption of bone in response to both 
biochemical and biophysical stimuli. The cellular composition of bone is comprised 
of a progenitor population (stem cells), bone depositing cells (osteoblasts and bone 
lining cells), and the fully committed bone sensing cells, the osteocytes, in addition 
to the bone resorbing osteoclast (Clarke, 2008).  
Osteoclasts are the only cells known to resorb bone and play a central role in the 
formation and regulation of bone mass. The multi-nucleated osteoclasts are formed 
by the fusion of mononuclear progenitors of the monocyte-macrophage lineage 
(Clarke, 2008, Teitelbaum, 2000). It is the relative activity of osteoclasts to that of 
the bone forming cells that dictates tissue homeostasis or alternatively the 
development of bone loss diseases such as osteoporosis. In osteoporosis, the skeletal 
mass decreases to the point of structural instability and risk of bone fracture, due to 
an imbalance in the activity of these two cell types (Teitelbaum, 2000). Osteoclasts 
formation relies heavily on the cytokines RANKL and M-CSF, which are produced 
by marrow stromal cells and osteoblasts. RANKL is critical for osteoclast formation, 
whereas M-CSF functions in proliferation, survival and differentiation of osteoclast 
precursors, in addition to osteoclast survival and cytoskeletal changes required for 
bone resorption (Clarke, 2008). Integrin receptors in the osteoclast membrane attach 
to bone matrix peptides, therefore binding them to the bone matrix. The family of 
integrin receptors facilitating bone resorption is the v3 integrin, which binds to 
osteopontin and bone sialoprotein (Figure 2.2). Reorganization of the fibrillar actin 
cytoskeleton of osteoclasts occurs following binding to the bone matrix, resulting in 
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the formation of an actin ring, which functions to promote formation of the sealing 
zone surrounding the bound osteoclast (Clarke, 2008, Teitelbaum, 2000).  
Figure 2.2: Organization of interaction between bone and extracellular matrix 
Terminally differentiated bone cells, known as osteocytes function, to support 
bone structure and metabolism. Making up 90-95% of the bone cellular component, 
osteocytes which are located within the bone matrix, are formed via the terminal 
differentiation of a subpopulation of osteoblasts that undergo passive encapsulation 
within osteoid that in turn mineralizes (Bonewald, 2011). Each osteocyte, enclosed 
within its mineralized lacuna, has many (perhaps as many as 60) cytoplasmic 
processes. During the differentiation of osteoblasts to osteocytes, alkaline 
phosphatase (ALP) decreases, while additional markers begin to become expressed, 
namely matrix extracellular phosphoglycoprotein (MEPE), dentin matrix protein 1 
(DMP-1), fibroblast growth factor 23, (FGF-23) and sclerostin (Bonewald, 2011). 
Osteocytes function in the regulation of bone mineralization and phosphate 
homeostasis via FGF-23 secretion but are believed to primarily act as 
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mechanosensory cells (Dallas et al., 2013). Osteocytes form dendritic processes, 
which extend toward the mineralizing front, vascular space and bone surface. The 
location of osteocytes within the lacunae with their processes protruding through 
canaliculi allows for this cell type to sense mechanical and biochemical stimulation 
and mediate cell-cell communication, acting as a sensory and signalling network for 
bone and the surrounding tissues (Bonewald, 2011, Ren et al., 2015).  
During development osteoblasts are derived from MSCs within condensing 
mesenchyme that differentiate along the edge of the cartilage anlagen and make up 
4-6% of bone cells. Furthermore, MSC homing plays an important role in fracture 
healing, where current paradigms relate such events to both biochemical paracrine 
signalling from bone committed cells and direct mechanical stimulation. The number of 
MSCs undergoing osteogenic lineage commitment is related to the number of secretory 
osteoblasts entering active synthesis (Wang et al., 2013). Commitment of MSCs to the 
osteoblast lineage is regulated by two families of growth factors, bone 
morphogenetic proteins (BMPs) and Wingless and integration 1 (Wnt) (Fakhry et al., 
2013). Additionally, the transcription factors Runt-related transcription factor 2 
(Runx2), Distal-less homeobox 5 (Dlx5) and osterix are required for this 
differentiation of MSCs to osteoblasts. Specifically, Runx2 is considered the master 
osteoblast transcription factor, whereby it initiates downstream osteoblast signalling 
(Fakhry et al., 2013). Osteoblast transition from MSCs occurs over various stages; 
pre-osteoblast, transitory osteoblast, secretory osteoblast, osteocytic osteoblast and 
osteocyte being the terminal form of this lineage. Osteoblast precursors alter their 
phenotypic appearance from spindle-shaped osteoprogenitors to large cuboidal 
differentiated osteoblasts on bone matrix surfaces after pre-osteoblasts stop 
proliferating (Clarke, 2008). Pre-osteoblast, while found near functioning osteoblasts 
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in the bone remodelling unit, are distinguished by their expression of ALP. 
Moreover, mature, active osteoblasts have large nuclei, extensive endoplasmic 
reticulum and enlarged Golgi structures and synthesize type I collagen and other 
matrix proteins including osteocalcin, osteonectin, bone sialoprotein, osteopontin as 
well as proteoglycans (decorin and biglycan) (Clarke, 2008). Following completion 
of matrix formation, osteoblasts can become embedded in bone as osteocytes, 
become inactive osteoblasts or bone lining cells, or undergo apoptosis (Matic et al., 
2016). The proportion of osteoblasts following each fate differs between species, age 
and bone type. In human cancellous bone approximately 65% of osteoblasts undergo 
apoptosis, while only 30% differentiate into osteocytes (Franz-Odendaal et al., 
2006). As mentioned previously, osteoblasts have a close relationship with 
osteoclasts in the maintenance of bone homeostasis, where the bone resorbed by 
osteoclasts is replaced by osteoblasts in a physiologic process called bone 
remodelling (Ducy et al., 2000). This bone remodelling is tightly regulated by local 
autocrine and/or paracrine and endocrine factors, for instance the sexual steroid 
hormones such as estradiol and parathyroid hormone (Ducy et al., 2000). Osteoblasts 
and lining cells are found in close proximity and joined by adherens junctions 
(Clarke, 2008). 
Flattened bone-lining cells are thought to be quiescent osteoblasts that form the 
endosteum on trabecular and endosteal surfaces and underlie the periosteum on the 
mineralized surface, functioning as a source of osteoblasts in addition to modulating 
osteoclast activity (Matic et al., 2016, Clarke, 2008). Furthermore, bone lining cells 
have been described as post-mitotic flat osteoblast lineage cells, which line the bones 
surface and forms an ionic partition between bone and the marrow space (Menton et 
al., 1984). While traditionally believed to be a population of inactive cells, bone 
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lining cells have recently been highlighted as having a role in adult bone formation. 
The speed by which new bone was formed following mechanical stimulation raised 
the question over the capability of MSCs to proliferate and become recruited in such 
a short amount of time, therefore shedding light on the potential for bone formation 
to occur via the reactivation of bone lining cells. In addition to rapid bone formation, 
Chow et al., noted that bone loading resulted in an alteration of morphological 
appearance of the bone lining cells, to those similar to that during osteoblast 
differentiation (Chow et al., 1998). More recently, Matic et al, demonstrated that 
labelled osteoblasts were observed at time points extending beyond the reported 
lifespan for this cell type, suggesting a continuous reactivation of bone lining cells. 
Following ablation of osteoblasts, this study showed that bone lining cells also make 
a major contribution to bone formation, which includes the ability to proliferate 
(Matic et al., 2016). Furthermore, these bone lining cells were shown to be a major 
source of osteoblasts and proliferating pre-osteoblasts and contribute to osteoblasts 
during normal bone turnover in adults (Matic et al., 2016). Therefore, a functional 
network of bone cells that extends from pre-osteoblast bone lining cells to mature 
osteocyte is important for maintaining the integrity of bone as a tissue.  
2.1.2 Stem cells  
There is still a widely held perception that bone marrow mesenchymal stem cells 
(MSCs) represent a phenotypically heterogeneous population of cells. MSCs, 
identified using nestin expression, have been shown to constitute an essential 
haematopoietic stem cell (HSC) niche component and have the ability to 
differentiate to lineages of mesenchymal tissues, including bone, cartilage, fat, 
tendon, muscle, and marrow stroma (Caplan, 1991, Mendez-Ferrer et al., 2010, 
Pittenger et al., 1999). The maintenance of the population of progenitor cells relies 
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heavily on MSCs as 95% of the bone cellular fraction is made up of non-proliferative 
bone cells such as osteocytes and osteoblasts and bone lining cells which possess 
limited proliferative capacity (Frost, 1960, Park et al., 2012, Kfoury and Scadden, 
2015).  
The first isolation of a population of multipotent cells from the bone marrow in 
1968 demonstrated the ability of this cell type to form fibroblastoid colonies (CFU-
F) when cultured on plastic (Friedenstein et al., 1968). Additionally, this study found 
that this population of cells could make bone and reconstitute the hematopoietic 
microenvironment when transplanted subcutaneously. However, debate remains 
around the definition of MSCs. The International Society for Cellular Therapy 
proposed a minimal criterion for defining MSCs, whereby (1) cells must be adherent 
to plastic in culture; (2) presence of CD105, CD73 and CD90 but absence of CD34, 
CD45, CD14 or CD11b, CD79α or CD19, and HLA-DR surface molecules; and (3) 
cells with the capacity to differentiate into osteoblasts, chondrocytes and adipocytes 
in vitro (Kfoury and Scadden, 2015). However, although these criteria are widely 
accepted, they may still be imperfect.  
The marrow is a highly vascularized organ where the medullary vascular 
network, much like the circulatory system of other organs, is lined by a continuous 
layer of endothelial cells and subendothelial pericytes (Bianco et al., 2001). 
Interestingly, it is believed that MSCs can generate a complete heterotopic bone or 
bone marrow organ in vivo including a compartment of perivascular cells with 
similar properties and phenotype as the original cells. Pericytes are cells which 
surround small vessels and have been identified as MSCs, while MSCs were 
determined to be morphologically similar to adventitial reticular cells (ARCs) with 
characteristic long projections and are located near hematopoietic niches such as 
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adjacent to vessel walls, on the endosteal surfaces of trabecular bone, within the 
interfibrillar spaces, or perivascular niches (Bianco et al., 2001, Jones and 
McGonagle, 2008) (Figure 2.3) 
 
Figure 2.3:  Schematic of cellular content of bone marrow depicted by hematopoietic lineage 
(lymphoid, macrophage, osteoclasts, stem cells), bone lineage (osteoprogenitors/stem cells, 
osteoblasts) and others. Image adapted from (Yu and Scadden, 2016). 
 
2.2 Bone Mechanobiology 
Bone is a complex and dynamic tissue, continually adapting and reforming its 
internal structure to meet the demands of its mechanical environment through a 
process referred to as “mechanoadaptation”. The bone mechanoadaptation 
hypothesis was developed by Julius Wolff through his observations of the 
similarities between the predicted stress fields of bone and the architecture of 
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trabeculae and cortical bone. Wolff suggested that the accumulation of mass within 
bone corresponds to the direction of principal stress within the tissue – allowing for 
efficient maximization of bone strength while minimizing bone mass (Wolff, 2010). 
The dynamic mechanically-mediated remodelling of bone is a direct result of the 
competing processes of bone formation (mediated by osteoblasts) and resorption 
(mediated by osteoclasts), believed to be coordinated by the most abundant cell type 
in bone, the osteocyte (Schaffler et al., 2014). Mechanical cues are capable of 
modulating cell differentiation and gene expression, in addition to causing epigenetic 
modifications of the genome (Guo et al., 2018). Elucidation of how these cells sense 
and transduce the mechanical environment of bone (mechanotransduction), 
facilitating this mechanoadaptation of the tissue will provide insight into the etiology 
of disease, tissue maintenance, as well as the potential for the development of novel 
therapeutics (Guo et al., 2018). 
As stated above, the osteocyte is believed to be the master orchestrator of bone 
mechanoadaptation, with ~42 billion osteocytes found throughout the human 
skeleton. Embedded within lacunae, osteocytes extend dendritic processes forming 
~23 trillion connections and are thus ideally positioned to act as a mechanosensory 
network for the tissue (Buenzli and Sims, 2015). In a seminal paper, Tatsumi et al., 
demonstrated that osteocytes play an important role in bone mechanobiology using 
an osteocyte ablation model where mice did not lose bone following hind limb 
suspension (Tatsumi et al., 2007). Loading-induced bending of bone generates 
regions of tension and compression resulting in a pressure difference that drives fluid 
flow through the lacunar-canalicular network applying fluid shear to resident 
osteocytes (Weinbaum et al., 1994, Cowin et al., 1995). Based on in vitro 
comparative analyses, fluid shear is thought to be the predominant form of 
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physiological mechanical stimulation, over that resulting from tissue deformation or 
pressure (Owan et al., 1997).  
Understanding the mechanisms by which osteocytes regulate bone 
mechanoadaptation has proven challenging given their location embedded within a 
mineralized tissue. However in vitro analyses of fluid shear effects on MLO-Y4 
osteocyte-like cells has demonstrated this cell type to be exquisitely 
mechanosensitive, eliciting upregulation in pro-osteogenic factors and down-
regulation of pro-resorptive factors in a magnitude and frequency dependent manner 
(Li et al., 2012, Cheng et al., 2001). These osteocyte derived factors in turn regulate 
osteogenesis and osteolysis via communication with osteoblasts and osteoclasts 
and/or their precursors (Taylor et al., 2007, You et al., 2008, Lau et al., 2010, 
Birmingham et al., 2012, Brady et al., 2015). A number of these secreted factors 
(Sclerostin, RANKL) are now being harnessed as new therapeutics to treat bone loss 
diseases such as osteoporosis. 
In addition to the osteocyte mediated bone mechanoadaptation discussed above, 
the osteocyte ablation mouse model was still capable of forming bone in response to 
loading, demonstrating an osteocyte independent mechanoadaptive response (Kwon 
et al., 2012). This finding is further reinforced by bone explants which undergo 
loading-induced bone formation in the absence of osteocyte signalling (Curtis et al., 
2018). Such mechanoadaptation is likely mediated by direct mechanical stimulation 
of the effector cells, osteoblasts, osteoclasts and/or their precursors.  
Similar to osteocytes, osteoblasts and osteoprogenitors/MSCs are responsive to 
fluid shear (Li et al., 2004, Tjabringa et al.). Different fluid shear regimes such as 
intermittent steady, pulsatile and oscillatory have been shown to have differential 
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effects on osteoblastic activity (Jaasma and O'Brien, 2008). The identification of the 
osteoblast mechanical environment is difficult due to the remodelling of the 
extracellular matrix. For example, the osteoblast microenvironment differs from that 
of the osteocyte microenvironment where osteoblasts are surrounded by soft osteoid 
matrix with bigger porosities than the lacunar-canalicular system, therefore 
osteoblasts would experience different mechanical environment (McGarry et al., 
2005). The in vitro stimulation of osteoblasts with fluid shear has resulted in the 
release of second messengers including nitric oxide, inositol triphosphate, calcium 
ion flux, ATP and cAMP (Liedert et al., 2005, You et al., 2001). Fluid shear has also 
been shown to induce increases in c-fos, cyclooxygenase 2 (Cox2), -Catenin, 
osteopontin (Opn), alkaline phosphatase (ALP) and runt related transcription factor 2 
(Runx2) (Norvell et al., 2004, Pavalko et al., 1998, You et al., 2000). 
In addition to osteocyte ablation models highlighting the role of osteoblasts and 
MSCs in loading-induced osteogenesis, an innovative study using transplanted 
fluorescently tagged MSCs in an ulna loading model found that the fluorescent 
MSCs were detectable within the bone matrix and in the vicinity of active bone 
forming surfaces (Chen et al., 2016). Although, the mechanism by which MSCs 
contribute to bone anabolism is yet to be fully elucidated, in vitro studies have 
highlighted that both indirect paracrine signalling and direct biophysical stimulation 
are at play. The application of strain to the pericellular matrix of MSCs or their 
underlying substrates in vitro, has been shown to lead to deformation of the cellular 
cytoskeleton, playing an important role in MSC mechanotransduction (Ruiz and 
Chen, 2008). The application of strain to MSCs leads to the activation of several 
mechanosensitive structures within the cell; focal adhesions and associated 
molecules, stretch activated ion channels, cytoskeletal reorganization, which in turn 
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activate numerous downstream signalling events such as calcium signalling, MAPK 
activation, release of nitric oxide, and the activation of RhoA and ROCK (Castillo 
and Jacobs, 2010, Castillo and Leucht, 2015, Gurkan and Akkus, 2008). 
Additionally, the application of shear stress to MSCs enhances Cox2, Opn and 
osteocalcin (OCN) gene expression as well as promoting cell proliferation and 
osteogenic differentiation (Tjabringa et al., 2006). Long term studies have also 
demonstrated osteogenic differentiation and the production of a collagenous 
mineralized matrix (Hoey et al., 2012d). Recently, Stavenschi et al., demonstrated a 
relationship between osteogenic gene expression and the magnitude and frequency of 
the oscillatory fluid shear applied to MSCs and that an optimized flow regime based 
off physiological parameters could induce long-term commitment of MSCs to an 
osteogenic lineage. This provides in vitro evidence for an important role for direct 
biophysical regulation of MSC differentiation by the fluid forces experienced by 
MSCs within the marrow space (Stavenschi et al., 2017). While MSCs can directly 
sense their mechanical environment, they are also subject to indirect biophysical 
regulation via osteoblasts and osteocytes, by either cell-cell contact or soluble 
factors. Medium from mechanically stimulated osteocyte cells induced a significant 
increase in ALP activity and osteocalcin gene expression in MSCs. Additionally, 
MSC proliferation and bone formation and was increased 2- and 4-fold, respectively 
(Heino et al., 2004). Further to this MSCs co-cultured with osteocytes deposit more 
calcium and ALP activity peaks earlier, than MSCs co-cultured with osteoblasts, 
suggesting that osteocytes have a more influential role on MSCs than osteoblasts 
(Birmingham et al., 2012).  
Moreover, osteoclasts can sense their mechanical environment and then 
modulate their activity to regulate bone resorption (Kurata et al., 2001). Rubin et al., 
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demonstrated that in vitro culture of murine bone marrow under hydrostatic pressure 
demonstrate reduced osteoclastogenesis (Rubin et al., 1997, Rubin et al., 1999), 
suggesting that in vivo bone loading may directly inhibit the formation of osteoclasts. 
Fluid shear stimulation was also shown to decrease fusion and resorption activity of 
osteoclasts (Kadow-Romacker et al., 2009). These studies demonstrate the potential 
mechanisms for osteocyte independent mechanoadaptation, and thus highlights the 
importance of understanding the mechanobiology of all cells within bone. 
A major challenge facing mechanobiologists is the delineation of the 
mechanisms of mechanotransduction. Deciphering how cells such as osteocytes, 
osteoblasts, osteoclasts and their progenitors sense the mechanical environment of 
bone and relay that information into a coordinated bone forming response is poorly 
understood. Great strides have been taken in identifying cellular mechanosensors 
such as integrins, connexins, cadherins, focal adhesions, cytoskeleton, ion channels, 
and more recently, primary cilia (Luo et al., 2013, Liedert et al., 2005, Singla and 
Reiter, 2006).  
5.3.1 In vivo models of bone mechanobiology  
The use of in vivo models for the study of mechanobiology has become a critical 
step in the assessment of bones to mechanical stimulation and while several species 
and loading models have been developed, most recent studies have been conducted 
in mice using non-invasive axial loading of either the ulna or the tibia. Mouse 
models allow for a better understanding of biomechanical mechanisms in the 
skeleton, where work has been carried out to develop recommended guidelines for 
the systematic evaluation of phenotypic changes, minimal reportable testing 
conditions, and outcome variables which allow for the comparison of multiple 
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studies (Jepsen et al., 2015). The focus of this thesis is on tibia loading, therefore 
ulna loading models will only be discussed briefly.  
The ulna loading model has been used in several studies involving rats and mice 
(McKenzie and Silva, 2011, Mosley and Lanyon, 1998, Torrance et al., 1994, Lee et 
al., 2002). Early work looking at the effect of different loading parameters on rat 
ulnae bone formation carried out by Torrance et al., found that rat ulnae respond best 
to loading at 10Hz, 20N and 10Hz, 15N and that the bone formation was 
proportional to the local surface strain (Torrance et al., 1994). The effect of strain 
rate on the adaptive response of rat ulnae to loading was further investigated by other 
groups. They found that bone was formed through enhanced periosteal bone 
formation on the lateral (tension) cortex, and arrest of resorption, with conversion to 
formation on the medial (compression) surface, highlighting the location dependent 
adaptation to load (Mosley and Lanyon, 1998). More recent work looking at the 
establishment of a loading protocol which just stimulates lamellar bone formation 
revealed loading stimulated woven and lamellar bone formation differently in a rat 
ulna loading model, where loading induced increases in Hist4 and Ccnd1 prior to 
woven bone formation but not in lamellar bone (McKenzie and Silva, 2011). Ulna 
loading resulted in woven bone with marked increases in vascularisation, and 
expression of the bone formation markers Runx2 and osterix compared to loading of 
lamellar bone (McKenzie and Silva, 2011). Studies in mice have resulted in similar 
responses, where loading to peak strains of 2000με stimulated lamellar periosteal 
bone formation, and short daily loading resulted in an osteogenic response related to 
peak strain magnitude (Lee et al., 2002). The development of the ulna loading model 
in mice allows for the assessment of the effects of loading using transgenics.  
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The application of axial tibia loading has been evaluated for its use as a 
mechanobiology model (Sun et al., 2018, Lynch et al., 2011, Brodt and Silva, 2010, 
Fritton et al., 2005, De Souza et al., 2005). There are various parameters which 
influence tibiae response to loading, for example Lynch et al., confirmed that peak 
force or strain magnitude in C57BL/6 mice can alter bones response to loading, 
where the mice did not respond to +1,200µ peak strain, but exhibited an anabolic 
response when loaded to +2,100µ (Lynch et al., 2011). Cortical bone was also 
shown to respond in a magnitude and age-dependant manner (Holguin et al., 2014, 
Brodt and Silva, 2010). The choice of tibia loading protocols can have practical 
implications on ease of implementation. A recent detailed study examining the 
effects of loading parameters on the anabolic response of murine bone to axial tibia 
loading looked at the incidence of woven bone as a function of strain magnitude and 
the effect of parameters related to duration and number of daily loading bouts (Sun et 
al., 2018). This study effectively compared a reference loading protocol that is 
commonly used in murine models with a strain matched novel protocol which 
interestingly produced comparable increases in bone formation, but with fewer daily 
cycles and study duration (Sun et al., 2018). The reference loading protocol was 
based on previous studies from the same group (Holguin et al., 2014, Holguin et al., 
2013). This comprehensive study highlighted the strong influence of peak strain 
magnitude, where a lower threshold of -1,000µ and the occasional induction of 
woven bone at -2,000µ was demonstrated While no effect of daily cycle number, 
or experimental length was found, loading for consecutive days as opposed to 
alternate day loading produced a more robust response (Sun et al., 2018). This study 




Age has also been shown to be an effector in the response of tibia to load. 
Loading for two weeks produced significant load magnitude-related increases in 
cortical bone formation that were similar in mice at 8-, 12- and 20-weeks of age, 
however, the loading protocol increases trabecular bone volume in 8-week old mice, 
but modifies trabecular organization with decreases in trabecular bone volume in 12- 
and 20-week old mice (De Souza et al., 2005). Age related differences in bone 
formation have been well characterised where no effect of loading in 2-month old 
mice was found, but significant increases in osteoblast/matrix genes in 12-month old 
mice (Silva et al., 2012). Moreover, it has been suggested that this difference in bone 
formation between cortical and cancellous bone and age is due to the overload of 
cortical bone during growth, while cancellous bone is somewhat underloaded during 
usual mechanical usage (Iwamoto et al., 1999). It was concluded that cortical bone 
will therefore be increased by adaptation to overload during growth, while 
cancellous bone will be decreased, which is suggestive of cancellous bone being less 
sensitive to mechanical loading (Iwamoto et al., 1999).  
2.3 Mesenchymal Stem Cell contributions to bone  
As discussed in the stem cell section of this literature review, MSCs play a 
crucial role in the formation and adaptation of bone, however, debate remains on 
how to accurately identify MSCs, and to their complete role in vivo. The current 
concept of a MSC is thought to be a cell type that is capable of generating a 
complete heterotopic bone or bone marrow organ in vivo including a compartment of 
perivascular cells with similar properties and phenotype as the original cells (Jones 
and McGonagle, 2008, Kfoury and Scadden, 2015, Chan et al., 2015). This section 
will discuss the isolation of MSCs based on cell surface markers and the use of 
genetically engineered mice to track these cells.  
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2.3.1 Mesenchymal Stem Cell surface markers    
There is no consensus on how to identify MSCs in vivo, and there is 
considerable variability in the frequency, prevalence during different stages of 
development, growth and adulthood, and multilineage potential using different 
markers. The establishment of reliable MSC markers is critical for the identification 
and tracking of MSCs in vivo. Historically, MSCs were identified as plastic-
adherent, colony forming, non-hematopoietic cells, which can differentiate into 
chondrogenic, adipogenic and osteogenic progeny (Zhou et al., 2014, Bianco et al., 
2008). Furthermore, MSCs are often perivascular in vivo, where mouse MSCs are 
characterized by their lack of expression of hematopoietic and erythropoietic 
markers (CD45- and TER-119-), and positive expression of Platelet Derived Growth 
Factor receptor alpha (PDGFRα) (Morikawa et al., 2009, Nakao et al., 2010, Zhou et 
al., 2014). While MSCs can be retrospectively identified based on the above 
parameters, an appropriate method for their prospective identification is lacking, and 
their location and physiological functions in vivo have been elusive.  
In recent years, several markers have been postulated to identify this cell 
population. The best characterized marker in human bone marrow is CD146, which 
labels a perisinusoidal cell population (Chan et al., 2015, Chan et al., 2018). 
Additionally, CD271 was shown to be present in all three germ layers and to label 
stromal cells in adult and fetal bone marrow. Moreover, CD271 positive cells enrich 
for CFU-F in the bone marrow (Chan et al., 2015, Jones et al., 2010). 
 In mice, the cell surface marker CD146 labelled adventitial reticular cells that 
were enriched for CFU-Fs and were able to transfer hematopoietic support in the 
form of heterotopic ossicles, and when cultured had the ability to self-renew, 
therefore identifying CD146-labeled uncultured cells the first specific MSC 
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population (Chan et al., 2015, Kfoury and Scadden, 2015). Consistent with the 
human MSC, CD271 single labelled, and dual labelled CD146+/CD271+ populations 
were capable of serial xenogenic transplantation, whereas CD271 in combination 
with Thy1 and CD106 enrich for clonogenic cells as demonstrated by in vitro-
limiting dilution and single-cell culture assays (Kfoury and Scadden, 2015). Other 
combinations of Sca-1, CD51, PDGFR, CD105, Thy1, Nestin, SMA, have also 
been identified to be multipotent and self-renewing MSCs (Chan et al., 2015). 
Interestingly it has been shown that the subpopulation of CD45/Ter-119+ and Tie2+ 
cells do not form bone, cartilage, or stroma, therefore excluding them as MSCs 
markers, and emphasizing the existence of distinct progenitors of bone, cartilage, and 
stromal tissue (Chan et al., 2015). Furthermore, this study beautifully described the 
ability of CD45+Ter119-Tie2-AlphaV+Thy-6C3-CD105-CD200+ cells to generate 
seven subpopulations in a linear fashion, starting with the pre- bone cartilage and 
stromal progenitor and the bone, cartilage, and stromal progenitor, therefore 
highlighting that the murine MSC is produced in a hierarchical fashion of 
increasingly fate limited progenitors (Chan et al., 2015). 
Leptin Receptor positive (LepR+) cells were identified as being perivascular and 
a major source of the stem cell fraction (Scf) within bone marrow (Zhou et al., 2014, 
Ding et al., 2012, Ding and Morrison, 2013). Additionally, these LepR+ cells were 
found to express the bone marrow MSC markers PDGFRα, and CD51 and to be 
highly enriched for fibroblast colony-forming units (CFU-F), and analyses indicated 
that LepR+ cells in the bone marrow largely overlap with Nestin, an intermediate 
filament protein that is known as a neural stem/progenitor cell marker in adult bone 
marrow (Zhou et al., 2014, Mizoguchi et al., 2014). LepR+ cells overlap with the 
transcription coactivator that is expressed during early limb bud mesoderm 
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development, Paired related homeobox 1 (PRX1) (Kfoury and Scadden, 2015). 
LepR+ cells not only express MSC markers, but were shown to be functional, in that 
they were the main source of new osteoblasts and adipocytes in adult bone marrow 
and could form bony ossicles that support haematopoiesis in vivo (Zhou et al., 2014).  
2.3.2 In vivo models for Mesenchymal Stem Cell tracking 
The presence of multipotent MSCs, mainly established by in vitro studies, has 
recently been challenged by experiments using lineage tracing in murine models. 
The labelling of different mesenchymal populations and specific ablation and knock-
in models allowed for the study of developmental origin and relative contribution of 
the cell populations to tissue maintenance and regeneration. Reporters and Cre 
recombinase expression, under the control of regulatory elements of genes known to 
be essential in the regulation of skeletal and mesenchymal lineages have been 
developed (Kfoury and Scadden, 2015). The in vivo models discussed in this section 
are summarised in Table 2.1.  
The chemokine attractant and ligand for the Chemokine receptor 4, Chemokine 
(C-X-C motif) ligand 12 (CXCL12), has been demonstrated to play a role in 
hematopoiesis at primitive and mature levels. Using a knockin model, the CXCL12-
GFP mouse, reticular cells within the intra-trabecular space of bone marrow had the 
strongest expression of GFP in comparison to endothelial cells and osteoblasts lining 
the endosteal surface, resulting in the naming of these cells as CXCL12 Abundant 
Reticular (CAR) cells (Kfoury and Scadden, 2015). This population of cells were 
also found to produce stem cell fraction and co-label to VCAM1, CD44, CD51, 
PDGFR, and PDGFR and can differentiate down the osteo- and adipogenic 
lineages.   
34 
 
One of the more widely used and first to be thoroughly investigated MSC mouse 
models is the Nestin-GFP transgenic mouse, which expresses GFP under the control 
of the 1.8 kb fragment of the Nestin gene that contains the second intron (Mendez-
Ferrer et al., 2015, Kfoury and Scadden, 2015, Mendez-Ferrer et al., 2010). 
Interestingly, Nestin-GFP labelled non-hematopoietic stromal cells with a 
perivascular distribution and following enzymatical digestion of the bone marrow, 
were clonogenic, formed mesenspheres and had a robust capability for self-renewal 
(Kfoury and Scadden, 2015). Furthermore, they were multipotent, and could undergo 
tri-lineage commitment. Two distinct populations of Nestin-GFP cells have been 
identified, Nestin-GFP bright and Nestin-GFP dim. Nestin-GFP bright cells localised 
around arterioles, contained CFU-F activity, however were rare and did not have any 
LepR labelling, while in contrast Nestin-GFP dim cells were more abundant, largely 
associated with sinusoids, reticular in shape and labelled strongly with LepR (Kfoury 
and Scadden, 2015, Mendez-Ferrer et al., 2015). Furthermore, Nestin-GFP cells were 
found to descend from collagen II (Col-II) expressing cells, a known marker for 
chondrocytes and chondro-progenitors, hence making it a potential marker of 
multipotent MSCs. 
Mx-1 Cre-recombinase labelled cells were also found to overlap with the Nestin-
GFP transgene, and a population of non-hematopoietic, non-endothelial osteogenic 
cells in the bone. Additionally, Mx-1 cells overlap with MSC markers such as 
CD140a, CD105, and Sca-1, and have CFU-F capabilities (Kfoury and Scadden, 
2015). Mx1-Cre transgene was shown to label osterix-, osteopontin-, and 
osteocalcin-expressing cells which contributed to the repair of fracture injury as 
endogenous cells or when transplanted.  
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Prx1 has already been discussed to be a transcription coactivator in most cells 
derived from the lateral plate mesoderm, most notably LepR+ cells. An overlap in 
expression with PDGFR- and Sca1, CFU-F activity and tri-lineage commitment 
activity have been demonstrated in the mouse model (Greenbaum et al., 2013).  
Gli1-CreERT2 positive cells have been found to reside perivascularly, where 
they act as mesenchymal stem cells and contribute to the production of osteoblasts in 
both endochondral and intramembranous bones, and contribute to chondrocyte and 
osteoblast production during bone fracture healing (Shi et al., 2017). Interestingly, 
Gli1+ cells below the growth plate were shown to be a likely contributor of Leptin 
receptor expressing cells in adult mice. Furthermore, Gli1+ cells were shown to 
express the MSC markers CD44, CD106/Vcam1, and CD146/Mcam (Shi et al., 
2017).  
Gremlin1, the BMP antagonist, does not overlap with Nestin-GFP, but is a self-
renewing population with the restricted ability to undergo osteo-, chondro- and 
reticular marrow stromal cell differentiation (Kfoury and Scadden, 2015). Gremlin1-
CreERT2 labelled cells give rise to osteo-chondro and reticular progenitors (OCR), 
while Mx1-Cre labels lineage-restricted osteoprogenitors. These markers and others 
which label mesenchymal progenitor cells such as -smooth muscle actin and Leptin 
receptor (Lepr-Cre), label cells that contribute to a proportion of the osteoblasts on 
the bone surface, but not the entire lineage (Matic et al., 2016).  
Leptin receptor has also been used in vivo to define primitive MSCs in adult 
bone marrow, where they have a multi-potent durable repopulating ability in vivo 
(Zhou et al., 2014). This study noted that Lepr-Cre; tdTomato positive cells only 
appear on E17.5 as a rare population and then appear to expand and become the 
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source of the majority of osteolineage cells at post-natal stages (Zhou et al., 2014). 
Lepr-Cre; tdTomato cells overlap with the endogenous markers PDGFR, CD51, 
CD105, and PDGFR. Moreover, they also overlap with the genetically labelled 
populations of Cxcl12-DSred and Nestin-GFP dim mice (Zhou et al., 2014, Ding et 
al., 2012, Mizoguchi et al., 2014). LepR+ cells not only express MSC markers, but 
were shown to be functional, in that they were the main source of new osteoblasts 
and adipocytes in adult bone marrow and could form bony ossicles that support 
haematopoiesis in vivo (Zhou et al., 2014). This study reported that the Lepr-Cre; 
tdTomato positive cells increased from 10 to 81% of Col2.3-GFP+ osteoblastic cells 
at 14 months of age, and that the increase found was not due to the induced 
expression of LepR at this age, but rather the differentiation of LepR cells overtime 
(Zhou et al., 2014). Furthermore, work on 15-week old mice showed that Nes-
Gfp/Lepr-Cre/Tomato cells in the bone tissue were osteocalcin- and dentin matrix 
protein 1 (DMP1)-expressing mature osteoblasts and osteocytes, respectively 
(Mizoguchi et al., 2014). Importantly, LepR mRNA was not detectable by 
quantitative real-time PCR in the osteoblasts, suggesting that LepR+ mature 
osteolineage cells do not autonomously express LepR, but are descendant of LepR+ 
precursors (Mizoguchi et al., 2014). 
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2.4 Mesenchymal Stem Cell Mechanotransduction  
2.4.1 Second messenger signalling  
Secondary messengers are one of the initiating biochemical components of 
intracellular signalling cascades triggered by a biophysical stimulus, for example 
Ca2+, cAMP, cGMP, IP3 and DAG. Ca
2+ has been the predominate 2nd messenger 
studied in response to fluid shear, where rapid fluxes in intracellular Ca2+ following 
OFS result in downstream transcriptional activity in bone cells (Hung et al., 1995, 
Lewis et al., 2017, Lyons et al., 2017). Moreover, human mesenchymal stem cells 
have demonstrated intracellular calcium increases following fluid shear that are 
required for downstream osteogenic gene expression (Liu et al., 2015, Corrigan et 
al., 2018). 
2.4.1.1 Calcium signalling  
Intracellular calcium has been the predominate 2nd messenger studied in cellular 
responses and the most tightly regulated. Calcium binds to thousands of proteins to 
effect changes in localization, association, and function (Clapham, 2007). Rapid 
fluxes in intracellular Ca2+ following OFS result in downstream transcriptional 
activity in bone cells (Lee et al., 2015, Corrigan et al., 2018). Utilizing advanced 
genetically encoded calcium indicators, Lee et al., has demonstrated that calcium 
signalling and particularly ciliary calcium levels are increased in response to fluid 
shear (Jin et al., 2014, Lee et al., 2015) and that this calcium signalling was required 
for loading induced increases in osteogenic signalling. Mechanosensitive calcium ion 
channel transient receptor potential vanilloid 4 (TRPV4) was shown to be involved 
in mechanotransduction, with the percentage of osteocytes responding to mechanical 
stimulation being reduced and the increases in ciliary Ca2+ and osteogenic gene 
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expression following flow being lost in TRPV4 deficient osteocytes (Lee et al., 
2015). As seen in osteocytes (Lee et al., 2015), TRPV4 has been identified as 
playing a major role in the MSC mechanotransduction (Corrigan et al., 2018). 
Recently, it was shown that TRPV4 is required for fluid shear induced calcium 
signalling and downstream osteogenic differentiation of MSCs (Corrigan et al., 
2018). A study in human MSCs showed that TRPV4 was required for Ca2+ 
oscillations during the initial stages of collagen matrix assembly. Furthermore, the 
inhibition of TRPV4 decreased collagen fibril assembly (Gilchrist et al., 2019).  
2.4.1.2 Cyclic adenosine monophosphate   
An alternative 2nd messenger utilized in mechanotransduction is cAMP which is 
known to regulate numerous physiologic processes, including cell proliferation, 
neuronal signalling, and intermediary metabolism (Montminy, 1997). There are three 
known types of cAMP effector proteins: protein kinase A (PKA), exchange proteins 
activated by cAMP (EPACs), and cyclic nucleotide gated ion channels (CNGs and 
HCNs). This second messenger is generated by adenylyl cyclase’s (Kamenetsky et 
al., 2006).  
In bone, osteocytes respond to oscillatory fluid shear in a biphasic manner, 
where cAMP levels decrease after 2 mins of stimulation and increase after 30 mins 
of stimulation. Interestingly this decrease in cAMP signalling was abrogated when 
primary cilia function was inhibited, implicating cAMP as another 2nd messenger 
utilized by the primary cilium during mechanotransduction in osteocytes (Masyuk et 
al., 2006, Kwon et al., 2010) and is consistent with findings in cholangiocytes in 
response to fluid flow (Masyuk et al., 2006). In contrast to osteocytes, cAMP 
signalling has been shown to increase in a magnitude and time dependent manner in 
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rat calvarial osteoblasts (Reich et al., 1990), indicating that cAMP is 
mechanoresponsive and plays a role as an important 2nd messenger in this cell type. 
A recent study in human MSCs demonstrated that activation of cAMP signalling 
augmented MSC osteogenesis in an ectopic bone formation model in immune-
deficient mice (Siddappa et al., 2008), indicating that MSCs may too utilize cAMP 
as a potential pre-osteogenic signal, however the role of cAMP as a 2nd messenger in 
MSC mechanotransduction is not known.  
2.4.2 Mesenchymal stem cell mechanosensors 
Mechanotransduction is defined as a cell’s responsivity to mechanical stimuli 
and how these are converted into biochemical signals, which in turn elicit specific 
cellular responses (Luo et al., 2013). Mechanotransduction is mediated via multiple 
mechanosensitive organelles including; the cell cytoskeleton including primary cilia, 
cell-matrix adhesion proteins (integrins), alterations in ion channel activity, 
connexins, MAPK, nitric oxide and calcium signalling and mechanically activated 
intracellular signalling systems (GPCRs). Interestingly, the primary cilium has 
recently emerged as an important contributor of MSC mechanotransduction (Luo et 
al., 2013, Singla and Reiter, 2006, Hoey et al., 2012b). 
2.4.2.1 Primary Cilia 
The primary cilium is a membrane bound cellular organelle that extends from 
the cytoplasm into the extracellular milieu (Figure 2.4). It contains an array of 
structural elements which work together to maintain the physical integrity of the 
organelle. The components of the primary cilia can be divided into two 
compartments; ciliary (axoneme) and sub-ciliary (cytoplasmic) (Hoey et al., 2012). 
The axoneme consists of a circumferential array of nine microtubule doublets which 
extend from the mother centriole/basal body forming a hollow cylindrical core 
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structure along the ciliary compartment. The ciliary membrane is a continuation of 
the plasma membrane and forms the outer surface of the ciliary compartment. At the 
neck of the cilium, a complex of intra-membrane structures forms a region of the 
cilia known as the ciliary necklace or transition zone which is located on the border 
of the ciliary and sub-ciliary compartments (Gilula and Satir, 1972). The necklace 
consists of strands of membrane particles, arranged in rows wrapping around the 
ciliary shaft and connected to the microtubule doublets. In addition to its role in the 
maintenance of the structural stability of the primary cilium, the basal body and 
associated fibres are also regulating protein entry and exit from the cilia 
compartment and onto the ciliary membrane (Berbari et al., 2009). 
Figure 2.4: Structure and organization of the primary cilium. Left: Schematic representation of a 
primary cilium and its organization. Right: XZ bending profiles of a kidney cell primary cilium under 
increasing flow rates. Adapted from Hoey et al. (2012). 
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Discovered initially in Chlamydomonas flagella, intraflagellar transport (IFT) 
plays a crucial role in the assembly and maintenance of primary cilia (Rosenbaum 
and Witman, 2002). Since protein synthesis machinery is absent from cilia and 
because of the continuous turnover of the axoneme at its distal tip, maintenance of 
cilia relies on the delivery of protein from the cell cytoplasm to the ciliary tip via 
intraflagellar transport of protein complexes along the microtubules (Pedersen and 
Rosenbaum, 2008). Anterograde (from the base to the tip) transport involves the 
formation of heteromeric complexes of motor proteins belonging to the kinesin 2 
family (KIF3A and KIF3B) and retrograde (from tip to base of the cilia) relies on 
motor protein complexes formed by dynein 2 protein family (DYNC2 proteins) to 
carry IFT particles along the cilium. These mechanisms have been described in detail 
by Pedersen et al., and Scholey et al. (Pedersen and Rosenbaum, 2008, Scholey, 
2003). Ift88, also referred to as Tg737 or Polaris, is a tetricopeptide repeat-
containing protein and a central part of the Ift complex B, which, as mentioned is 
transported by kinesin in the anterograde direction and is essential for the formation 
of the primary cilium. A global Ift88/Tg737/Rpw (ORPK) model which has 
continued expression of alternatively spliced transcripts and low levels of Ift88, was 
created using a transgene insertion-induced hypomorphic allele of Ift88, which 
resulted in a partial loss of gene function, allowing for the homozygous mutant mice 
to survive postnatally (Yuan and Yang, 2015). Several phenotypic abnormalities 
including; severe growth retardation, cystic renal phenotype, scruffy hair, preaxial 
polydactyly in all limbs, additionally defects in skeletal patterning and growth, along 
with craniofacial abnormalities, unfused tibia and fibula and cleft palate are observed 
in this model (Zhang et al., 2003). An attenuated chemotactic response towards 
platelet-derived growth factor  (PDGF-) was also observed.  
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Numerous studies have demonstrated a critical role for the primary cilium in 
organ development, physiology (Fry et al., 2014), and in disease (Liu et al., 2018), 
where the cilium contributes to mechanosensing/transduction, 
chemosensing/transduction and also as a cellular signalling centre regulating key 
pathways such as Hedgehog signalling (Singla and Reiter, 2006). While cilia have 
more recently demonstrated roles in the regulation of cell behaviour in tissues such 
as the liver, brain, retina, endothelium, and cartilage (Guemez-Gamboa et al., 2014, 
Luu et al., 2018, Mansini et al., 2018, Satir et al., 2010), their function has been best 
studied in the kidney. Kidney primary cilia extend in the lumen of the nephron and 
deflect under flow conditions, which is required for tissue homeostasis as defects in 
the cilium results in polycystic kidney disease (Praetorius and Spring, 2003). 
Primary cilia have also been shown to exist in bone, where osteocytes, 
osteoblasts and bone MSCs extend a primary cilium, both in vitro and in vivo (5). 
Studies in vitro have reported that approximately 60% of osteocytes and osteoblasts 
possess a primary cilium, with a length between 4 to 9μm (Malone et al., 2007, Xiao 
et al., 2006). In vitro, primary cilia were reported in 69 to 86% of MSCs isolated 
from mouse and human bone marrow, respectively, with cilia length between 0.4 to 
8.1μm (Brown et al., 2014, Hoey et al., 2012b) However, very few studies have 
looked at cilia incidence in vivo. Only 4% cilia incidence was observed in the 
osteocytes of ovine cervical vertebrae and mouse femurs (Tonna and Lampen, 1972, 
Coughlin et al., 2015). Coughlin et al., reported a cilia incidence of 0.9 to 1.5% in 
ovine trabecular bone marrow. However, a study by Uzbekov et al., reported a cilia 
incidence of 94% in osteocytes of rat tibia (Uzbekov et al., 2012). This disparity 
between the different studies is likely due to differences in analysis techniques and in 
criteria used to define the primary cilium. Coughlin et al., quantified only cilia 
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longer than 1μm. Furthermore, differences between in vitro and in vivo studies are 
likely due to cell culture techniques. In vitro experiments are often performed in 
serum starved medium to stop proliferation, therefore increasing ciliogenesis. No 
published data has shown the presence of primary cilia in osteoclasts, however 
emerging data suggests that osteoclasts may also possess primary cilia (Deepak and 
Yang, 2018). 
A collection of elegant studies investigating the role of the primary cilium in 
MSC mechanotransduction which have highlighted the pivotal role primary cilia 
play in mechanosensing and transduction have recently been conducted. Briefly, as 
the role of the primary cilium in MSC mechanotransduction is discussed in greater 
detail in the following sections, mechanical signals have been shown to promote 
osteogenesis of MSCs via primary cilia (Chen et al., 2016, Delaine-Smith and Reilly, 
2012, Chen and Jacobs, 2013). Mechanically activated signalling in hMSCs was 
shown to be primary cilia dependent, where ablation of the primary cilium resulted 
in loss of the fluid flow induced COX2 and BMP2 gene expression (Hoey et al., 






Figure 2.5: Bone cells and primary cilium. (A) Histological image of cortical bone at the diaphysis of 
a mouse femur. Immunostaining of osteoblasts like cells MC3T3 (B), osteocytes like cells MLO-Y4 
(C) and human skeletal stem cells (D), all stained with acetylated α-tubulin to label the primary cilium 
(red), DAPI to label nuclei (blue), and CEP135 or pericentrin to label the centrosome (green, B and 
C). (E) Percentage of ciliated cells in bone cells, both in vitro and in vivo. A: Scale bar represents 
200µm. B, C and D: scale bar represent 5µm. B and C: Adapted from Malone et al. 2007, Copyright 




2.4.2.2 Integrins  
Integrins are a family of heterodimeric transmembrane glycoproteins 
consisting of noncovalently associated  and  subunits known to mediate cell-
cell and cell-matrix interactions (Albelda and Buck, 1990, Hughes et al., 1993). 
Integrins facilitate increased cytoskeletal interaction and provide binding sites for 
a multitude of effectors, activating key mechano-signalling pathways. Intracellular 
signals can activate integrins, inducing a conformational change which promotes 
high-affinity extracellular ligand binding, while integrins which bind to proteins 
of the extracellular matrix initiate integrin clustering, cell adhesion and 
intracellular signalling (Marie, 2013). This integrin clustering results in actin-
binding intracellular ligands to the cytoplasmic tails of integrins, such as paxillin, 
vinculin, talin and -actinin, in addition to activating signalling proteins such as 
focal adhesion kinase, Rac, Rho and integrin-linked protein kinase (Marie, 2013).  
Integrins have been shown to contribute to mechanotransduction mechanisms 
involved in MSC osteogenesis. Work has shown that increasing the expression of 
α5β1 resulted in an activation of the FAK-ERK pathway, with enhanced expression 
and activity of Runx2. Additionally, α4β1 is expressed in MSCs undergoing 
osteoblastic differentiation, and can be targeted by a peptidomimetic–bisphosphonate 
complex to improve recruitment of MSCs to bone, and for promoting their 
subsequent differentiation into osteoblasts. Moreover, fluid shear over MSCs was 
shown to induce focal adhesion kinase and an ERK1/2 signalling response, where 
the associated osteogenic pathways were dependent on 1 integrin (Liu et al., 2014). 
Approaches that target α4β1, α5β1, or β1 integrins in general may lead to the 
development of novel strategies to increase bone formation in age-related bone loss 
and promote repair of non-healing fractures in humans (Marie, 2013).  
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2.4.2.3 G-protein coupled receptors 
G-protein-coupled receptors (GPCRs) are the largest group of membrane 
receptors and mediate most cellular responses in bone. They are characterized by 
their ability to couple to catalytic heterotrimeric G-proteins, which through 
phosphorylation on serine/threonine residues, activate intracellular signalling 
cascades (Rosenbaum et al., 2009). All GPCRs are characterized by the presence of 
seven membrane spanning (7TM) α-helical segments separated by alternating 
intracellular and extracellular loop regions (Rosenbaum et al., 2009). Heterotrimeric 
G proteins consist of G, , and  subunits, and during ligand activation of a GPCR, 
G is activated by exchange of GDP for GTP that induces the dissociation of Gα 
from G and allows all subunits to engage in activities of downstream effectors. 
The plethora of GPCR ligands or mechanical stimulation act on their respective 
GPCRs where they converge to activate an amazingly small number of second 
messengers including cAMP, cGMP, Ca2+, IP3 and DAG, which translate the 
extracellular signal to a large variety of intracellular physiological responses (Tuteja, 
2009, Chachisvilis et al., 2006).  
Signalling through stimulatory G-proteins (Gsα) activate adenylyl cyclase’s 
(ACs) which in turn initiates the cAMP pathway (Figure 2.6) (Chen et al., 1997). 
Taking the human β2AR as an example, the binding of adrenaline and noradrenaline 
to cells in the target tissues of sympathetic neurotransmission leads to the activation 
of the stimulatory subunit of the heterotrimeric G protein (Gsα), the stimulation of 
adenylyl cyclase, the accumulation of cAMP, the activation of cAMP-dependent 
PKA, and the phosphorylation of proteins involved in muscle-cell contraction. 
Moreover, many important calciotrophic hormones including PTH and calcitonin, 
and local effectors such as parathyroid hormone-related protein (PTHrP), ATP, and 
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prostaglandins initiate profound autocrine and paracrine events through the 
activation of GPCRs. As such this family of receptors provide the most promising 
targets for pharmacological intervention in diseases of bone loss including 
osteoporosis (Bowler et al., 1998). 
Three families of GPCRs have been shown to be present in MSCs, Sphingosine-
1-phosphate (S1P), lysophosphotidic acid (LPA) and prostaglandin receptors (EP1-4) 
(Doze and Perez, 2013). S1P and LPA play a role in stem cell recruitment and 
differentiation, while both have also been shown to inhibit MSC migration in 
humans but stimulate migration in mice. Interestingly, S1P is required for the 
differentiation of MSCs into smooth muscle cells, where a knockout of S1P results 
in a lack of vascular maturation caused by a deficiency of MSC-derived-vascular 
smooth muscle cells and pericytes (Doze and Perez, 2013). LPA also stimulates 
migration of osteoblast precursors through ERK phosphorylation. Prostaglandins are 
lipids of the eicosanoid family and act through receptor isoforms EP1–4. 
Prostaglandins function in MSC survival through the binding of its receptor EP4 and 
has antiapoptotic effect on MSCs that correlates with intracellular S1P synthesis 




Figure 2.6:  Dynamics of GPCR and AC interactions and downstream signalling. 
2.5The Primary Cilium 
2.5.1 Primary cilium function in the skeleton 
The role of primary cilia in postnatal bone physiology and mechanobiology is 
poorly understood. Using transgenic murine models, researchers can now target 
ciliary genes in a cell type or tissue specific manner, enabling the study of primary 
cilia in postnatal bone. This has facilitated the in vivo study of ciliary function in 
osteocytes, osteoblasts and MSCs detailed below.  
2.5.1.1 Osteocyte 
The Dentin matrix protein1 (Dmp1) is an acidic phosphoprotein utilized as a 
marker of osteocytes in vivo. The generation of the Dmp1-Cre transgenic mouse has 
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opened the door to the study of the role of specific genes in the osteocyte population 
using cre-lox recombination (Canalis et al., 2013). A preliminary study presented at 
the Orthopedic Research Society (Nguyen and Jacobs, 2014) detailed the 
establishment of a mouse model of an osteocyte specific primary cilia deletion 
through the cross of a Dmp1-Cre and Ift88fl/null mouse. Interestingly, these 
conditional knockout mice were normal at birth and throughout development, 
showing no signs of a skeletal phenotype up to 16weeks of age. Therefore, the 
osteocyte primary cilium may not be required for postnatal skeletal development. To 
determine the role of the osteocyte primary cilium in bone mechanobiology, this 
conditional knockout mouse was subjected to axial compressive loading at 16 weeks 
and bone formation was compared to non-loaded internal limb and to a control 
animal. The Dmp1-Cre;Ift88fl/null mouse responded to loading with a significant 
increase in bone formation rate, although when compared to control animals, this 
increase was significantly reduced by 47%. This data therefore highlights a critical 
role for osteocyte primary cilia in bone mechanobiology. 
2.5.1.2 Osteoblast 
Col1α1*2.3-Cre and Oc-Cre (osteocalcin) mouse lines are available to generate 
a conditional deletion of genes of interest in osteoblast progenitors and mature 
osteoblasts, respectively (Yuan and Yang, 2015). These have been used to generate a 
deletion of the primary cilium in osteoblast cells by crossing with a Kif3afl/fl mice to 
generate Col1α1*2.3-Cre;Kif3afl/fl and Oc-Cre;Kif3afl/fl mouse models. Similar to the 
Dmp1-Cre;Ift88fl/null, the Col1α1*2.3-Cre;Kif3afl/fl mouse did not present with any 
alterations in skeletal morphology in embryonic or skeletally mature mice, which is 
suggestive that primary cilia in osteoblasts do not play a role in skeletal development 
(Temiyasathit et al., 2012). The Oc-Cre;Kif3afl/fl model targets the osteocalcin 
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expressing mature osteoblast which synthesizes new bone (Qiu et al., 2012). Further 
investigation is required to have a better understanding of the mechanisms involved 
in these observations. Moreover, Yuan et al., evaluated the effect of a targeted 
deletion of Ift80 in osteoblast precursor cells using an osterix conditional deletion. 
Osx-Cre;Ift80fl/fl mice have a significantly decreased bone mass due to impaired 
osteoblast differentiation (Kaku and Komatsu, 2017). This collection of studies 
provides strong evidence for a role for the early/mature osteoblast primary cilium in 
postnatal skeletal development.  
Regarding the role for the osteoblast primary cilium in bone mechanobiology, 
the Col1α1*2.3-Cre;Kif3afl/fl mouse was subjected to axial compressive ulnar 
loading as in the case of the Dmp1-Cre;Ift88fl/null mouse. Similarly, the Col1α1*2.3-
Cre;Kif3afl/fl responded to loading with enhanced bone formation rates, but the rate 
was significantly inhibited when compared to control animals. (Temiyasathit et al., 
2012). Moreover, osteoblasts were isolated from the Oc-Cre;Kif3afl/fl model and 
were found to have inhibited calcium signalling and osteogenic gene expression in 
response to fluid shear (Qiu et al., 2012). It is worth noting that a deletion of the 
primary cilium utilizing the Col1α1*2.3-Cre or Oc-Cre will also result in a deletion 
in their progeny, i.e. the osteocyte. Therefore, abnormalities in response to loading 
may be as a result of altered osteocyte mechanotransduction as demonstrated in the 
Dmp1-Cre;Ift88fl/null mouse (Qiu et al., 2012).  
2.5.1.3 Mesenchymal stem cells 
Numerous studies have highlighted markers that can be used to target stem cell 
populations at different stages of differentiation (Chen et al., 2018). Various mouse 
models have been developed to investigate these markers in skeletal homeostasis. 
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The identification of paired related homeobox 1 (Prx1) as a regulator of skeletal 
development in the limb bud and the development of Prx1-Cre mice has allowed for 
the study of the primary cilium in the developing limb bud and in osteochondral 
progenitor cell population (Logan et al., 2002). Haycraft et al., used this model to 
develop Prx1-Cre;Ift88flox/null mice, which present with severe defects in embryonic 
skeletal development with polydactyly, shortened limbs and a defect in endochondral 
bone formation (Haycraft et al., 2007). Recently, Moore et al., used Prx1 to target 
periosteal stem cells using a Prx1-Cre inducible model (Prx1-CreER). This allowed 
for the deletion of primary cilia only in cells expressing Prx1 following tamoxifen 
injection. The use of an inducible knockout allows the mice to fully develop, 
facilitating the study of MSC primary cilia in postnatal development. Using Prx1-
CreER-GFP;Ift88flox/flox they demonstrated that by inducing primary cilia deletion at 
P7 or P17, that primary cilia in Prx1-expressing cells are important for the 
population of the growth plate. Furthermore, mice lacking primary cilia in these cells 
have stunted intramembranous ossification (Moore et al., 2018). Effects of Kif3a 
deletion have been evaluated in a similar model. Conditional deletion of Kif3a in 
Prx1-expressing cells with Prx1-Cre;Kif3aflox/null mice results in similar observations 
found with Ift88 deletion using the Prx1-Cre;Ift88flox/null mice (Haycraft et al., 2007). 
These studies highlight the role of the MSC primary cilium in postnatal skeletal 
development. 
To investigate the role of the MSC primary cilium in bone mechanobiology, 
Chen et al. generated a chimeric animal whereby bone marrow harvested from 
Kif3afl/fl;GFP;Cre-ERT2 mice was transplanted into lethally irradiated wild-type mice 
(Chen et al., 2016). Upon engraftment, tamoxifen injection resulted in the deletion of 
Kif3a and thus ciliogenesis in all transplanted bone marrow cells, including MSCs. 
53 
 
Subjecting this animal to ulna compressive loading resulted in a decrease in 
mineralizing surface and bone formation rates (Chen et al., 2016), demonstrating a 
role for the MSC primary cilium in loading-induced bone formation. 
2.6 Cilia Mechanobiology/Mechanotransduction  
While in vivo models give us great insight into the importance of primary cilia in 
bone, in vitro experimentation is still required to help identify the specific functions 
of the primary cilium and elucidate the molecular mechanisms that govern these 
functions. As mentioned previously, the primary cilium has demonstrated both a role 
in mechanosensing/transduction and chemosensing/transduction in many cell types 
and tissues throughout the body. This section will focus on these specific roles for 
the primary cilia in bone cells including MSCs and discuss what is known about the 
mechanisms mediating these functions in bone.  
Similar to mature bone cells, MSCs have also been shown to mediate 
mechanotransduction in a primary cilium dependent manner. Human MSCs with 
reduced ciliogenesis, following treatment with siRNA targeting IFT88, demonstrate 
inhibited osteogenic signalling in response to oscillatory fluid shear (Hoey et al., 
2012b). Ca2+ has been demonstrated as an important 2nd messenger in MSC 









2.6.1 Transient receptor potential vanilloid 4 
Transient receptor potential vanilloid 4 (TRPV4) is an osmo- and 
mechanosensitive cation channel that has been linked to several skeletal dysplasia’s, 
such as spondylometaphyseal dysplasia (Leddy et al., 2014) and has been previously 
found in areas of high strain, such as focal adhesions and the primary cilium in 
chondrocytes (Phan et al., 2009). Interestingly, TRPV4 was also shown to localize to 
the primary cilium of MSCs (Corrigan et al., 2018). TRPV4 could be targeted 
pharmacologically via the specific agonist GSK101 which elicited a similar calcium 
and osteogenic response to loading. Moreover, GSK101 activation of TRPV4 in 
MSCs with defective primary cilium resulted in an inhibition of specific osteogenic 
gene expression, demonstrating a partial role in cilia-mediated osteogenic signalling 
(Corrigan et al., 2018). Collectively these studies show that Ca2+ signalling, via 
TRPV4 is an important mechanism in cilia-mediated osteocyte mechanotransduction 
in MSCs (Figure 2.7A). 
Figure 2.7: The primary cilium as a mechanotransducer in osteocytes. (A) Primary cilium and 
calcium signalling. Fluid flow induces the opening of stretch activated calcium channels TRPV4, 
localised in the osteocyte primary cilia. The entry of calcium ions into the cilium and then the cytosol 
induces the release of calcium from intracellular storage (endoplasmic reticulum) and trigger a 
downstream osteogenic response. (B) Primary cilium and cAMP signalling. Application of fluid flow 
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activates adenylyl cyclases 6 (AC6) which lead to the conversion of ATP in cAMP, which then 
trigger the osteogenic response.  
2.6.2 Adenylyl cyclase’s  
Cyclic AMP is universally generated by adenylyl cyclases, a family of enzymes 
that catalyze the cyclization of ATP into cAMP (Kamenetsky et al., 2006).  Adenylyl 
cyclase’s comprise of a family of nine distinct transmembrane isoforms (AC1-AC9), 
where each of the transmembrane ACs have individual regulatory properties, and the 
nine subtypes are expressed in only a limited number of tissues (Hanoune and Defer, 
2001, Defer et al., 2000). Each AC consists of two hydrophobic domains (with 6 
transmembrane spans) and of two cytoplasmic domains, resulting in a pseudo-
symmetrical protein, where the protein complex has a higher global structural 
symmetry than expected by sequence (Defer et al., 2000). The catalytic sites on the 
cytoplasmic domains are subject to intracellular regulation, specific to each subtype 
(Defer et al., 2000). 
Stimulation by heterotrimeric G proteins upon activation of GPCRs by 
extracellular hormones and neurotransmitters is the major mechanism by which ACs 
are activated and the cAMP level is elevated (Steegborn, 2014). In particular the 
catalytic activity, as well as the sites for interaction with forskolin (FSK) and 
stimulatory G protein, α subunit (Gs), requires both cytoplasmic moieties (Defer et 
al., 2000). In addition to their ability to respond to Gs and to FSK, the different 
isoforms can receive signals from a variety of sources, including other G proteins, 
e.g. Gi (AC inhibition) and G (G inhibition), protein kinases (PKA, PKC, and 
calmodulin (CaM) kinase), phosphatases (calcineurin), calcium, and Ca2+/CaM, and 
these isoforms are able to support and integrate differential regulatory pathways 
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through cross-talk with other signal transduction systems (Hanoune and Defer, 
2001).  
All AC activities are inhibited by high, non-physiological concentrations of Ca2+ 
in the sub-millimolar range, possibly by competition with magnesium. In certain 
tissues, including the pituitary gland, platelets, and heart, AC activity has been 
reported to be inhibited by concentrations of Ca2+ in the micromolar range (Defer et 
al., 2000). 
2.6.2.1  Adenylyl cyclase 6  
 While activated via Gs and FSK, AC6 is calcium-inhibitable at the micro-
molar and sub-micro-molar range and inhibited by Gi (Hanoune and Defer, 2001). 
The presence of two distinct calcium binding sites on AC6, with apparent high and 
low affinities account for the calcium inhibition (Cioffi et al., 2002). The activation 
of AC6 occurs via Gs, where receptor activation results in a dissociation of Gs 
from G, where the now activated Gs stimulates AC6 (Chen et al., 1997). The 
stimulation of AC6 results in the cyclization of ATP to cAMP and subsequent 
downstream signalling cascades.  
 AC6 is expressed in various tissues throughout development, including the 
brain, heart, along the nephron but more abundant in the collecting tubule and in the 
thick ascending limb of the kidney, adrenal, liver, and lung, at low levels in the testis 
and adult muscle of mice and in the uterus of rats and humans (Defer et al., 2000). 
Furthermore, AC6 can exist as multiple variants and is not evenly distributed 
between the various organs. AC6 has also been implicated as a key player in cell 
differentiation, where mesodermal differentiation of pluripotent P19 cells is 
accompanied by an upregulation of AC6 (Hanoune and Defer, 2001).  
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 AC6 plays a role in mechanotransduction. Work in cholangiocytes found that 
the increases of cAMP by forskolin treatment were decreased following fluid flow in 
an AC6 dependent manner (Masyuk et al., 2006). Specifically, AC6 has been shown 
to be expressed in mature bone cells and is required for loading-induced bone 
formation in vivo (Lee et al., 2014). Interestingly, skeletally mature mice, with a 
global deletion of AC6, did not present with a skeletal phenotype but formed 
significantly less bone than control mice following ulnar loading, demonstrating that 
AC6 is involved specifically in mechanotransduction leading to functional bone 
mechanoadaptation (Lee et al., 2014). Additional in vitro studies have demonstrated 
a role for AC6 in osteocyte mechanotransduction (Kwon et al., 2010), but the 
potential role of AC6 in MSCs remains unknown (Figure 2.7B). 
2.6.3 Cilia associated signalling  
In addition to the important role of primary cilia in mediating bone cell 
mechanotransduction, primary cilia are also equipped with receptors that can detect 
and transmit specific ligands, hormones, growth factors and morphogens, via a 
process known as chemosensation (Satir et al., 2010). This is a critical process 
mediating osteocyte coordinated bone mechanoadaptation as factors release by 
osteocytes and/or bone ECM would in turn be sensed by effector cells driving this 
remodelling response. The primary cilium has been shown to be involved in the 
chemosensation and transduction of a host of cytokines known to be important in 
bone physiology, such as platelet derived growth factor (PDGFs), bone morphogenic 
proteins (BMPs), transforming growth factor beta (TGF-β), Hedgehog and GPCR 
signalling. While no studies to date have explored whether the osteocyte utilizes the 
primary cilium in such a role, it has been reported that osteoblasts and MSCs utilize 
the primary cilium to sense the extracellular biochemical milieu. 
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2.6.3.1 Platelet derived growth factor 
Platelet derived growth factors (PDGFs) are a group of growth factors consisting 
of four ligands and two receptors (PDGFR-α and PDGFR-β) which are involved in 
the regulation of cell proliferation and migration and have been shown to play a role 
in skeletal development and patterning (Hoch and Soriano, 2003). A link between 
PDGF signalling and the primary cilia was first reported in a study which showed 
that PDGFR- α localised to the primary cilium in fibroblasts, indicating that the 
primary cilia plays a broader role than previously thought in regulating cell mitosis 
and tissue homeostasis. More recently, Noda et al., reported that PDGFR-α was 
present on the ciliary membrane of osteoblasts. They have also shown that the 
disruption of ciliogenesis via Ift20 deletion down-regulated PDGFR-α production, 
suppressed PDGF-Akt signalling and decreased osteogenesis (Noda et al., 2016).  
2.6.3.2 Bone morphogenic proteins  
Another key group of cytokines that have been shown to interact with 
osteoblasts via chemosensing at the primary cilia are bone morphogenic proteins 
(BMPs), which are known to have multiple functions in embryonic development, 
bone formation and remodelling. One interesting area where the role of the primary 
cilia as a chemosensing organelle is interacting with bone therapies is in the 
mechanism through which pulsed electromagnetic fields (PEMF) can be used to treat 
osteoporosis. Previous studies have demonstrated that the primary cilium is 
necessary for the promotion of mineralization in osteoblasts by PEMFs although the 
mechanism through which this occurs is not fully understood. However, a recent 
study showed that PEMF stimulated osteogenic differentiation in osteoblasts via 
activation of BMP-Smad1/5/8 signalling and the study showed that BMP-receptor II 
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expression and localization to the ciliary base was increased by the therapy, 
demonstrating chemosensory mechanisms in the osteoblast primary cilium and as 
well as the therapeutic potential of the primary cilium as a chemosensory organelle 
(Xie et al., 2016). Furthermore Clement et al., in their investigations of TGF-β1 
signalling and primary cilia chemosensing demonstrated that activation of the 
SMAD1/5 pathway required for BMP signalling is regulated partly by trafficking of 
receptors within the primary cilium (Clement et al., 2013). 
2.6.3.3 Transforming growth factor beta 
Labour et al. demonstrated that the primary cilium plays a major role in 
transforming growth factor beta 1 (TGFβ1) chemosensing and downstream 
signalling in human MSCs (Labour et al., 2016). The ubiquitous growth factor plays 
a key role in bone metabolism, stem cell recruitment and differentiation among many 
other functions (Janssens et al., 2005, Labour et al., 2016, Tang et al., 2009). It was 
shown that the primary cilium is essential for TGFβ1 mediated MSC chemotaxis, 
where p-TGFβ RII was found to localize to the ciliary membrane, ideally positioning 
it to sense the extracellular environment. Moreover, downstream TGFβ signalling 
components such as TGFβRI and p-SMAD3 were identified at the base of the cilium 
as well as localization of pSMAD2 and SMAD4 within the ciliary compartment. The 
primary cilium was required for TGFβ1-induced increases in p-TGFβRI and p-
SMAD3. Additionally, a recent paper by Zhang et al., demonstrated that cilia length 
was altered in MSCs by substrate topography with osteogenic surface topologies 
inducing longer cilia which exhibited increased levels of ciliary p-TGFβRII (Zhang 
et al., 2017).  
2.6.3.4 Hedgehog signalling  
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Hedgehog (Hh) is a signalling pathway that is vital for embryonic development 
and adult stem cell function. Additionally, Hh is one of a few signalling pathways 
that is used repeatedly for intracellular communication in development and solely 
dependent on the primary cilium (Bangs and Anderson, 2017). In mammals, there 
are three Hh proteins, Sonic (Shh), Indian (Ihh), and Desert (Dhh; (Bangs and 
Anderson, 2017). Anomalies in the Shh signalling pathway appears to trigger the 
skeletal abnormalities in skeletal ciliopathies such as JATD, while in contrast, 
defective Ihh signalling is observed in EvC-null mice (Ruiz-Perez et al., 2007, 
Waters and Beales, 2011). Hedgehog is believed to occur where the binding of the of 
the Shh ligand, Smoothened (Smo) to its receptor Patched 1 (Ptch1) triggers a 
reciprocal change in localization at the ciliary membrane (Mukhopadhyay and 
Rohatgi, 2014, Milenkovic et al., 2009). When the Hh ligands are not present, Ptch1 
localizes along the length of the cilium and in vesicles at the ciliary base, whereas 
Smo is present at low levels, upon activation of Hh, Ptch1 is removed from the 
cilium and Smo accumulates in the ciliary membrane (Figure 2.8) (Mukhopadhyay 
and Rohatgi, 2014).  
Indian Hh signalling is vital for intramembranous ossification. Ihh knockout 
mice have smaller calvaria, with reduced thickness and mineralization, and widened 
structures when compared to wild type mice (Yang et al., 2015). This study found 
that Ihh, which is located at the edge of these growing cranial bones promoted bone 
formation by regulating osteoblastic differentiation, rather than proliferation. This 
loss of Ihh also resulted in reduced BMP2/4, which is suggestive of BMP2/4 being 
downstream of Ihh in this process. When Ihh signalling is abolished, this study found 
a loss of endochondral ossification due to inhibited osteoblast differentiation (Yang 
et al., 2015). In contrast, studies have shown that osteoblast progenitors which are 
61 
 
deficient of Ptch1 differentiated at an accelerated rate, which was as a response to 
increases in Runx2 and a blocking the generation of Gli3 repressor. Further to this, 
Gli1-haploinufficicent mice had reduced bone mass which resulted from impaired 
osteoblast differentiation and an increase in osteoclastogenesis (Yang et al., 2015). 
Moreover, Hh signalling was activated in mature osteoblasts of an adult mouse 
model, and resulted in fragile long bones, which had reduced bone density. This Hh 
signalling in mature osteoblasts promoted RANKL expression via upregulation of 
PTHrP (Yang et al., 2015, Mak et al., 2008). Ihh and Ptch1 are upregulated in the 
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first stages of fracture repair, while Shh is activated in osteoblasts at the remodelling 
sites. (Yang et al., 2015). 
Figure 2.8: Primary cilia associated Hedgehog signalling.  
2.6.3.5 Hedgehog signalling in bone development  
Multiple ciliopathies (Jeune asphyxiating thoracic dystrophy, Ellis van Creveld 
syndrome) which present with skeletal phenotypes, are a result of dysregulation of 
the hedgehog pathway. Sonic Hh has been implicated in limb patterning and 
development, where Shh is expressed in the zone of polarizing activity (ZPA) and 
instructs the developing limb to form along the anteroposterior axis (Yang et al., 
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2015). Mutations in Shh expression leads to abnormal digit numbers and/or changes 
in digit identity (Yang et al., 2015) 
Endochondral ossification requires PTHrP expression in prehypertrophic 
chondrocytes, where there is a feedback loop with Ihh to regulate long bone and 
regular growth plate development (Yang et al., 2015). Ihh stimulates PTH expression 
in periarticular chondrocytes, where it diffuses into the growth plate region and 
promotes the proliferation of chondrocytes. These chondrocytes then exit the cell 
cycle where they undergo hypertrophy when PTH drops below a critical level (Yang 
et al., 2015). However, in the absence of Ihh, PTH levels remain low, leading to an 
acceleration of chondrocyte proliferation. Moreover, abolished osteoblast 
differentiation leads to loss of endochondral ossification in the absence of Ihh, where 
BMPs, fibroblastic growth factors (FGFs) and mechanical loading have effects on 
this feedback system (Yang et al., 2015). The function of Ihh in chondrocytes is 
primarily to suppress Gli3 repressor function, whereas, Ihh signalling in osteoblast 
differentiation is via the activation of Gli2 activator (Yang et al., 2015).  
2.6.3.6 G-protein coupled receptors 
As discussed in an earlier section of this thesis, GPCRs are the most abundant 
family of receptors and are characterized by their ability to couple to catalytic 
heterotrimeric G-proteins, which through phosphorylation on serine/threonine 
residues, activate intracellular signalling cascades (Bowler et al., 1998). GPCRs have 
7 transmembrane domain receptors, which are separated by alternating extracellular 
and intracellular hydrophilic loops, where they transduce extracellular signal from 
the receptor to a variety of intracellular signalling pathways (Bowler et al., 1998). In 
bone many important calciotropic hormones including PTH and calcitonin, and local 
64 
 
effectors such as PTHrP, ATP and prostaglandins initiate profound autocrine and 
paracrine events through the activation of GPCRs.  
Although the ciliary membrane is continuous with the plasma membrane, only 
certain GPCRs localize to cilia. This is clearly demonstrated by the somatostatin 
receptors, a group of pertussis toxin-sensitive G-proteins, such as Gi. There are five 
somatostatin receptor genes present in humans and rodents (Sstr1-5); (Berbari et al., 
2008). They are all members of the GPCR superfamily of cell-surface receptors that 
couple to heterotrimeric G proteins and regulate numerous downstream effectors 
(Berbari et al., 2008). 
2.6.3.6.1 G-protein coupled receptor 161 
Recently, the orphan GPCR, Gpr161, was shown to both localize to the primary 
cilium and regulate Hh signalling via cAMP in mice (Mukhopadhyay et al., 2013). 
Gpr161 regulates the basal suppression machinery of sonic hedgehog pathway by 
means of activation of cAMP‐PKA signalling in the neural tube and loss of Gpr161 
results in embryonic lethality by E10.5 (Shimada and Mukhopadhyay, 2017). 
Gpr161, promotes the processing of Gli3 and Gli3R during neural tube development. 
Gpr161 overexpression correlates with poor prognosis in triple negative breast 
cancer (TNBC) patients. Gpr161 was identified as a marker for proliferation and 
invasion, where down regulation of Gpr161 impairs growth of TNBC cell lines 
(Feigin et al., 2014). Localization of Gpr161 at primary cilia has been shown to be 
mediated by TULP3 and the IFT-A complex to primary cilia and acts as a regulator 
of the PKA-dependent basal repression machinery in Shh signalling by increasing 
cAMP levels, leading to promote the PKA-dependent processing of Gli3 into Gli3R 
and repress Shh signalling (Mukhopadhyay et al., 2013). Gpr161 was shown to be a 
tumour suppressor in Shh subtype medulloblastoma, where Gpr161 depletion 
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increased the downstream activity of Shh (Shimada et al., 2018). Interestingly, a 
study looking at the phosphorylation of Gpr161, found that when Gpr161 and PKA 
regulatory subunits (RI) formation reduced cAMP-induced Gpr161 phosphorylation, 
leading to their hypothesis that Gpr161:RI complex formation is required for 
physiological cAMP fluxes (Bachmann et al., 2016). Furthermore, Gpr161 
deficiency in craniofacial mesenchyme prevented intramembranous bone formation 
in calvarium, and Gpr161 conditional knockouts were unable to undergo osteoblast 
differentiation (Hwang et al., 2018).  
 
2.7 Summary  
Mesenchymal stem cells are known to be an important contributor to adult bone 
formation and potentially mechanoadaptation. Although MSCs are 
mechanosensitive, the mechanisms by which this cell type can sense and transduce a 
biophysical stimulus into a biochemical bone forming response is poorly understood. 
Most major signalling pathways in vertebrates converge on the primary cilium, and 
along with its location in the extracellular space where it has access to environmental 
and paracrine signals, primary cilia are ideally equipped as mechano- and chemo-
sensors. In this chapter, well established and newly emerging pathways as potential 
mechanisms by which primary cilia function in bone were discussed, however the 
exact molecular mechanisms that play a role in the function of the primary cilium in 
different bone cell types is yet to be elucidated. Exploring these mechanisms and 
how they relate to skeletal pathologies will open the door to investigating the 
mechanotherapeutic potential of the primary cilia, for example as a novel anabolic 
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3.1 Abstract  
Mechanical loading is a potent stimulus regulating bone adaptation, that requires 
the replenishment of the osteoblast from a progenitor population. One such 
progenitor is the mesenchymal stem cell which undergoes osteogenic differentiation 
in response to oscillatory fluid shear. Yet, the identification of the mechanism 
mediating stem cell mechanotransduction, and thus the ability to target this 
therapeutically, is poorly understood. In this study, it was demonstrated that MSCs 
utilize cAMP as a 2nd messenger in mechanotransduction, that is required for flow 
mediated increases in osteogenic gene expression. Furthermore, this study shows 
that this mechanosignalling is dependent on the primary cilium and the ciliary 
localised adenylyl cyclase 6. Lastly, it was also demonstrated that this 
mechanotransduction mechanism can be targeted therapeutically to enhance cAMP 
concentrations and MSC osteogenesis, mimicking the beneficial effect of physical 
loading. Our findings therefore demonstrate a novel mechanism of MSC 
mechanotransduction which can be targeted therapeutically, demonstrating a 




3.2 Introduction  
Bone has long been established as a mechanosensitive organ, which can adapt 
its structure to meet the demands of its mechanical environment, maintaining an 
optimal strength to weight ratio (Robling et al., 2007, Robling and Turner, 2002, 
Frost, 1963). This mechanically driven adaptation requires a continued 
replenishment of bone forming osteoblasts, achieved through the differentiation of 
mesenchymal stem cells (MSCs) (Knight and Hankenson, 2013). This loading 
induced-MSC osteogenic lineage commitment is thought to occur in part via direct 
mechanosensing of physical stimuli leading to MSC osteogenic differentiation and 
bone formation (Govey et al., 2013, Hoey et al., 2012b, Curtis et al., 2018). Loading-
induced deformation of bone creates a complex mechanical microenvironment 
within the stem cell niche consisting of strain, pressure and fluid flow (Gurkan and 
Akkus, 2008). A large body of work has demonstrated that physiological OFS is a 
potent regulator of bone homeostasis, triggering an osteogenic response in 
osteoblasts, osteocytes and stem cells (Yourek et al., 2010, Thompson et al., 2012). 
In particular, a systematic study investigating the effect of OFS on MSCs 
demonstrated that OFS triggers an increase in Cyclo-oxygenase 2 (Cox2), 
Osteopontin (Opn) and Runt-related transcription factor 2 (Runx2) expression at 
early time points, that resulted in enhanced collagen and mineral deposition over 21 
days (Stavenschi et al., 2017). Despite the known contribution of mechanical loading 
to MSC osteogenic differentiation and bone formation, the mechanism by which 
these cells transduce mechanical stimuli into cellular activity, mechanotransduction, 
remains poorly understood. Deciphering these mechanisms would greatly aid in the 
development of mechanotherapies to prevent bone loss and promote regeneration in 
skeletal diseases such as osteoporosis (Rando and Ambrosio, 2018). 
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Secondary messengers are one of the initiating biochemical components of 
intracellular signalling cascades triggered by a biophysical stimulus. Intracellular 
Ca2+ has been the predominate 2nd messenger studied in response to fluid shear, 
where rapid fluxes in intracellular Ca2+ following OFS result in downstream 
transcriptional activity in bone cells (Hung et al., 1995, Lewis et al., 2017, Lyons et 
al., 2017). Moreover, human mesenchymal stem cells have demonstrated 
intracellular calcium increases following fluid shear that are required for downstream 
osteogenic gene expression (Liu et al., 2015, Corrigan et al., 2018). Alternatively, 
cAMP is another 2nd messenger activated in response to fluid shear but its role in the 
osteogenic lineage is less well studied (Kamenetsky et al., 2006). Fluid shear has 
been shown to induce an increase in cAMP production in a time and magnitude 
dependent manner in rat calvarial osteoblasts (Reich et al., 1990), indicating that 
cAMP is mechanoresponsive in bone cells. Moreover, cAMP signalling is biphasic 
in osteocytes undergoing an initial decrease followed by increase after 30 minutes of 
OFS (Kwon et al., 2010). A recent study in human MSCs demonstrated that 
activation of cAMP signalling augmented MSC osteogenesis in an ectopic bone 
formation model in immune-deficient mice (Siddappa et al., 2008), indicating that 
MSCs may too utilize cAMP as a potential pre-osteogenic signal, however the role 
of cAMP as a 2nd messenger in MSC mechanotransduction is poorly understood.  
Cyclic AMP is universally generated by ACs, a family of enzymes that catalyze 
the cyclization of ATP into cAMP (Kamenetsky et al., 2006). Adenylyl cyclase’s 
comprise of a family of nine distinct transmembrane isoforms (AC1-AC9), where 
each of the transmembrane ACs have individual regulatory properties, and the nine 
subtypes are expressed in only a limited number of tissues (Hanoune and Defer, 
2001, Defer et al., 2000). Specifically, adenylyl cyclase 6 has been shown to be 
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expressed in mature bone cells and is required for loading-induced bone formation in 
vivo (Lee et al., 2014). Interestingly, skeletally mature mice, with a global deletion of 
AC6, did not present with a skeletal phenotype but formed significantly less bone 
than control mice following ulnar loading, demonstrating that AC6 is involved 
specifically in mechanotransduction leading to functional bone mechanoadaptation 
(Lee et al., 2014). Additional in vitro studies have demonstrated a role for AC6 in 
osteocyte mechanotransduction (Kwon et al., 2010), but the potential role of AC6 in 
MSCs remains unknown. 
Primary cilia are solitary, immotile microtubule-based organelles, that protrude 
from the membrane in various cell types, including bone (Hoey et al., 2012) and 
have recently emerged as a nexus of intra- and extra-cellular signalling (Singla and 
Reiter, 2006, Lee et al., 2015). Extending into the extracellular milieu, the primary 
cilium are ideally positioned to relay both biochemical (Hh (Singla and Reiter, 
2006), TGFβ (Clement et al., 2013, Labour et al., 2016), BMP (Monnich et al., 
2018)) and biophysical (fluid shear (Hoey et al., 2012b), compression (Wann et al., 
2012), pressure (Luo et al., 2014)) cues and are required to maintain tissue 
homeostasis, with defects in the cilium leading to a number of diseases known as 
ciliopathies (Hildebrandt et al., 2011). Specifically, in bone, the depletion of primary 
cilia in mature bone cells or their progenitors results in an inhibition of the 
osteogenic response to fluid shear (Malone et al., 2007, Hoey et al., 2011, Hoey et 
al., 2012b), with these findings verified using in vivo models (Temiyasathit et al., 
2012, Chen et al., 2016), demonstrating the important role of the cilium in bone and 
stem cell mechanobiology. To identify new anabolic therapeutics, recent efforts have 
attempted to decipher the molecular mechanism of cilia-mediated 
mechanotransduction with contrasting results. Cilia-mediated mechanotransduction 
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is predominately believed to be propagated by calcium signalling with initial studies 
by Praetorius and Spring (Praetorius and Spring, 2001) being verified by advanced 
cilia localised genetically encoded calcium indicators (Jin et al., 2014, Lee et al., 
2015). Interestingly, work has recently emerged suggesting that primary cilia are not 
calcium-responsive mechanosensors as previously thought (Delling et al., 2016). 
Although these discrepancies may be associated to differences in calcium sensors 
utilized, it has raised the possibility of alternative second messengers in cilia 
mechanotransduction, namely cAMP. Previous work has demonstrated that that 
ciliary cAMP levels are fivefold higher than cytosolic cAMP in mouse embryonic 
fibroblasts and murine inner medullary collecting duct cells (IMCD3) and that this 
compartmentalized cAMP is regulated by ACs which localizes to the ciliary 
microdomain (Moore et al., 2016). Moreover, AC6 was shown to localize to the 
primary cilium of cholangiocytes and osteocytes and was required for fluid shear 
induced cAMP signalling (Masyuk et al., 2006, Mick et al., 2015, Kwon et al., 
2010), indicating that cilium may also be a cAMP-responsive mechanosensor and 
that molecular mechanisms may be cell type dependent. However, despite the 
progress in cilia-mediated mechanotransduction in mature bone cells, the molecular 
mechanism of cilia-mediated mechanotransduction in stem cells remains unknown.  
Therefore, the aim of this study was to determine the molecular mechanism of 
cilia-mediated mechanotransduction in mesenchymal stem cells, which would 
facilitate the development of novel mechanotherapies to promote MSC osteogenesis. 
Here, with the use of custom-built bioreactors, this study demonstrates MSCs 
utilized cAMP signalling as a second messenger in mechanotransduction and that 
this cAMP response is dependent on the primary cilium and the localization of AC6 
to this organelle. Moreover, a mechanotherapeutic potential by biochemically 
72 
 
targeting cAMP signalling, mimicking the beneficial effect of physical loading, 
demonstrating a potential novel anabolic treatment to enhance MSC osteogenesis 
was demonstrated. 
3.3 Materials and Methods 
3.3.1 Mesenchymal Stem Cell Culture  
The murine mesenchymal stem cell line C3H10T1/2 was obtained from ATCC 
(LGC Standards, Teddington, Middlesex, UK). MSCs were maintained in 
Dulbecco’s modified Eagle’s medium (DMEM) with low glucose (Sigma-Aldrich 
Ireland Ltd. Arklow, Ireland) supplemented with 10% fetal bovine serum (FBS; 
South American origin, Labtech International, Ltd. Heathfield, East Sussex, UK) and 
1% Penicillin Streptomycin (P/S; Sigma).  
3.3.2  Mechanical Stimulation  
Oscillatory fluid flow induced shear stress was applied to MSCs with the use of 
in house designed parallel plate flow chambers as described previously (Stavenschi 
et al., 2017). MSCs were seeded on fibronectin (10µg/ml) coated glass slides, 
assembled between two plates and attached to a programmable syringe pump (New 
Era Pump Systems Inc. Farmingdale, NY, USA). Oscillatory fluid flow was applied 
through a 10ml syringe (BD Plastipak, VWR, Dublin, Ireland) at 52.5ml/min and 
1Hz frequency subjecting cells to a shear stress of 1Pa. This stimulus was applied for 
2 hours. The no flow controls take account of the confined environment experienced 
by the cells in the chambers, they consist of glass slides prepared in the same way 
and similarly remain in the chambers for 2 hours but are not attached to the syringe 
pump. 
3.3.3 Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
73 
 
Immediately after treatment, TRI reagent (93289, Sigma) was used to extract 
RNA per the manufacturer’s protocol. The concentration of RNA in each sample 
was measured using a Nanodrop spectrophotometer and sample purity was checked 
via 260/280 and 260/230 absorbance ratios. 400ng of RNA was reverse transcribed 
to cDNA using the High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Foster City, CA, USA). Commercially available primers for 18s, Cox2, 
Runx2, Osteopontin, Ac1-9 and Ift88 were acquired for analysis of flow and forskolin 
mediated osteogenic changes and validation of knockdowns (4472920; Sigma 
Aldrich, St Louis, MO, USA). Quantitative RT-PCR was performed using a 20 µl 
reaction mix containing 10 µl SYBR green PCR MasterMix (Invitrogen Ltd, Paisley, 
UK), 0.8 µl of each primer, and 8.4 µl of dH2O and sample mix. In the case of 
Runx2 and Ac1-9, 0.6 µl of each primer was used. Plates were run in an ABI 7500 
Fast PCR System (Life Technologies, Carlsbad, CA, USA). The cycle parameters 
were as follows: Uracil N-glycosylase (UNG) activation was run for 2 min at 50°C, 
DNA polymerase activation for 10 min at 95°C, the melt cycle was run for 15s at 
95°C and the annealing–extending cycle for 1 min at 60°C for Cox2, Runx2, 
Osteopontin and Ift88, apart from 18s and Ac1-9, which were run at 65°C. A no-
template control (NTC) was run in each 96-well plate to confirm the absence of 
contamination. 
For AC6 knockdown and related OFS experiments, qRT-PCR reactions were 
prepared using TaqMan Universal PCR Mix (4304437; Applied Biosystems) with 
ROX passive dye and a pre-designed Taqman Gene Expression Assay (Applied 
Biosystems, 4331182) for amplification using the ABI 7500 real time PCR system 
(Applied Biosystems). The relative quantity of each sample was calculated with 
reference to 18s and expressed as fold change normalised to the no flow control 
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group. For validation of AC6 knockdown, the relative quantity of AC6 was 
calculated with reference to Actβ. All primer sequences and concentrations are 
outlined in Table S3.1.  
 
3.3.4 Quantification of cAMP signalling 
Cyclic AMP concentration was analysed using the commercially available 
Cyclic AMP XP® Assay Kit (Cell signalling technology, Danvers, MA, USA). 
Following OFS or treatment with the adenylyl cyclase inhibitor or activator, cells 
were rinsed with ice cold phosphate buffered saline (PBS; Sigma Aldrich, St Louis, 
MO, USA) and lysed on ice with 200 μl RLT lysis buffer containing 
phenylmethylsulfonyl fluoride (PMSF; 1:200; Sigma Aldrich). Experimental 
samples (50 µl) were loaded onto the anti-cAMP XP® rabbit mAb coated plate, with 
50 µl HRP-linked cAMP solution and incubated on an orbital plate shaker for 3 hrs 
at room temperature. Wells were washed with 200 µl 1X wash buffer four times, 
before incubating with 100 µl 3,3’,5,5’-Tetramethylbenzidine (TMB) substrate for 
30 min at room temperature. Following 30 min, 100 µl stop solution was added. 
Plate absorbance was read at 450 nm. All samples and standard curve were run in 
triplicate. 
3.3.5 Immunocytochemistry 
MSCs were seeded on fibronectin coated glass coverslips for 24 hours before 
serum starvation in DMEM low glucose, 0.5% FBS, 1% P/S for 48 hours. After 
fixation in neutral buffered formalin for 10 minutes (Sigma-Aldrich), coverslips 
were permeabilized in 0.1% Triton X-100 and non-specific binding sites were 
blocked using 1% w/v BSA (Sigma-Aldrich) in PBS for 2 hours at room 
temperature. The primary antibody targeting the primary cilium (anti-acetylated α 
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tubulin, ab24610, Abcam, Cambridge, UK) was applied overnight at 4°C, diluted 
1:1500. Next, primary antibody targeting AC6 (anti-AC6, ab14781; Abcam, 
Cambridge, United Kingdom) was applied for 1 hour at room temperature at a 
dilution of 1:500. Next, Alexa 594 and Alex 488 secondary antibodies (A21203, 
A11008; Life Technologies, California, USA) were applied in tandem for 1 hour at 
room temperature at 1:500. Finally, DAPI (Sigma) was applied for 5 minutes in PBS 
prior to sample mounting on glass slides using Prolong gold mounting medium 
(Invitrogen). For cilium incidence and length studies, the primary antibody for 
centrioles (anti-pericentrin, ab4448, Abcam, Cambridge, United Kingdom) was used 
in conjunction with acetylated α tubulin to clearly identify the base of the cilium, at a 
dilution of 1:1000. Imaging was performed on an Olympus IX83 epifluorescent 
microscope with a 100W halogen lamp at 100x (N.A. 1.40 Oil) or the Leica SP7 
(Leica Microsystems, Wetzlar, Germany) scanning confocal microscope at 63x 
(N.A. 1.40 Oil). Controls in the absence of primary antibody were used to test for 
non-specific binding and background staining of the secondary antibodies.  
3.3.6 Ift88/Primary cilium and AC6 Knockdown  
The formation of functional primary cilia and Adenylyl Cyclase 6 was inhibited 
by siRNA-mediated depletion of IFT88, an intraflagellar transport protein (IFT) 
required for functional ciliogenesis, and AC6, respectively. Lipofectamine 
RNAiMAX (Invitrogen) was diluted 1/135 in OptiMEM (Gibco, Foster City, CA, 
USA) reduced serum transfection medium. For Ift88 knockdown this was mixed 1:1 
with predesigned Stealth RNAi targeting Ift88 (MSS211714, Invitrogen) at a dilution 
of 16.7µM in OptiMEM and incubated at room temperature for 15 minutes before 
application, while for AC6 knockdown lipofectamine was mixed 1:1 with Silencer 
Select Ambion siRNA (4390825; Bio-Sciences Limited, Dublin, Ireland) at a 
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dilution of 60pmol for 5 minutes before adding 550µl per slide and incubated for 8 
hours at 37°C, following which 10 ml DMEM (0.5% FBS, 1% P/S) was added to the 
cells for 24hrs. The off-target control was Stealth RNAi Negative Control, Medium 
GC (12935300, Invitrogen) and Silencer™ Negative Control (AM4641, Thermo-
Fisher), respectively. For Ift88 knockdown studies, additional medium was added to 
each transfection after 24 hrs. 48 hours following transfection the transfected cells 
were seeded for experimentation in DMEM (0.5% FBS, 1% P/S). Transfection 
efficiency and validation of knockdown was verified 72 hours after transfection by 
quantitative real-time PCR (qRT-PCR) and immunocytochemistry as described 
above. Percentage of ciliated cells were determined, and cilia length analysed by 
epifluorescence microscopy using an Olympus IX83 fitted with 100x objective. Cilia 
length were measured using Image J freeware. 
3.3.7 Biochemical Inhibition and Activation of cAMP Signalling  
Cyclic AMP was diminished through the inhibition of adenylyl cyclase activity 
by MDL-12,330A hydrochloride (MDL; M182; Sigma (Zhang et al., 2010)). A dose 
response study was performed for 15 min to determine the optimum concentration of 
MDL that would inhibit AC activity but does not affect basal cAMP levels. Cells 
were treated for 15 min to replicate OFS conditions for cAMP. Following this, 10µM 
was chosen to be optimal and therefore was used for further studies investigating the 
role of AC activity and cAMP concentration in MSC mechanotransduction. MSCs 
were treated with MDL supplemented medium throughout application of the 1Pa 
mechanical stimulation, and controls were incubated for the same time frame with 




To modulate cAMP  via activation of adenylyl cyclase, the general AC agonist 
forskolin (FSK; F3917; Sigma (Doorn et al., 2012)) was utilized (Seamon et al., 
1981). Dose response studies were also carried out, where cells were treated with 
increasing doses of FSK for 15 min. As with MDL treatment, cells were treated with 
FSK supplemented medium for 15 min, and controls were incubated for the same 
time frame with vehicle (0.01% DMSO) treated medium, for both cAMP and 
osteogenic gene expression studies. Media was supplemented with 1µM 3-Isobutyl-
1-methylxanthine (IBMX) for all cAMP studies.  
3.3.8 Data Analysis  
The relative expression of each gene with reference to 18s was calculated and 
the results expressed as fold change gene expression relative to the no flow 
scrambled or vehicle control group along with the standard error of the mean. For the 
OFS and forskolin with AC6 or Ift88 knockdown studies a two-way ANOVA 
analysis was performed with Bonferroni correction post-hoc tests. Dose response 
studies for MDL and FSK were analysed using a one-way ANOVA, with Bonferroni 
post-hoc tests. All other analysis was performed using two-tailed unpaired student’s 
t-test with Wilcoxon correction. All data was analysed using GraphPad Prism 5. 
Only primers with PCR efficiencies between 90% and 110% were used. Statistically 




3.4 Results  
3.4.1 MSCs utilize cAMP signalling as a 2nd messenger in mechanotransduction 
To determine whether mesenchymal stem cells utilize cAMP as a second 
messenger in fluid shear mechanotransduction, cAMP levels were quantified 
immediately following exposure for 2, 15, and 30 min of OFS. It was found that 
cells subjected to 15 min of oscillatory fluid shear significantly increased cellular 
cAMP levels 2.9-fold compared to no flow controls (p<0.05; Figure 3.1A), 
indicating cAMP as a second messenger in MSC mechanotransduction. This 
response was temporal, in that no changes were seen following 2 min OFS and 
returned to basal levels after 30 min OFS (Figure 3.1A), demonstrating similar 
profiles to that seen with calcium signalling. As no change was seen following either 
2- or 30-min OFS, our remaining experiments focused on investigating the 
mechanisms involved in flow-induced increases of cAMP after 15 min OFS.  
As cAMP is predominately regulated via ACs, a general AC inhibitor was 
utilized, MDL-hydrochloride, to investigate whether this OFS-induced increase in 
cAMP was AC dependent. Firstly, a dose response study was performed for 15 min 
to determine the optimum concentration of MDL that would inhibit AC activity, but 
that did not affect basal cAMP levels. MDL at concentrations of 100 and 200µM, 
resulted in significant decreases in basal cAMP levels (Figure 3.1B). A concentration 
of 10µM was chosen as it was the lowest concentration of MDL-hydrochloride and 
did not elicit any significant changes in cAMP levels (Figure 3.1B). It was found that 
treating MSCs with 10µM MDL-hydrochloride blocked the OFS-induced increases 
of cAMP (p<0.05; Figure 3.1C), demonstrating that the OFS-mediated cAMP 
response was dependent on AC activity. Thereafter, to investigate whether cAMP 
second messenger signalling is required for fluid shear-induced MSC osteogenesis, 
AC activity was inhibited as above and osteogenic gene expression was analysed 
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following 2hrs OFS. This study found that MSCs display a positive osteogenic 
response when subjected to a regime that has previously been shown to elicit 
osteogenic responses at 2hrs OFS at 1Pa, 1Hz (11), where there was a significant 
increase in the expression of the osteogenic genes, Cox2 and Osteopontin (p<0.05) 
and a trend to significance in Runx2 (p=0.072) when compared to static No Flow 
conditions (Figure 3.1D-F). However, when cAMP signalling is blocked with MDL-
hydrochloride this significant increase was lost in all genes analyzed (Figure 3.1D-







Figure 3.1: MSCs utilize cAMP as a 2nd messenger during mechanotransduction. Effect of 
oscillatory fluid flow over MSCs at 1Pa, 1Hz for 2, 15 and 30 min on cAMP concentration (N=3, 
n=6; A). Dose response test of the AC inhibitor MDL-12,330A hydrochloride on cAMP concentration 
in MSCs (N=3, n=6; B). Effect of 10µM MDL-12,330A hydrochloride on cAMP concentration 
following oscillatory fluid flow at 1Pa, 1Hz for 15 min (N=3, n=9; C). Effect of MDL-12,330A 
hydrochloride on gene expression following oscillatory fluid flow at 1Pa, 1Hz for two hours (Cox2, 
Runx2, and Osteopontin; N=2, n=6; D, E, F). All groups are compared to no flow vehicle control. 
Statistical test employed an unpaired two tailed student t-test with Wilcoxon correction (A), a one-
way ANVOA with Bonferroni post-test (B), and a two-way ANOVA with Bonferroni post-tests (C, 
D, E, F). Values are means ± SEM for three independent replicates. *p<0.05, **p<0.01. N refers to 






3.4.2 MSCs express seven of the nine transmembrane Adenylyl Cyclase isoforms, 
including AC6. 
Adenylyl cyclases are GTP-dependent enzymes that are responsible for the 
conversion of ATP to cAMP. Nine membrane-bound isoforms have been identified, 
with seven of these, AC2-7 and 9 expressed in mature bone cells. To determine what 
AC isoforms are expressed in progenitor cells, utilizing Quantitative Real-Time 
Polymerase Chain Reaction (qRT-PCR), this study found that there are also seven 
isoforms present in MSCs, but interestingly the expression pattern is different to that 
seen in osteocytes. Herein it was found that AC1, AC3-4, AC6-9 are expressed, 
while AC2 and AC5 were not detected (Figure 3. 2A). Interestingly, of the seven 
isoforms present, AC6 was one of the more abundantly expressed and has previously 
be shown to be critical for loading-induced bone formation. To investigate AC6 
further, AC6 protein expression and spatial organization was examined using 
immunocytochemistry and found that AC6 is expressed across the MSC cell 
membrane (Figure 3.2B). No staining was found when AC6 primary antibody was 






Figure 3.2: MSCs express seven of the nine transmembrane Adenylyl Cyclase isoforms, including 
AC6. qRT-PCR targeting adenylyl cyclases (AC) 1-9 in MSCs. AC2 and 5 were not detected (n=3; 
A). Data was normalized to 18S. Adenylyl Cyclase 6 (AC6) expression in MSC verification on a 
protein level with the use of immunocytochemistry. Cells were stained for AC6 (green) and nuclei 
counterstained with DAPI (blue; B). Scale bar 20 µm. 
 
3.4.3 Adenylyl Cyclase 6 is required for fluid shear-induced cAMP signalling in 
MSCs 
To investigate the role of AC6 in flow-mediated changes in cAMP 
concentration, AC6 was depleted in MSCs using small-interfering RNA (siRNA). 
Gene expression levels, as quantified by qRT-PCR, were 75% lower in MSCs 
treated with AC6 siRNA when compared to scrambled siRNA controls (p<0.001; 
Figure 3.3A). MSCs treated with either off-target scrambled or AC6 siRNA were 
subjected to 15 min OFS to assess the role of AC6 in OFS induced increase in 
cAMP. When exposed to flow, MSCs treated with scrambled siRNA exhibited a 2.6-
fold increase in cAMP (p<0.05; Figure 3.3B), demonstrating no effect of the 
transfection treatment. However, upon depletion of AC6 no changes in cAMP 
concentration was found in MSCs following shear (Figure 3.3B), demonstrating the 




Figure 3.3: Adenylyl Cyclase 6 is required for fluid shear induced increases in cAMP concentrations 
in MSCs. AC6 expression was successfully knocked down in MSCs using siRNA technology, as 
verified by qRT-PCR (n=13; A). Effect of oscillatory fluid flow over MSCs treated with scrambled 
and AC6 siRNA at 1Pa, 1Hz for 15 min on cAMP concentration (N=3, n=8-9; B). All groups are 
compared to no flow scrambled control. Statistical tests employed an unpaired two tailed student t-test 
(A) and a two-way ANOVA with Bonferroni post-tests. Values are means ± SEM for a minimum of 
three independent replicates. *p<0.05, ***p<0.001. 
 
3.4.4 Adenylyl Cyclase 6 is required for fluid shear induced osteogenic gene 
expression in MSCs 
Given the demonstrated role of AC6 in fluid shear-induced increases in cAMP 
signalling, whether AC6 also plays a role in downstream osteogenesis was 
investigated next. MSCs treated with either scrambled or AC6 siRNA as above, were 
subjected to OFS at 1Pa, 1Hz as previously described. Cox2, Runx2 and Osteopontin 
in the No Flow control group were unaffected by the AC6 siRNA treatment 
demonstrating that AC6 activity does not significantly influence basal osteogenic 
gene expression (Figure 3.4.A-C). Furthermore, analysis of osteogenic gene 
expression in MSCs treated with scrambled siRNA and exposed to flow, resulted in 
a significant 4-, 3.16-, and 3.60-fold increases in Cox2, Runx2 and Osteopontin 
mRNA levels compared to scrambled siRNA no flow controls, respectively (p<0.05; 
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Figure 3.4A-C). However, similar to that seen with cAMP signalling, depletion of 
AC6 results in a complete loss of the fluid shear induced increases in osteogenic 
gene expression (Figure 3.4A-C), demonstrating that AC6 is a critical component of 






Figure 3.4: Adenylyl Cyclase 6 is required for fluid shear induced osteogenic gene expression in 
MSCs. Effect of oscillatory fluid flow at 1Pa, 1Hz on osteogenic gene (Cox2, Runx2, and 
Osteopontin) expression after 2 hours (N=4, n=9-12; A, B, C). All groups are compared to no flow 
scrambled control. Statistical tests employed a two-way ANOVA with Bonferroni post-tests. Values 
are means ± SEM for a minimum of three independent replicates. *p<0.05, ***p<0.001. 
 
3.4.5 AC6 is localizes to the microdomain of the primary cilium in MSCs 
Given the previously demonstrated role of the primary cilium in MSC 
mechanotransduction and spatial organization of ACs at the primary cilium in other 
cell types, it was next examined whether AC6, responsible for the flow mediated 
changes in cAMP and gene expression, is localised to the primary cilium in MSCs. 
Utilizing ICC, MSCs were co-immunostained for AC6 and acetylated α-tubulin, 
which is enriched within the primary cilium. Primary cilia were identified in the 
perinuclear region of the cell, extending as rod-like structures from the cell surface. 
As previously demonstrated, AC6 was found throughout the cell membrane but upon 
co-staining with the primary cilium a distinct spatial organization was revealed with 
intense staining found along the ciliary microdomain (Figure 3.5). No staining was 
found when AC6 primary antibody was withheld (Figure S3.2). This therefore 
indicates that cilia-mediated MSC mechanotransduction may be dependent on AC6 
and its regulation of cAMP signalling. 
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Figure 3.5: Adenylyl Cyclase 6 is localised to the primary cilium in MSCs. AC6 co-localization to 
the primary cilia identified by immunostaining for primary cilia, identified as linear structures 
enriched in acetylated α-tubulin, (red) and AC6 (green). Nuclei are counterstained with DAPI (blue; 







3.4.6 Primary cilium-mediated mechanotransduction in MSCs is cAMP dependent 
The primary cilium has previously been shown to be required for stem cell 
mechanotransduction, specifically with regards to fluid shear induced increases in 
osteogenic gene expression (Hoey et al., 2012b). Therefore, given the localization of 
AC6 to the primary cilium compartment and the demonstrated role of cAMP in MSC 
mechanotransduction, the role of the primary cilium in fluid shear induced increase 
in cAMP concentration was next investigated. The formation of cilia was inhibited 
through the utilization of siRNA targeting Ift88, which is a principal motor protein 
required for ciliogenesis. The transfection resulted in significantly diminished Ift88 
mRNA expression which in turn significantly reduced the incidence of primary cilia 
by 74% as demonstrated by immunocytochemistry (p<0.05; Figure 3.6A-D). MSCs 
transfected with siRNA targeting Ift88 or scrambled siRNA were subjected to OFS, 
and cAMP concentrations were analyzed as above. The scrambled siRNA treatment 
did not affect basal or fluid shear induced increases in cAMP in MSCs following 
fluid shear (3.74-fold, p<0.05; Figure 3.6E). However, upon removal of the primary 
cilium, the fluid shear induced increase in cAMP was lost (Figure 3.6E), mirroring 
that with AC6 depletion. This therefore demonstrates that the cilium is a cAMP 
responsive mechanosensor in MSCs, which potentially utilizes AC6 to mediate this 
second messenger and downstream osteogenic response, demonstrating a novel 






Figure 3.6: Primary cilium-mediated mechanotransduction in MSCs is cAMP dependent. 
Intraflagellar transport protein 88 (Ift88) expression was successfully knocked down in MSCs using 
Ift88 siRNA as verified by immunostaining (A, B) and qRT-PCR (n=4; C). Cells were treated with 
either scrambled siRNA (A) or Ift88 siRNA (B) and stained for primary cilia, identified as linear 
structures enriched in acetylated α-tubulin, (red; arrows) and centrioles (green; arrow head). Nuclei 
are counterstained with DAPI (blue). Scale bars represent 5μm and 1μm (insert). Effect of Ift88 
siRNA treatment on cilia incidence (N=4, n=143-187; D). Effect of oscillatory fluid flow over MSCs 
treated with scrambled and Ift88 siRNA at 1Pa, 1Hz for 15 min on cAMP concentration (N=3, n=9; 
E). Statistical test employed an unpaired two tailed student t-test with Wilcoxon correction (C, D) and 
a two-way ANOVA with Bonferroni post-tests (E). Values are means ± SEM for three independent 




3.4.7 cAMP signalling can be biochemically activated with an AC activator 
demonstrating artificial mechanotransduction and mechanotherapeutic 
potential.  
Next, this study wanted to investigate whether the biochemical activation of this 
novel MSC mechanotransduction mechanism via adenylyl cyclases could mimic the 
responses seen to OFS. A dose response study was carried out to determine whether 
the AC activator, FSK, could biochemically mimic the effects of OFS on cAMP. 
This study found that the 0.01mM and 0.001mM of FSK could induce a 25- and 12-
fold increase in cAMP levels following 15min treatment, respectively (p<0.001; 
Figure 3.7A), which while robust does not mirror that seen following OFS. 
However, cAMP levels increased 2.5-fold compared to the vehicle control in cells 
treated with 0.1µM FSK (p<0.05; Figure 3.7B). As the aim of this study was to 
biochemically induce the increases in cAMP seen with fluid shear, cells were treated 
with 0.1µM FSK for further studies. Importantly, 0.1µM FSK treatment was not only 
able to mimic increases in cAMP concentration following OFS, but also that of the 
osteogenic response, where treatment with 0.1µM FSK resulted in a significant 
increase in Cox2, Runx2, and Osteopontin (p<0.05; Figure 3.7C-E), to a similar 
degree to that seen with fluid shear demonstrating artificial mechanotransduction and 
highlighting FSK as a potential anabolic mechanotherapeutic to enhance MSC 
osteogenesis. Moreover, given the demonstrated role of AC6 in fluid shear-induced 
increases in cAMP and osteogenic gene expression, this study next investigated 
whether AC6 also plays a role in FSK induced increases in osteogenesis. MSCs 
treated with either scrambled or AC6 siRNA as above, were subjected to 0.1µM FSK 
as previously described. Furthermore, analysis of osteogenic gene expression in 
MSCs treated with scrambled siRNA and exposed to FSK, resulted in a significant 
3.19-, 3.43-, and 2.59-fold increases in Cox2, Runx2 and Osteopontin mRNA levels 
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compared to scrambled siRNA no flow controls, respectively (p<0.05; Figure 3.7F-
H). However, similar to that seen with cAMP signalling and OFS, depletion of AC6 
results in a complete loss of the FSK induced increases in osteogenic gene 
expression (Figure 3.7F-H), demonstrating that AC6 is a critical component of MSC 
mechanotransduction.  
Primary cilia have been shown previously to be required for fluid flow induced 
increases in osteogenic gene expression and this study has demonstrated its role in 
OFS induced increases in cAMP. Therefore, the role of the primary cilium of the 
FSK induced increases in osteogenesis was investigated. As previously described the 
formation of cilia was inhibited with the treatment of Ift88 siRNA. MSCs transfected 
with siRNA targeting Ift88 or scrambled siRNA were subjected to treatment of 
0.1µM FSK, and the osteogenic gene expression was analyzed as above. The 
scrambled siRNA treatment did not affect basal or FSK induced increases in Cox2, 
Runx2 or Osteopontin in MSCs following forskolin treatment (3.14-, 3.41- and 2.59-
fold, p<0.05; Figure 3.7I-K). However, upon removal of the primary cilium, the FSK 
induced increase in osteogenic gene expression was lost (Figure 3.7 I-K), mirroring 
that with AC6 depletion. This therefore demonstrates that activating osteogenic 








Figure 3.7: Cyclic AMP can be biochemically activated with an AC activator demonstrating artificial 
mechanotransduction. Effect of forskolin treatment on cAMP concentration in MSCs (N=3, n=6 A-
B). Effect of forskolin treatment on gene expression (Cox2, Runx2, and Osteopontin; N=3, n=9; C, D, 
E). Adenylyl Cyclase 6 is required for forskolin induced osteogenic gene expression in MSCs (Cox2, 
Runx2, and Osteopontin) expression after 2 hours (N=2, n=5-6; F, G, H). Ift88 is required for 
forskolin induced osteogenic gene expression in MSCs (Cox2, Runx2, and Osteopontin) expression 
after 2 hours (N=2, n=5-6; I, J, K). DMSO concentration for shown is 0.01%. Statistical test 
employed an unpaired two tailed student t-test with Wilcoxon correction (A-E). Statistical tests 
employed a two-way ANOVA with Bonferroni post-tests (F-K). Values are means ± SEM for three 
independent replicates.  *p<0.05, **p<0.01, ***p<0.001 
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3.5 Discussion  
Mechanical loading is a potent stimulus regulating bone adaptation that requires 
the replenishment of the osteoblast from a progenitor population. One such 
progenitor is the mesenchymal stem cell which undergoes osteogenic differentiation 
in response to oscillatory fluid shear (Stavenschi et al., 2017). Yet, the identification 
of the mechanism mediating stem cell mechanotransduction, and thus the ability to 
target this therapeutically, is poorly understood. In this study, it was demonstrated 
that MSCs utilize cAMP as a 2nd messenger in mechanotransduction, that is required 
for flow mediated increases in osteogenic gene expression. Furthermore, this study 
demonstrated that this mechanosignalling is dependent on the primary cilium and the 
ciliary localised adenylyl cyclase 6. Importantly, this study also demonstrated that 
this mechanotransduction mechanism can be targeted therapeutically to enhance 
MSC osteogenesis, mimicking the beneficial effect of physical loading. The findings 
therefore demonstrate a novel mechanism of MSC mechanotransduction which can 
potentially be targeted therapeutically, demonstrating a potential mechanotherapy for 
bone loss diseases such as osteoporosis.  
MSCs utilise cAMP as a 2nd messenger to transduce a biophysical stimulus into 
a biochemical osteogenic response. By mimicking the marrow mechanical 
environment via application of OFS, MSCs were shown to rapidly upregulate 
intracellular cAMP levels 2.6-fold over static controls. This rapid increase in cAMP 
is in agreement with work carried out in osteoblasts, where there was an increase in 
cAMP not only over time, but also over increasing shear magnitudes demonstrating 
mechanosensitivity (Reich et al., 1990), and demonstrates the utilization of cAMP 
signalling as an important 2nd messenger in the skeleton. Interestingly, when this 
cAMP response was inhibited MSCs exhibited a loss in flow-induced increases in 
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osteogenic genes, Cox2, Runx2 and Osteopontin, suggesting that the initial increase 
in cAMP is a critical component of loading-induced MSC osteogenesis. Mechanical 
loading-induced osteogenesis has previously been linked to both cAMP and Ca2+ 
signalling (Thompson et al., 2012, Liu et al., 2015, Reich et al., 1990). However, we 
recently demonstrated that a complete loss of calcium signalling following TRPV4 
inhibition only partially blunted the osteogenic response to fluid shear in MSC 
(Corrigan et al., 2018). Given the complete loss of osteogenesis following cAMP 
inhibition in this study, this may suggest a more dominant role for cAMP signalling 
as a 2nd messenger in MSC mechanotransduction. This alternative mechanism of 
cAMP signalling agrees with previous work in bone mesenchymal stem cells 
(BMSCs), where phosphate promoted osteogenesis via an ATP-induced cAMP/PKA 
pathway (Wang et al., 2016). Further to this, work in vivo has shown that activation 
of the cAMP pathway results in robust increases in bone formation in transplanted 
hMSCs (Siddappa et al., 2008). Our findings therefore support a role for cAMP as an 
important messenger in mesenchymal stem cell mechanotransduction and 
osteogenesis. 
Adenylyl Cyclase 6 is required for OFS-induced increases in cAMP and 
osteogenic gene expression. There is a growing body of evidence detailing the 
expression patterns of ACs within lineage committed cells, while the isoforms that 
are expressed within progenitors have not been established. Using qRT-PCR MSCs 
were found to express only 7 of the 9 AC isoforms, which is similar to the number 
seen in the differentiated osteocyte (Kwon et al., 2010). In our studies, MSCs 
express AC1, 3-4 and 6-9, while AC2 and 5 were not detected. This contrasts with 
that seen in osteocytes that do not express AC1 or 8 (Kwon et al., 2010). These 
differences in AC expression indicate a preferential change in AC expression with 
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lineage commitment. Of the four highly expressed ACs in MSCs (AC3, 6, 7, and 9), 
AC6 has been shown to have an important role in bone mechanoadaptation both in 
vitro and in vivo (Kwon et al., 2010, Lee et al., 2014), while AC3, 7 and 9 have 
predominately been associated with the brain (Kamenetsky et al., 2006). Therefore, 
this study focused specifically on AC6. Lee et al., showed that mice with a global 
knockout of AC6 had no skeletal phenotype, however, they exhibited diminished 
loading-induced bone formation demonstrating a critical role for AC6 in skeletal 
mechanoadaptation. Additionally, primary mature bone cells from these mice had an 
attenuated fluid shear-induced increase in Cox2 mRNA expression compared to 
controls. However, it is currently unclear if AC6 plays a role in MSC 
mechanotransduction. Therefore, this study wanted to further investigate the 
expression pattern of AC6 specifically in MSCs, where immunocytochemistry was 
employed, and AC6 was found to be abundantly expressed throughout the plasma 
membrane of MSCs. Knocking down AC6 expression in MSCs did not affect basal 
cAMP levels but abolished the increase in cAMP signalling in response to fluid 
shear, demonstrating a similar mechanotransduction specific role as in the AC6 
knockout animal. This trend was also evident when examining MSC osteogenesis, 
suggesting the defect in loading induced bone formation in vivo may be attributable 
to a defect in mechanotransduction in many cell types along the osteogenic lineage. 
Interestingly the complete loss of the cAMP and osteogenesis responses to OFS 
following AC6 knock down mirrors that seen following generic AC inhibition, 
indicating that AC6 is the dominant AC mediating MSC mechanotransduction. 
Hence, our data demonstrates a novel role for AC6 in MSC mechanotransduction, 




The primary cilium, an organelle required for fluid shear-induced MSC 
osteogenesis in vitro and in vivo (Hoey et al., 2012b, Chen et al., 2016), localises 
AC6 and is required for fluid shear-induced cAMP signalling. Recently, it has been 
shown that several ACs localise to primary cilia in numerous cell types. Most 
notably AC6 is colocalised to the primary cilium in osteocytes (Kwon et al., 2010). 
Furthermore, mouse embryonic fibroblasts and IMCD3s have elevated basal ciliary 
cAMP levels as a result of AC5/6 localised activity, indicating a link between AC6, 
cAMP and the primary cilium (Moore et al., 2016), leading us to further investigate 
the role of AC6 in the previously demonstrated primary cilia-mediated MSC 
mechanotransduction. In this study, AC6 was shown to preferentially localise to the 
primary cilium. This specific localization to an area of high strain may potentially 
increase the mechanosensitivity of the cell. Furthermore, due to the discrete 
microdomain of the cilium and the specific localization of a plethora of signalling 
molecules, localization of AC6 to this signalling centre may amplify and enhance the 
rate of AC6-mediated mechanosignalling. Intriguingly, in MSCs which do not 
possess primary cilia, fluid shear-induced increases in cAMP are lost, which is 
consistent with that seen with AC6 knockdown. This therefore suggests that the 
localization of AC6 to the cilium is functionally significant and demonstrates a 
potential calcium independent mechanism of cilia-based mechanotransduction 
(Malone et al., 2007, Delling et al., 2016). In summary, primary cilium mediate 
MSC mechanotransduction via cAMP signalling that is likely dependent on AC6 
localization to the ciliary microdomain, demonstrating a novel molecular mechanism 
of cilia-mediated MSC mechanotransduction.  
Biochemical activation of adenylyl cyclase’s elicits a cAMP 2nd messenger and 
osteogenic response that mirrors that seen with oscillatory fluid shear in MSCs. The 
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AC agonist forskolin, a diterpene which stimulates cAMP production by directly 
activating ACs (Lorenzo et al., 1986) induced a cAMP response in MSCs similar to 
that elicited by OFS. Furthermore, forskolin induced a robust osteogenic response in 
term Cox2, Runx2 and Osteopontin, as seen following OFS, revealing itself as a 
potential novel therapeutic that mimics the beneficial effect of mechanical loading. 
This potential therapeutic role for FSK is consistent with previous findings where 
cAMP activation enhanced bone formation of transplanted MSCs in vivo, where both 
8-bromo-cAMP and FSK resulted in increased bone formation in pre-treated MSCs 
(Doorn et al., 2012). Additionally, direct activation of PKA with cAMP and 
forskolin in rat and human osteoblast-like cell lines led to activation of the 
osteocalcin promoter (Boguslawski et al., 2000). Ablation of AC6 in MSCs was 
found to inhibit the FSK induced increases in osteogenic gene expression, although 
somewhat surprising as forskolin is recognized as a broad-spectrum AC inhibitor, 
similar results have been demonstrated in vascular smooth muscle cells (VSMCs). 
This study demonstrated that the downstream consequences of cAMP signalling is 
not common to all isoforms of ACs in VSMCs, siRNA directed at AC6 was 
sufficient to reduce FSK activated AC activity (Gros et al., 2006). Moreover, 
knockdown of AC6 alone could inhibit the forskolin induced increases in cAMP and 
synthesis and arborization in control and cells with an overexpression of AC6 (Gros 
et al., 2006). Our findings agree with this study in that a knockdown of AC6 was 
sufficient to inhibit the effect of FSK in MSCs. Similarly, this study found that the 
inhibition of primary cilia formation via Ift88 siRNA blocked the forskolin induced 
increases in Cox2, Runx2 and Osteopontin. This data suggests that the primary 
cilium, and the ciliary localised AC6 are both required for forskolin induced 
alternations of osteogenic gene expression. This consistent lack of a response is an 
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interesting result which requires research, but further points to the importance of 
primary cilia. Together with our observations, this demonstrates that biochemically 
targeting mechanotransduction mechanisms, such as that identified in this study, is a 
potential strategy to enhance MSC osteogenesis and bone formation by mimicking 
the beneficial effects of physical loading. 
In summary this chapter demonstrates a novel mechanism of MSC 
mechanotransduction, whereby it was shown that MSCs utilise cAMP as an 
important 2nd messenger to initiate an osteogenic response post fluid shear 
stimulation. This was further explored and found that fluid shear-induced cAMP 
signalling is mediated by AC6 and the primary cilium. These findings add to the 
growing body of evidence detailing the importance of ciliary-based signalling in 
MSCs and highlight a calcium independent mechanism of cilia-based 
mechanotransduction in stem cells. Therefore, this study highlights this pathway, and 
the various components within, as potential targets to enhance MSC osteogenesis 
and bone formation. Importantly we have demonstrated proof of concept whereby 
forskolin activated this novel mechanism eliciting a cAMP and osteogenic response 
mirroring that seen with oscillatory fluid shear, demonstrating mechanotherapy 





























Figure S3.1: Controls in the absence of primary antibody to test for non-specific binding and 
background staining of the secondary antibodies. AC6 (green) and nuclei are counterstained with 





Figure S3.2: Controls in the absence of primary antibody to test for non-specific binding and 
background staining of the secondary antibodies. Acetylated α-tubulin, (red) and AC6 (green). Nuclei 







Table S3.1: Table related to primer sequences and concentrations employed in quantitative PCR 
analysis. 




Sequence Amplicon Size 
18s 65 400 nM 5’-GTAACCCGTTGAACCCCATT-3’ 151bp 
3’-CCATCCAATCGGTAGTAGCG-5’ 




Runx2 60 300 nM 5’-ACAAGGACAGAGTCAGATTAC-3’ 196bp 
3’-CAGTGTCATCATCTGAAATACG-5’ 
Opn 60 400 nM 5’-GGATGAATCTGACGAATCTC-3’ 188bp 
3’-GCATCAGGATACTGTTCATC-5’ 
AC1 65 300 nM 5’-AAGTCCATCTCCTCCCACC-3’ 213bp 
3’-ATCATCTCCAGCAACCACG-5’ 
AC2 65 300 nM 5’-CAGCATCTCTTCAGACCTCG-3’ 206bp 
3’-CCCCAGGACTCCAAGTACC-5’ 
AC3 65 300 nM 5’-GAAGAGACGAGGTCATCC-3’ 58bp 
3’-CAAGAAAAAGGTCAGAAGCTCC-
5’ 
AC4 65 300 nM 5’-GAACACCGAGACCCATCAA-3’ 78bp 
3’-CTCCAGAGAAGACAGCAATCC-5’ 
AC5 65 300 nM 5’-GAGCTGACCAAAGATGTTTCC-3’ 63 
3’-GTAGCACCTCCACCATGC-5’ 








AC8 65 300 nM 5’-TTCCACCGCATCTACATCC-3’ 84bp 
3’-GAGCATCCTGACCAGCTCC-5’ 
AC9 65 300 nM 5’-CATCCGTGAGAAACCTGATGC-3’ 84bp 
3’-CTATATGATCGCTCCAGCTCC-5’ 
Actb 60 1x Mm00607939_s1 115bp 













Chapter 4: Primary cilium-mediated MSC 
mechanotransduction is dependent on 





Mechanical loading is a potent stimulus regulating bone adaptation, that requires 
the replenishment of the osteoblast from a progenitor population. One such 
progenitor is the mesenchymal stem cell which undergoes osteogenic differentiation 
in response to oscillatory fluid shear. We and others have recently demonstrated a 
significant role for the primary cilium in bone mechanobiology and 
mechanotransduction, particularly in mesenchymal stem cells. Understanding the 
molecular components of cilium-mediated MSC mechanotransduction may reveal 
new insights to bone pathologies and identify more effective therapeutic targets to 
treat bone loss diseases such as osteoporosis. In this study, it was demonstrated that 
Gpr161 is a mechanoresponsive GPCR that localises to the primary cilium and is 
required for fluid shear induced cAMP signalling and downstream osteogenesis. This 
Gpr161 mediated mechanotransduction is dependent on the primary cilium but acts 
upstream of cilia localised AC6, suggesting that Gpr161 may act through AC6 to 
regulate cAMP and MSC osteogenesis. Moreover, this study demonstrates that Hh 
signalling is positively correlated with osteogenesis and demonstrate that Hh 
signalling is mechanically regulated and required for loading-induced MSC 
osteogenic differentiation through a primary cilium-Gpr161-AC6-cAMP mechanism. 
Therefore, this study has delineated a molecular mechanism of MSC 
mechanotransduction which occurs at the primary cilium, highlighting numerous 
novel therapeutic targets to enhance MSC osteogenesis, mimicking 




4.2 Introduction  
The importance of physical loading in regulating skeletal adaptation has long 
been established (Robling et al., 2007, Frost, 1963, Hu et al., 2012). Due to the finite 
lifespan and non-proliferative nature of the bone forming osteoblast (Park et al., 
2012), this cell type must be replenished from a progenitor stem cell population (Ren 
et al., 2015, Chen et al., 2016, Chan et al., 2018, Zhou et al., 2014). Therefore, it is 
hypothesised that skeletal mechanoadaptation must require the osteogenic 
differentiation of lining cells, osteoprogenitors or MSCs (Matic et al., 2016, Knight 
and Hankenson, 2013, Stavenschi et al., 2017b). However, the specific mechanism 
by which MSCs sense a mechanical stimulus and translate this into a bone anabolic 
response is not understood. Deciphering the mechanisms of stem cell 
mechanotransduction may provide novel insight into disease aetiology, in addition to 
new targets for mechanotherapeutic development to promote bone formation, by 
mimicking the beneficial effects of loading at a molecular level for diseases such as 
osteoporosis (Rando and Ambrosio, 2018, Komm et al., 2015). 
The primary cilium is a solitary cellular appendage which has recently emerged 
as a critical mediator of MSC mechanotransduction and bone mechanoadaptation 
(Chen et al., 2016, Hoey et al., 2012, Johnson et al., 2018). Extending from the 
surface of the cell into the extracellular space, the cilium is ideally positioned to 
sense environmental biophysical cues such as oscillatory fluid shear, which can drive 
osteogenic lineage commitment of MSCs (Stavenschi et al., 2017). We recently 
demonstrated the primary cilium acts as a cAMP responsive mechanosensor in 
MSCs, whereby fluid shear activates cAMP signalling and downstream osteogenesis 
that is cilium dependent (Johnson et al., 2018). Moreover, we demonstrated that that 
this cAMP and osteogenic response was mediated by AC6 which is localised to the 
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ciliary microdomain. However, although these studies have highlighted a role of the 
cilium and AC6 in stem cell mechanotransduction, it is currently unclear how 
physical manipulation of the cilium and/or AC6 can lead to downstream MSC 
osteogenesis. 
Hedgehog (Hh) signalling is an important pathway regulating stem cell 
differentiation during development (Shi et al., 2015), critical for limb patterning and 
skeletal morphogenesis (Ehlen et al., 2006), in addition to regulating adult MSC 
osteogenic lineage commitment (James et al., 2012, Spinella-Jaegle et al., 2001a). 
Hh signalling is coordinated at the primary cilium, where Smoothened activates the 
Gli transcription factors at the ciliary tip (Berbari et al., 2009, Bangs and Anderson, 
2017). Anomalies in the Hh pathway trigger skeletal abnormalities similar to that 
seen in ciliopathies (mutations in genes that encode for IFT) (Ruiz-Perez et al., 2007, 
Ehlen et al., 2006). Interestingly, cAMP has been highlighted as a regulator of Hh 
signalling. Despite a number of studies demonstrating a negative association 
(Hammerschmidt et al., 1996, Vuolo et al., 2015), a positive role for the cAMP 
pathway in Hh signalling was demonstrated in chick embryos essential for limb 
development (Tiecke et al., 2007). Moreover, activation of cAMP in mouse 
embryonic fibroblasts increases smoothened (Smo) trafficking to the cilium 
activating Hh signalling (Tiecke et al., 2007, Wilson et al., 2009). However, despite 
the role of Hh signalling in MSC osteogenesis and Hh association with cAMP and 
the primary cilium, it is currently unclear whether Hh is required for MSC 
mechanotransduction. 
G protein coupled receptors (GPCRs) constitute one of the most important 
components of cell signalling cascades, where they are the primary receiver of 
external stimuli (Tuteja, 2009). Upon contact with a ligand, or mechanical stimulus, 
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GPCRs undergo conformational changes thereby activating the exchange of 
GDP/GTP associated with the Gα (Tuteja, 2009, Chachisvilis et al., 2006), 
transducing external signals to appropriate downstream effectors. For example, 
signalling through stimulatory G-proteins (Gsα) activates adenylyl cyclase’s which in 
turn initiates cAMP signalling (Chen et al., 1997). The orphan GPCR, Gpr161, was 
recently shown to localize to the primary cilium and regulate Hh signalling via 
cAMP in mice (Mukhopadhyay et al., 2013). Furthermore, Gpr161 deficiency in 
craniofacial mesenchyme prevented intramembranous bone formation in calvarium, 
and Gpr161 knockouts were unable to undergo osteoblastic differentiation (Hwang 
et al., 2018). Given the known role for the ciliary localised Gpr161 in Hh signalling, 
via cAMP, and its critical role in skeletal development, Gpr161 represents a potential 
important component of stem cell osteogenic differentiation and possible key factor 
in cilium-mediated stem cell mechanotransduction.  
Therefore, the aim of this study was to delineate the molecular components of 
cilia-mediated stem cell mechanotransduction leading to osteogenesis; the 
identification of which could lead to new mechanotherapeutics to enhance bone 
regeneration. Herein it was demonstrated that Hh signalling is positively correlated 
with osteogenesis and demonstrates that Hh signalling is mechanically regulated and 
required for loading-induced MSC osteogenic differentiation. Moreover, this study 
identified that fluid shear activated Hh and osteogenic signalling is dependent on the 
primary cilium and ciliary localised AC6, through their control of the cAMP second 
messenger. Importantly, this study also identified an upstream component of cilium-
mediated mechanotransduction in the form of the orphan GPCR, Gpr161, which 
localises to the primary cilium. It was also demonstrated, for the first time, that 
Gpr161 is mechanoregulatory mediating loading-induced cAMP, hedgehog, and 
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osteogenic gene expression, therefore highlighting a novel mechanosensitive GPCR. 
Therefore, this study has delineated a molecular mechanism of MSC 
mechanotransduction which occurs at the primary cilium, whereby a biophysical 
stimulus triggers a Gpr161-AC6-cAMP-Hh pathway leading to MSC osteogenesis.  
4.3 Materials and Methods 
4.3.1 Mesenchymal Stem Cell Culture  
The murine mesenchymal stem cell line C3H10T1/2 was obtained from ATCC 
(LGC Standards, Teddington, Middlesex, UK). MSCs were tested to confirm lack of 
mycoplasma contamination MycoAlert PLUS detection kit (LT07, Brennan &Co). 
MSCs were maintained in Dulbecco’s modified Eagle’s medium (DMEM; D6046, 
Sigma-Aldrich, St Louis, MO, USA) with low glucose (Sigma-Aldrich, St Louis, 
MO, USA) supplemented with 10% fetal bovine serum (FBS; South American 
origin, Labtech International, Ltd. Heathfield, East Sussex, UK) and 1% Penicillin 
Streptomycin (P/S; P4333, Sigma Aldrich, St Louis, MO, USA).   
4.3.2 Mechanical Stimulation  
MSCs were seeded on fibronectin (10 µg/ml) coated glass slides and oscillatory 
fluid flow induced shear stress was applied to MSCs with the use of in house custom 
designed parallel plate flow chambers (Stavenschi et al., 2017). OFS of 1Pa was 
applied to cells at 1Hz frequency for 2 hrs for gene expression studies and 15 mins 
for cAMP studies. The no flow controls take account of the confined environment 
experienced by cells within the chambers. They consist of cell seeded glass slides 
prepared in the same way, where slides were placed within the chambers for 2 hrs or 
15 mins but are not attached to the syringe pump. 
4.3.3 Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) 
Immediately after treatment, cells were lysed with TRI Reagent® (93289; 
Sigma Aldrich, St Louis, MO, USA), and mRNA was extracted as per the 
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manufacturer’s protocol. The concentration of RNA in each sample was measured 
using a Nanodrop spectrophotometer and 400ng of RNA was reverse transcribed to 
cDNA using the High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Foster City, CA, USA). The expression of ribosomal RNA 18s (18s), 
Protein patched homolog 1 (Ptch1), Zinc finger protein GLI1 (Gli1), runt-related 
transcription factor 2 (Runx2), Osteopontin (Opn), and G Protein-Coupled Receptor 
161 (Gpr161) were amplified for analysis following treatments with cyclopamine, 
oscillatory fluid shear, and MDL-12,330A hydrochloride. Validation of transient 
siRNA knockdowns (Sigma Aldrich, St Louis, MO, USA) was also assessed by 
mRNA expression. Quantitative RT-PCR (qRT-PCR) was performed using a 20 µl 
reaction mix containing 10 µl SYBR green PCR MasterMix (Invitrogen Ltd, Paisley, 
UK), 0.8 µl of each primer, and 8.4 µl of sample and H2O mix. In the case of Runx2, 
Ac6 and Gpr161 0.6 µl of each primer was used, where an additional 0.4 µl H2O was 
added to maintain the final volume of 20 µl. Plates were run in an ABI 7500 Fast 
Real-Time PCR machine (Life Technologies, Carlsbad, CA, USA). The cycle 
parameters were as follows: Uracil N-glycosylase (UNG) activation was run for 2 
min at 50°C, DNA polymerase activation for 10 min at 95°C, the melt cycle was run 
for 15s at 95°C and the annealing–extending cycle for 1 min at 60°C for Ptch1, Gli1, 
Runx2, Opn, Ift88 and Gpr161, apart from 18s and Ac6 which was run at 65°C. A 
no-template control (NTC) was run in each 96-well plate to confirm the absence of 
contamination. Each sample was normalized to reference gene 18S and to static or 
no treatment control using relative quantification method. All primer sequences and 
concentrations are outlined in (Table S4.1).  
4.3.4 Quantification of cAMP signalling 
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Cyclic AMP activity was analysed using the commercially available Cyclic 
AMP XP® Assay Kit (Cell signalling technology, Danvers, MA, USA). Cells were 
rinsed with ice cold phosphate buffered saline following OFS (PBS; Sigma Aldrich, 
St Louis, MO, USA) and lysed on ice with 200 μl RLT lysis buffer containing 
phenylmethylsulfonyl fluoride (PMSF; 1:200; Sigma Aldrich, St Louis, MO, USA). 
Experimental samples (50 µl) were loaded into the anti-cAMP XP® rabbit mAb 
coated plate, with 50 µl HRP-linked cAMP solution and incubated on an orbital plate 
shaker for 3 hrs at room temperature (RT). Wells were washed with 200 µl 1X wash 
buffer four times, before incubating with 100 µl 3,3’,5,5’-Tetramethylbenzidine 
(TMB) substrate for 30 min at RT. Following 30 min, 100 µl stop solution was 
added. Plate absorbance was read at 450 nm. All samples including the standard 
curve were run in triplicate. Media was supplemented with 1µM 3-Isobutyl-1-
methylxanthine (IBMX) for all cAMP studies. 
4.3.5 Immunocytochemistry 
MSCs were seeded on fibronectin coated glass coverslips for 24 hours before 
serum starvation in DMEM low glucose, 0.5% FBS, 1% P/S for 48 hours. After 
fixation in neutral buffered formalin for 10 min (Sigma Aldrich, St Louis, MO, 
USA), coverslips were permeabilized in 0.1% Triton X-100 and non-specific binding 
sites were blocked using 1% w/v BSA (Sigma Aldrich, St Louis, MO, USA) in PBS 
for 2 hrs at room temperature. Primary antibody targeting the primary cilium (anti-
acetylated α-tubulin, ab24610, Abcam, Cambridge, UK) was applied at 1:1500 
overnight at 4°C. Next the primary antibody for centrioles (anti-pericentrin, ab4448, 
Abcam, Cambridge, United Kingdom) was used at a dilution of 1:1500 for 1h at RT 
to clearly identify the base of the cilium. The secondary antibodies AlexaFluor 594 
and AlexaFluor 488 (A21203, A21202; Life Technologies, California, USA) were 
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applied in tandem at 1:500 for 1h at room temperature in the dark. For validation of 
AC6 knockdown, the primary antibody targeting AC6 (anti-AC6, ab14781, Abcam) 
was applied for 1 h at room temperature at a dilution of 1:500. the secondary 
antibody AlexaFluor 488 (A21202; Life Technologies, California, USA) was applied 
at 1:500 for 1h at room temperature in the dark. For Gpr161 expression and spatial 
organization, the primary antibody targeting GPR161 (ab58679; Abcam, Cambridge, 
United Kingdom) was applied for 1h at room temperature at a dilution of 1:200 
followed by AlexaFluor 488 secondary antibody (A21202; Life Technologies, 
California, USA) for 1h at room temperature at 1:500. Finally, DAPI at 1:2000 in 
PBS (32670; Sigma-Aldrich) was applied to all samples for 5 min prior to sample 
mounting on glass slides using Prolong gold mounting medium (P36934; 
Invitrogen). Imaging was performed on the Leica SP7 (Leica Microsystems, 
Wetzlar, Germany) scanning confocal microscope at 63x (N.A. 1.40 Oil). Controls in 
the absence of primary antibody were used to test for non-specific binding and 
background staining of the secondary antibodies.  
4.3.6 Ift88/Primary cilium, Ac6 and G161 Knockdown  
Intraflagellar transport protein 88 (Ift88), Ac6 and Gpr161 were inhibited by 
siRNA. Lipofectamine RNAiMAX (Invitrogen) was diluted 1/135 in OptiMEM 
reduced serum transfection medium (Gibco, Foster City, CA, USA). For Ift88 
knockdown this was mixed 1:1 with predesigned Stealth RNAi targeting Ift88 
(MSS211714, Invitrogen) at a dilution of 16.7µM in OptiMEM and incubated at 
room temperature for 15 min before application, while for Ac6 and Gpr161 
knockdown lipofectamine was mixed 1:1 with Silencer Select Ambion small-
interfering RNA (siRNA; 4390825, AM16704; Bio-Sciences Limited, Dublin, 
Ireland) at a dilution of 60 pmol for 5 min before adding 600µl of the reaction mix to 
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cells and incubating for 8 hours at 37°C, following which 10 ml DMEM (0.5% FBS, 
1% P/S) was added to the cells for 24h. The off-target control was Stealth RNAi 
Negative Control, Medium GC (12935300, Invitrogen) and Silencer™ Negative 
Control (AM4641, Thermo-Fisher), respectively. Forty-eight hours following 
transfection the transfected cells were seeded for experimentation in DMEM (0.5% 
FBS, 1% P/S). Transfection efficiency and validation of knockdown was verified 72 
hrs after transfection by qRT-PCR and immunocytochemistry as described above.  
4.3.7 Biochemical modulation of Hedgehog signalling  
Hedgehog signalling was modulated by means of cyclopamine treatment (sc-
200929; Santa Cruz Biotechnology, Inc., Dallas, Texas, U.S.A). Cyclopamine is a 
plant derived pathway antagonist that acts at the level of Smo and thus over short 
term treatment is known to inhibit hedgehog signalling. However, long term 
treatment can result in hedgehog activation due to corrective feedback loop (Alcedo 
et al., 2000). Dose and time response studies were performed to determine the 
optimum concentration and duration of treatment of cyclopamine that effectively 
inhibited hedgehog signalling. The optimal dose and time combination of 1µM and 6 
hrs was chosen for further studies investigating the effect of Hh inhibition on OFS 
changes in Hh and osteogenic gene expression. Controls were incubated for the same 
duration of time with vehicle (Ethanol;0.02%) treated medium for both dose 
response and OFS studies.  
4.3.8 Biochemical Inhibition of cAMP Signalling  
Cyclic AMP signalling was diminished through the inhibition of adenylyl 
cyclase activity by MDL-12,330A hydrochloride as previously described (MDL; 
M182; Sigma-Aldrich, (Johnson et al., 2018)). MSCs were treated with MDL 
supplemented medium throughout application of the 1Pa mechanical stimulation, 
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and controls were incubated for the same time frame with vehicle (H2O) treated 
medium. 
4.3.9 Data Analysis  
The relative expression of each gene with reference to 18s was calculated and 
the results expressed as fold change in gene expression relative to the no flow 
scrambled or vehicle control group along with the standard error of the mean. For the 
cyclopamine, OFS, MDL treated, Ac6, Ift88 and Gpr161 knockdown studies a two-
way ANOVA analysis was performed with Bonferroni correction post-hoc tests. 
Mechanical regulation of Gpr161, Gpr161 expression post Ift88 knockdown and 
validation of Gpr161 knockdown studies were analysed using two-tailed unpaired 
student’s t-test with Wilcoxon correction. All data were analysed using Graph Pad 
Prism 8. Only primers with PCR efficiencies between 90% and 110% were used. In 
all experiments, p<0.05 was considered statistically significant. Technical replicates 




4.4 Results  
4.4.1 Hedgehog signalling is positively correlated with MSC osteogenesis 
To determine if hedgehog signalling is associated with MSC osteogenesis, 
hedgehog and osteogenic gene expression was quantified following treatment with 
hedgehog antagonist cyclopamine. Firstly, a dose response study was performed 
where cells were treated with either vehicle control (ethanol;0.02%), 1-, 5-, or 10 µM 
cyclopamine for 6, 12, or 24 h to determine the optimum concentration and time of 
cyclopamine treatment that inhibits hedgehog signalling as determined by Ptch1 and 
Gli1 gene expression (P<0.05, Figure 4.1A-E). This study found that all three 
concentrations of cyclopamine reduce hedgehog gene expression at 6 hrs (Ptch1 and 
Gli1; P<0.05; Figure 4.1A-B). However, 1- and 5 µM increased hedgehog genes at 
12 hrs (P<0.001; Figure 4.1A-B), while 10 µM did not have a significant effect at the 
later timepoints, suggestive of a biphasic effect of cyclopamine and presence of 
regulatory feedback loop.  
Interestingly, the trends seen in hedgehog signalling following cyclopamine 
treatment very closely mirror that seen in osteogenic gene expression. At 6hrs 
treatment, all three concentrations of cyclopamine reduced osteogenic gene 
expression (Runx2 and Opn; P<0.05; Figure 4.1C-D). However, at 12hrs, 1- and 5 
µM increased osteogenesis significantly (Runx2 and Opn; P<0.01; Figure 4.1C-D). 
The similar trends seen between hedgehog activity and osteogenesis indicate a strong 
positive correlation in MSCs.  
In order to study the effect of Hh signalling on downstream osteogenesis, a 
concentration of 1 µM at 6 h was chosen for all further studies, as it was the lowest 
concentration and shortest treatment time which resulted in an inhibition of all Hh 
associated genes analysed. 
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Figure 4.1: Inhibition of Hedgehog signalling in MSCs is associated with osteogenic gene 
expression. Dose and time response test of the hedgehog inhibitor cyclopamine of (A) Ptch1, (B) 
Gli1, (C) Runx2, and (D) Opn gene expression (n=3). Statistical tests employed was a two-way 
ANOVA with Bonferroni post-hoc. Values are means ± s.e.m. for three independent replicates. 
*P<0.05, **P<0.01, ***P<0.001 
 
4.4.2 Hedgehog signalling is mechanoresponsive and is required for fluid shear-
induced osteogenesis in MSCs 
Given the demonstrated correlation between Hh signalling and osteogenesis 
(Figure 4.1) and known role for mechanical loading in driving MSC osteogenic 
differentiation (Stavenschi et al., 2017, Stavenschi et al., 2018), this study next 
sought to determine whether Hh signalling was mechanoresponsive and involved in 
loading-induced osteogenesis. To determine if Hh signalling is mechanoresponsive 
in MSCs, hedgehog gene expression following 2 hrs OFS was quantified. Ptch1 and 
Gli1 expression were significantly upregulated 3.6-fold and 3.3-fold respectively 
when compared to static controls (P<0.05; Figure 4.2A-B), demonstrating that Hh 
signalling is mechanically regulated. To determine whether this Hh activation is 
required for downstream osteogenesis, MSCs were treated with cyclopamine as 
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previously described. As expected cyclopamine results in a decrease in basal Hh 
gene expression but importantly inhibits the increase in Hh signalling seen with 
mechanical loading.  
The application of 2hrs OFS significantly upregulates osteogenic genes Runx2 
and Opn 3.1-fold and 5-fold respectively (P<0.01; Figure 4.2C-D), which is 
consistent with our previous findings (Johnson et al., 2018). However, following 
inhibition of the mechano-activation of Hh signalling via cyclopamine treatment, the 
increase in MSC osteogenesis is lost, demonstrating that Hh signalling is an 
















Figure 4.2: Hedgehog signalling is mechanoresponsive and required for fluid shear induced 
hedgehog and osteogenic gene expression in MSCs. Effect of oscillatory fluid flow over cells treated 
with 1µM cyclopamine at 1Pa, 1Hz on (A) Ptch1, (B) Gli1, (C) Runx2 and (D) Opn gene expression 
after 2 hours (N=2, n=6). Cells were treated with 1µM cyclopamine for 4 hours prior and during the 2 
hours of flow. Statistical tests employed a two-way ANOVA with Bonferroni post-hoc. Values are 




4.4.3 Fluid shear-induced hedgehog and osteogenic signalling in MSCs is 
dependent on the primary cilium 
The primary cilium has previously been shown to be required for stem cell 
mechanotransduction, specifically with regards to fluid shear-induced increases in 
osteogenic gene expression (Hoey et al., 2012b). Furthermore, the cilium has long 
been associated with Hh signalling (Bangs and Anderson, 2017). Therefore, this 
study next sought to determine whether the cilium was required for mechanically 
mediated Hh and osteogenic signalling. The formation of primary cilia was inhibited 
through the utilization of siRNA targeting Ift88, which is a principal motor protein 
required for ciliogenesis. Primary cilia were identified in the perinuclear region of 
the cell, extending as rod-like structures on the apical surface (Figure 4.3A). This 
transfection procedure resulted in a reduced incidence of primary cilia as 
demonstrated by immunocytochemistry (Figure 4.3A–B) and qPCR (Figure 4.3C). 
The transfection resulted in significantly diminished Ift88 mRNA expression, which 
in turn significantly reduced the incidence of primary cilia by 70%, and shortened 
the remaining cilia demonstrated by immunocytochemistry (P<0.05; Figure 4.3C-E).  
Scrambled siRNA transfection did not affect the Hh response to fluid shear, with 
significant 2.8-fold increases in Ptch1 and 2.8-fold increase in Gli1 (P<0.05; Figure 
4.3F-G). Moreover, deletion of the primary cilium did not significantly affect basal 
Hh signalling, although a slight increase was seen in Ptch1 expression. However, in 
MSCs which have absent or defective primary cilia, the fluid shear-induced 
activation of Hh is lost, demonstrating an important role for the primary cilium in 
mechanically-mediated Hh signalling. Similarly, with regards to osteogenic gene 
expression, scrambled siRNA transfection did not affect the osteogenic response to 
fluid shear, with significant 3.2-fold increases in Runx2 and 2.9-fold increase in Opn 
(P<0.05; Figure 4.3H-I), nor did primary cilia deletion affect basal osteogenic gene 
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expression. Yet, treatment with Ift88 siRNA resulted in a loss of the fluid shear-
induced increase in osteogenic gene expression. Taken together, this data 
demonstrates that the primary cilium is required for fluid shear induced hedgehog 











Figure 4.3: Ift88 is required for fluid shear induced hedgehog and osteogenic gene expression in 
MSCs. (A-B) Intraflagellar transport protein 88 (Ift88) expression was successfully knocked down in 
MSCs using Ift88 siRNA as verified by immunostaining (A,B) and qRT-PCR (n=4; C). Cells were 
treated with either scrambled siRNA (A) or Ift88 siRNA (B) and stained for primary cilia, identified 
as linear structures enriched in acetylated α-tubulin, (red; arrows) and centrioles (green; arrow head). 
Nuclei are counterstained with DAPI (blue). Scale bars represent 10μm and 1μm (insert). Effect of 
Ift88 siRNA treatment on cilia incidence (N=4,n= 143-187; D). (F-I) Effect of oscillatory fluid flow at 
1Pa, 1Hz over cells treated with scrambled or Ift88 siRNA on (F) Ptch1, (G) Gli1, (H) Runx2 and (I) 
Opn gene expression after 2 hrs (N=2, n=6). Statistical tests employed a two-way ANOVA with 
Bonferroni post-hoc. Values are means ± s.e.m. *P<0.05, **P<0.01, ***P<0.001  
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4.4.4 Primary cilium localised adenylyl cyclase 6 is required for fluid shear-
induced hedgehog signalling in MSCs 
As AC’s have a demonstrated role in OFS-induced osteogenesis in MSCs via 
regulation of the second messenger cAMP (Johnson et al., 2018), this study 
endeavoured to further investigate the role of ACs in hedgehog dependent 
osteogenesis. AC activity was inhibited by MDL-12,330A hydrochloride (MDL) 
treatment, as previously described (Johnson et al., 2018) and MSCs were subjected 
to OFS at 1Pa, 1Hz for 2h. Expression of Ptch1 and Gli1 in vehicle treated MSCs 
exposed to OFS increased by 3.3- and 8.8-fold respectively (P<0.05; Figure 4.4A-B), 
however, this response was lost in MSCs treated with MDL, demonstrating that 
mechanical activation of Hh signalling is AC and subsequently cAMP dependent.  
We have previously demonstrated that this cAMP dependent 
mechanotransduction mechanism, was mediated by the specific adenylyl cyclase, 
AC6, which co-localises to the primary cilium (Johnson et al., 2018). Therefore, to 
investigate the role of AC6 specifically in loading-induced Hh signalling, AC6 was 
depleted in MSCs using siRNA, as verified by immunocytochemistry (Figure 4.4C-
D) and qPCR (Figure 4.4E). AC6 mRNA levels were diminished by 44% in AC6 
siRNA treated cells (Figure 4.4E). AC6 is located across the cell membrane but is 
concentrated along the ciliary axoneme (Figure 4.4C), in close contact with the 
hedgehog machinery known to localise to the ciliary microdomain (Goetz et al., 
2009). No staining was found when AC6 primary antibody was withheld (Figure 
S4.1). MSCs were treated with either off-target scrambled or Ac6 targeting siRNA 
and were subjected to 2 hrs of OFS to assess the role of AC6 in OFS-induced 
expression of Ptch1 and Gli1. Hedgehog genes in the no flow group were unaffected 
by the AC6 siRNA treatment, demonstrating that AC6 activity does not influence 
basal hedgehog signalling. When exposed to fluid shear, MSCs treated with 
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scrambled siRNA exhibited a 6.9- and 3.7-fold increase in Ptch1 and Gli1 gene 
expression, respectively (P<0.01; Figure 4.4F-G), demonstrating no effect of the 
transfection treatment.  However, upon depletion of Ac6 no change in hedgehog gene 
expression was found in MSCs following oscillatory fluid shear (Figure 4.4F-G), 
demonstrating the specific role of AC6 in regulating mechanically activated 










Figure 4.4: Adenylyl cyclases are required for fluid shear induced hedgehog gene expression in 
MSCs. (A-B) Effect of MDL on (A) Ptch1 and (B) Gli1 gene expression following oscillatory fluid 
flow at 1 Pa, 1 Hz for two hours (N=2, n=6). (C-D) Adenylyl Cyclase 6 expression was knocked 
down in MSCs using Ac6 siRNA as verified by immunostaining (C-D; N=3, n=50-77) and qPCR (E; 
N=4, n=12). Cells were treated with either scrambled siRNA (C) or Ac6 siRNA (D) and stained for 
primary cilia, identified as linear structures enriched in acetylated α-tubulin, (red; arrows) and AC6 
(green). Nuclei are counterstained with DAPI (blue). Scale bars: 10μm and 1μm (insert). (F-G) Effect 
of oscillatory fluid flow at 1 Pa, 1 Hz over cells treated with scrambled or Ac6 siRNA on expression 
of hedgehog genes (F) Ptch1 and (G) Gli1 after 2 hrs (N=4, n=9–12). Statistical tests employed a two-




4.4.5 Gpr161 is expressed by MSCs and localised to the primary cilium, where it is 
mechanically regulated upstream of AC6 
The orphan G-protein coupled receptor 161 (Gpr161) is known to localize to the 
cilium and be involved in the regulation of hedgehog signalling in the neural tube 
(Mukhopadhyay et al., 2013). Importantly Gpr161 also regulates forelimb formation, 
limb patterning and skeletal morphogenesis in a primary cilium-dependent manner 
(Hwang et al., 2018). To investigate the potential role of GPR161 in cilium-mediated 
MSC mechanotransduction, this study first determined the expression and spatial 
organization of GPR161 in MSCs using immunocytochemistry. GPR161 is 
expressed across the MSC cell membrane (Figure 4.5A) and interestingly upon co-
staining for acetylated α-tubulin, a distinct spatial organization was revealed within 
the primary cilium, with intense staining identified along the ciliary axoneme (Figure 
4.5A). No staining was found when GPR161 primary antibody was withheld (Figure 
S4.2).  
Being an orphan GPCR, the ligand for Gpr161 is unknown, however a number 
of GPCRs are mechanosensitive (Xu et al., 2018). To determine whether this is the 
case for orphan Gpr161, MSCs were subjected to 1Pa, 1Hz OFS for 2hrs and it was 
revealed that Gpr161 mRNA levels significantly increased 2.7-fold following 
exposure (P<0.01; Figure 4.5B), demonstrating the mechanoresponsive nature of this 
GPCR. Interestingly, deletion of the primary cilium significantly reduced Gpr161 
expression (P<0.05; Figure 4.5C), and Gpr161 gene expression failed to increase 
following OFS in MSCs treated with Ift88 siRNA (Figure 4.5D), indicating the 
cilium is an important regulator of this receptor. As cilia-localised GPR161 has been 
previously shown to couple to stimulatory Gsα to activate ACs and produce cAMP 
(Mukhopadhyay et al., 2013), this study next sought to investigate whether AC6 is 
involved in Gpr161 mechanoregulation. Transient deletion of Ac6 via siRNA in 
124 
 
MSCs had no effect on either basal, nor OFS-induced expression of Gpr161, 
indicating that AC6 is not a direct regulator of Gpr161 and likely acts downstream in 
MSC mechanotransduction (P<0.05; Figure 4.5E).  
Figure 4.5: Gpr161 is expressed in MSCs and localised to the primary cilium., where it is 
mechanically regulated via primary cilia but not Ac6. (A) GPR161 (green) co-localization to the 
primary cilia, identified as linear structures enriched in acetylated α-tubulin (red; arrows). Nuclei are 
counterstained with DAPI (blue). Scale bar: 10μm and 1μm (insert). (B) Effect of oscillatory fluid 
flow at 1Pa, 1Hz on Gpr161 gene expression after 2 hours. (C) Gene expression of Gpr161 following 
treatment with Ift88 siRNA. (D) Gpr161 gene expression following fluid flow over cells treated with 
scrambled or Ift88 siRNA. (E) Effect of fluid flow on Gpr161 expression over cells treated with 
scrambled or Ac6 siRNA. (N=2, n=6). Statistical test: unpaired two tailed student t-test with 
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Wilcoxon correction (B-C) and a two-way ANOVA with Bonferroni post-hoc (D-E). Values are 
means ± s.e.m. *P<0.05, **P<0.01, ***P<0.001 
 
4.4.6 Gpr161 is required for fluid shear-induced cAMP second messenger 
signalling in MSCs 
As we have previously demonstrated that the primary cilium acts as a cAMP 
responsive mechanosensor in MSCs (Johnson et al., 2018) and given the spatial 
organization of GPR161 at the primary cilium, this study next examined whether 
Gpr161 is responsible for the flow-mediated changes in cAMP signalling. To 
investigate the role of Gpr161 in cAMP signalling, Gpr161 was depleted in MSCs 
using siRNA targeting Gpr161. GPR161 was found to be abundant and localize to 
the cilium in cells treated with scrambled siRNA (Figure 4.6A), while treatment of 
Gpr161 siRNA resulted in a near complete loss of GPR161 protein expression as 
verified by immunocytochemistry (Figure 4.6B). Furthermore, Gpr161 mRNA levels 
decreased by 60% compared to scrambled control following siRNA treatment 
(P<0.001; Figure 4.6C). MSCs treated with either scrambled or Gpr161 siRNA were 
subjected to 15 min OFS to assess cAMP signalling (Figure 4.6D). OFS increased 
cAMP levels within the cell 3.21-fold compared to no flow controls in cells treated 
with scrambled siRNA (P<0.05; Figure 4.6D), which is consistent with previous 
findings (Johnson et al., 2018) and demonstrates no effect of scrambled treatment on 
MSC behaviour. However, MSCs deficient in Gpr161 do not respond to OFS with 
an activation of cAMP signalling (Figure 4.6D), indicating that Gpr161 is required 








Figure 4.6: Gpr161 is required for fluid flow induced increases in cAMP and Hedgehog gene 
expression in MSCs. (A-C) Gpr161 expression was knocked down in MSCs using Gpr161 siRNA as 
verified by immunocytochemistry (A-B) and qRT-PCR (C, N=2, n=4). Cells were treated with either 
scrambled siRNA (A) or Gpr161 siRNA (B) and stained for primary cilia, identified as linear 
structures enriched in acetylated α-tubulin, (red, arrows) and GPR161 (green). Nuclei are 
counterstained with DAPI (blue). Scale bars: 5 μm and 1 μm (insert). (D) Effect of oscillatory fluid 
flow over MSCs treated with scrambled and Gpr161 siRNA at 1 Pa, 1 Hz for 15 min on cAMP 
concentration (N=3, n=9). Statistical test: unpaired two tailed student t-test with Wilcoxon correction 
(C) and a two-way ANOVA with Bonferroni post-hoc (D-F). Values are means ± s.e.m. for a 




4.4.7 Fluid flow-induced increases in hedgehog and osteogenic signalling is 
dependent on GPR161 in MSCs 
Finally, this study wanted to investigate whether cilia localised GPR161 plays a 
role in OFS-induced increases in hedgehog and osteogenic signalling. Firstly, to 
analyse Hh signalling, both scrambled and Gpr161 siRNA treated MSCs were 
subjected to 2 hrs OFS and expression of Ptch1 and Gli1 were analysed. In the 
scrambled control MSCs, expression of Ptch1 and Gli1 increased 2.8- and 3.4- fold 
respectively, compared to no flow controls (P<0.05; Figure 4.7A-B). However, 
similar to that seen with cAMP signalling, depletion of Gpr161 resulted in a 
complete loss of the fluid shear-induced increases in hedgehog gene expression 
(Figure 4.7A-B), demonstrating that Gpr161 is a critical component of hedgehog 
activation through the regulation of cAMP second messenger signalling. 
Secondly, to determine whether Gpr161 was required for loading-induced 
osteogenesis, MSCs treated with either scrambled or Gpr161 siRNA were subjected 
to OFS for 2h, following which expression of Runx2 and Opn were analysed. MSCs 
treated with scrambled siRNA and exposed to fluid shear resulted in significant 5.35- 
and 4.7-fold increases in Runx2 and Opn mRNA levels, respectively, compared to 
no-flow controls (P<0.05; Figure 4.7C-D). However, similar to that seen with cAMP 
and Hh signalling, depletion of Gpr161 resulted in a loss of the fluid shear-induced 
increases in osteogenic gene expression (Figure 4.7 C-D), demonstrating that Gpr161 




Figure 4.7: Fluid flow-induced increases in Hedgehog and Osteogenic signalling is dependent on 
Gpr161 in MSCs. Effect of oscillatory fluid flow at 1 Pa, 1 Hz over cells treated with scrambled or 
Gpr161 siRNA on expression of hedgehog genes Ptch1 (A) and Gli1 (B) after 2 hrs. Effect of 
oscillatory fluid flow at 1 Pa, 1 Hz on expression of osteogenic genes (C) Runx2 and (D) Opn after 2 
h (N=4, n=9–12), as determined by qRT-PCR. All groups are compared to no-flow scrambled control. 
Statistical test: two-way ANOVA with Bonferroni post-hoc. Values are means ± s.e.m. for a 





Figure 4.8: Schematic of proposed molecular mechanism of cilia mediated mechantoransduction in 
MSCs. (1-2) Fluid flow activates GPR161 to bind to AC6. (3-5) AC6 catalyzes the conversion of 
ATP into cAMP that stimulates an increase in the hedgehog genes Ptch1 and Gli1, further resulting in 





The benefits of physical loading to skeletal mass and architecture is well known, 
yet the mechanisms mediating mechanoadaptation are poorly understood. We and 
others have recently demonstrated a significant role for the primary cilium in bone 
mechanobiology and mechanotransduction, particularly in mesenchymal stem cells 
(Chen et al., 2016, Corrigan et al., 2018, Hoey et al., 2012b, Johnson et al., 2018, 
Labour et al., 2016). Although the cilium can be targeted directly to module MSC 
mechanosensitivity and osteogenesis (Corrigan et al., 2019), understanding the 
molecular components of cilium-mediated MSC mechanotransduction may reveal 
new insights to bone pathologies and identify more effective therapeutic targets to 
treat bone loss diseases such as osteoporosis. In this study, it was demonstrated that 
GPR161 is a mechanoresponsive GPCR, which localises to the primary cilium, and 
is required for fluid shear induced increases in cAMP and downstream osteogenesis. 
This GPR161 mediated mechanotransduction is dependent on the primary cilium but 
acts upstream of AC6, suggesting that GPR161 may act through AC6 to regulate 
cAMP and MSC osteogenesis. Moreover, this study demonstrates that Hh signalling 
is positively correlated with osteogenesis and demonstrate that Hh signalling is 
mechanically regulated and required for loading-induced MSC osteogenic 
differentiation through a primary cilium-Gpr161-AC6-cAMP mechanism. Therefore, 
this study has delineated a molecular mechanism of MSC mechanotransduction 
which occurs at the primary cilium, whereby a biophysical stimulus triggers a 
GPR161-AC6-cAMP-Hh pathway leading to MSC osteogenesis, highlighting 
numerous novel therapeutic targets to enhance MSC osteogenesis, mimicking 
mechanotransduction at a molecular level.  
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Hedgehog activity is positively correlated with osteogenic signalling, is 
mechanoresponsive, and required for loading-induced increases in MSC 
osteogenesis. The correlation between Hh activation and osteogenic gene expression 
demonstrated here is consistent with previous findings in rodent bone marrow 
MSCs, where treatment with N-terminal Sonic Hh (Shh) increases the percentage of 
cells responding positively to BMP2, in terms of alkaline phosphatase production, 
proliferation and osteogenic differentiation (Cai et al., 2012, Kinto et al., 1997, 
Spinella-Jaegle et al., 2001b, Chen et al., 2016c). Moreover, these studies found 
decreased adipocyte differentiation, highlighting the potential for Hh agonists to 
constitute novel therapeutics for preventing osteopenic disorders. Interestingly, Hh 
signalling is activated in response to fluid shear and is required for downstream 
osteogenesis in MSCs, identifying a key pathway in MSC mechanotransduction. 
Hedgehog signalling in chondrocytes has been shown to be mechanoresponsive to 
cyclic tensile strain and hydrostatic pressure where application of both stimuli 
increased Hh gene expression, and transcription of Ptch1 and Gli1 genes (Thompson 
et al., 2014, Shao et al., 2012). Similarly, our lab has previously shown that both 
cyclic hydrostatic pressure and oscillatory fluid shear can induce osteogenic linage 
commitment in MSCs (Stavenschi et al., 2018, Stavenschi et al., 2017), indicating 
that Hh signalling may regulate osteogenesis in response to multiple forms of 
biophysical stimuli. Hence this data adds to the significance of Hh signalling in 
regulating stem cell behaviour and demonstrates the importance of Hh in MSC 
mechanotransduction and loading-induced osteogenesis. 
Gpr161 is novel mechanosensitive GPCR required for loading-induced stem cell 
differentiation. Gpr161 is an orphan GPCR (Hwang et al., 2018, Mukhopadhyay et 
al., 2013), however upon application of mechanical stimulation via OFS, an 
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upregulation of Gpr161 was found, therefore leading us to believe that Gpr161 may 
be mechanoresponsive. Moreover, the removal of Gpr161 in MSCs results in an 
altered response to fluid shear in relation to cAMP concentrations and downstream 
osteogenic gene expression, that was upstream of AC6. Stimulatory G-proteins (Gsα) 
and AC complexes have been long studied as a model for signal transduction (Chen 
et al., 1997). Gsα stimulates AC’s resulting in increased cAMP levels and activating 
the PKA‐dependent gene transcription pathway (Wilson et al., 2009). Previously, we 
demonstrated that OFS activates an AC6-dependent cAMP pathway mediating early 
osteogenic gene expression (Johnson et al., 2018), indicating that GPR161, as a Gsα, 
may be acting through AC6 to coordinate MSC osteogenesis. Interestingly, studies 
using knockout mouse models found that deletion of Gsα in osterix expressing cells 
results in severe osteoporosis with fractures at birth and an increase in bone marrow 
adipocytes (Sinha et al., 2014, Wu et al., 2011). Furthermore, given the demonstrated 
role for Gpr161 in skeletal development (Hwang et al., 2018) and the importance of 
mechanics in developmental biology (Nowlan et al., 2007), Gpr161 may represent a 
novel mechanosensor in the mechanobiology of development. Interestingly, this 
study also demonstrates that Gpr161 is required for increases in Hh signalling which 
is consistent with a Gsα-AC-cAMP mediated activation of PKA mechanism resulting 
in trafficking of Smo into the cilium and the activation of Hh signalling (Wilson et 
al., 2009, Bachmann et al., 2016). While our data points to a positive association 
between Gpr161 and Hh signalling via cAMP, studies have presented conflicting 
results where Gpr161 acting as a negative regulator of Hh (Mukhopadhyay et al., 
2013). While this discrepancy is currently unclear and requires further analysis, our 
data convincingly demonstrates a critical role for Gpr161 in stem cell 
mechanotransduction. The identification of a regulatory GPCR in MSC 
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mechanotransduction opens this GPCR up as a future target for 
mechanotherapeutics. 
Both Gpr161 and Hh mediated-MSC mechanotransduction require the primary 
cilium, highlighting two new components of cilium-mediated mechanotransduction. 
The primary cilium is known to play an important role in stem cell and bone 
mechanobiology in vitro and in vivo (Chen et al., 2016, Hoey et al., 2012b) but the 
mechanisms by which the cilium coordinates this process are poorly understood. The 
identification of Gpr161 as a cilia-localised GPCR acting upstream of AC6 
coordinating cAMP signalling and osteogenesis is an important step in the 
elucidation of the mechanism of cilium mechanotransduction and identifies a 
missing upstream mechanosensitive component that can activate AC6 likely via Gsα. 
The identification of a cilia-localised mechanosensitive GPCR may also aid in the 
explanation of recently identified calcium independent cilia-mechanosensing 
mechanisms (Malone et al., 2007, Delling et al., 2016). While it is well reported that 
Hh signalling is linked to the primary cilium in mammalian cells (Shao et al., 2012, 
Bangs and Anderson, 2017, Goetz et al., 2009), this study highlights the regulation 
of mechanically-induced Hh via primary cilia. Interestingly, this study also 
demonstrates that this Hh signalling is dependent on Gpr161 and AC6, which we 
previously demonstrated was a critical component of cilium-mediated 
mechanotransduction. In summary, this study has delineated a novel molecular 
mechanism of MSC mechanotransduction which occurs at the primary cilium, 






Figure S4.1: Controls in the absence of primary antibody for AC6 to test for non-specific binding and 
background staining of the secondary antibodies. Acetylated α-tubulin, (red) and AC6 (green). Nuclei 
are counterstained with DAPI (blue; C). N=3, n= 72-80. Scale bars: 10μm and 1μm (insert).  
 
Figure S4.2: Controls in the absence of primary antibody for GPR161 to test for non-specific binding 
and background staining of the secondary antibodies. Acetylated α-tubulin, (red) and GPR161 
(green). Nuclei are counterstained with DAPI (blue; C). Scale bars: 10μm and 1μm (insert).   
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Table S4.1: Table related to primer sequences and concentrations employed in 

























































Chapter 5: Tibia loading reactivates 
Leptin-receptor expressing bone lining cells 





Bone marrow stem cells represent a quiescent cell population that replenish the 
non-replicative osteoblast bone forming cell over time and in response to injury, 
maintaining bone mass and repair. A potent mediator of stem cell differentiation in 
vitro and bone formation in vivo is physical loading, yet it is unclear whether 
loading-induced bone formation requires the osteogenic differentiation of resident 
stem cells. Therefore, in this study we utilized Leptin Receptor to identify and trace 
the contribution of bone marrow stem cells to bone mechanoadaptation. Lepr-Cre; 
tdTomato+ mice were subjected to compressive tibia loading with a 11N peak load 
for 40 cycles, every other day for 2 weeks. Histological analysis revealed that Lepr-
Cre; tdTomato+ cells arise perinatally around blood vessels and on bone surfaces 
overtime. Lepr-Cre ;tdTomato+ stem cells within the marrow increase over time and 
following tibial compressive loading. Mechanical loading induces an increase in 
bone mass and bone formation parameters, yet loading does not result in an increase 
in Lepr-Cre; tdTomato+ osteoblasts or osteocytes. Moreover, Lepr-Cre; tdTomato+ 
mice were further crossed with AC6fl/fl mice to generate a LepR specific knockout of 
AC6, in order to investigate the role of AC6 in this mechanoadaptive response. Lepr-
Cre; tdTomato+; AC6fl/fl animals have an attenuated response to compressive tibia 
loading, where bone is not formed on the endosteal surface, nor is there a change in 
the percentage of Lepr-Cre; tdTomato+ cells. This therefore demonstrates that LepR+ 
cells on the bone surface directly contribute to bone formation and that adenylyl 
cyclase 6 is required for activation of these cells in response to loading, highlighting 
an activation of the resident bone lining cells via AC6 as the predominant 
mechanism mediating short term loading-induced bone formation.  
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5.2 Introduction  
Physical loading is a potent regulator of bone anabolism, yet the cellular mechanisms 
by which this occurs are poorly understood (Frost, 1990, Meakin et al., 2014). Due 
to the finite lifespan of bone forming osteoblasts (Park et al., 2012), it is 
hypothesized that these cells must be replenished from a bone marrow stem cell 
(MSC) population in response to loading, as is seen in response to injury (Zhou et 
al., 2014, Park et al., 2012, Liu et al., 2019, Stavenschi et al., 2017, Knight and 
Hankenson, 2013). Although, loading induced MSC differentiation can be 
coordinated indirectly by the osteocyte, numerous studies have demonstrated bone 
mechanoadaptation in the absence of osteocytes (Kwon et al., 2012) or in models 
where the osteocyte is not directly loaded (Curtis et al., 2018). This indicates that the 
application of a mechanical stimulus may directly stimulate bone marrow skeletal 
stem cells (BMSCs) within the marrow to undergo osteogenic differentiation 
(Stavenschi et al., 2018, Stavenschi et al., 2017). However, whether loading 
regulates BMSC differentiation in vivo and how BMSCs sense this loading is 
currently unknown. 
The establishment of a robust BMSC marker is critical for the identification and 
lineage tracing of BMSCs in vivo. BMSCs are traditionally described as plastic-
adherent, colony forming, non-hematopoietic cells, which can differentiate into 
chondrogenic, adipogenic and osteogenic progeny (Zhou et al., 2014, Bianco et al., 
2008). Furthermore, BMSCs are often perivascular in vivo, where murine BMSCs 
are characterized by their lack of expression of hematopoietic and erythropoietic 
markers (CD45- and TER-119-), and positive expression of PDGFRα, Sca1, CD51, 
CD105, CD90, Nestin, αSMA, and combinations thereof (Morikawa et al., 2009, 
Nakao et al., 2010, Zhou et al., 2014, Chan et al., 2015). While MSCs can be 
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retrospectively identified based on the above parameters, an appropriate method for 
their prospective identification is lacking, and their location and physiological 
functions in vivo have been elusive. Recently, Leptin Receptor positive (LepR+) cells 
were identified as being perivascular and a major source of the Scf within bone 
marrow (Zhou et al., 2014, Ding et al., 2012, Ding and Morrison, 2013). 
Additionally, these LepR+ cells were found to express the bone marrow MSC 
markers PDGFRα, and CD51 and to be highly enriched for fibroblast colony-
forming units (CFU-F). Moreover, analyses indicated that LepR+ cells in the bone 
marrow largely overlap with Nestin, an intermediate filament protein that is known 
as a neural stem/progenitor cell marker in adult bone marrow (Zhou et al., 2014, 
Mizoguchi et al., 2014). LepR+ cells not only express BMSC markers, but were 
shown to be functional, in that they were the main source of new osteoblasts and 
adipocytes in adult bone marrow, are recruited to sites of injury, and could form 
bony ossicles that support haematopoiesis in vivo (Zhou et al., 2014), therefore 
making them an ideal candidate when investigating the role of BMSCs in loading 
induced bone formation. 
BMSCs utilize cAMP as a second messenger in mechanotransduction, a signal 
that is mediated by adenylyl cyclase’s (Johnson et al., 2018). Adenylyl cyclases are a 
family of transmembrane enzymes responsible for the catalyzation of the cyclization 
of ATP into cAMP (Kamenetsky et al., 2006). Adenylyl cyclase’s comprise of a 
family of nine distinct transmembrane isoforms (AC1-AC9), where each of the 
transmembrane ACs have individual regulatory properties, and the nine subtypes are 
expressed in only a limited number of tissues (Hanoune and Defer, 2001, Defer et 
al., 2000). Specifically, AC6 has been shown to be expressed in mature bone cells 
and is required for loading-induced bone formation in vivo (Lee et al., 2014). 
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Interestingly, skeletally mature mice, with a global deletion of AC6, did not present 
with a skeletal phenotype but formed significantly less bone than control mice 
following ulnar loading, demonstrating that AC6 is involved specifically in 
mechanotransduction leading to functional bone mechanoadaptation (Lee et al., 
2014). Interestingly, in a previous study we have demonstrated a novel MSC 
mechanotransduction pathway whereby fluid shear increases in cAMP and 
osteogenesis were regulated via AC6 (Johnson et al., 2018). This highlights the 
importance of AC6 in MSC mechanotransduction, however, the role of AC6 in 
BMSC mechanobiology in vivo is unknown.  
While LepR+ marrow stromal cells have been shown to be critical to adult bone 
formation, the role of these cells in mechanoadaptation is not known, therefore, this 
study aimed to characterise the contribution of LepR+ marrow stromal cells to 
loading-induced bone formation. Utilising Lepr-Cre; tdTomato+ mice, we 
demonstrate that LepR+ cells arise perinatally in the brain and bone regions, 
appearing perivascularly before expanding overtime and undergoing osteoblastic and 
osteocytic differentiation, acting as the main source of bone forming cells. The 
application of compressive loading increases bone formation in mice tibia and also 
increases the percentage of Lepr-Cre; tdTomato+ stromal cells within the morrow. 
However, no changes in the percentage of Lepr-Cre; tdTomato+ osteoblasts or 
osteocytes were found, suggesting that physical loading is not playing a role in the 
recruitment of LepR+ cells, but rather the activation of resident cells at the bone 
surface. Furthermore, the role of AC6 in MSC mechanobiology in vivo was 
investigated using LepR specific deletion, as previous studies found AC6 to be a 
pivotal regulator of fluid shear induced osteogenesis. AC6 deletion in LepR+ cells 
resulted in a loss of cortical bone mechanoadaptation, further highlighting the 
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contribution of LepR+ bone lining cells to loading-induced bone formation and 
critical role of AC6 in this process. 
5.3 Materials and Methods  
5.3.1 Mice 
All transgenic mice were maintained in a C57BL/6 background. Transgenic 
mice B6.129-Leprtm2(cre)Rck/J, B6.Cg-Ct(ROSA)26Sortm9(CAG-tdTomato)Hze/J and B6;129-
Adcy6tm1.1Dek/J were purchased from Jackson laboratories (Maine, USA), and 
rederived in house. B6.129-Leprtm2(cre)Rck/J and B6.Cg-Ct(ROSA)26Sortm9(CAG-
tdTomato)Hze/J were crossed to generate heterozygous B6.129-Leprtm2(cre)Rck/J and 
heterozygous B6.Cg-Ct(ROSA)26Sortm9(CAG-tdTomato)Hze/J breeding pairs. B6.129-
Leprtm2(cre)Rck/J::B6.Cg-Ct(ROSA)26Sortm9(CAG-tdTomato)Hze/J offspring heterozygous 
for B6.Cg-Ct(ROSA)26Sortm9(CAG-tdTomato)Hze/J were used for all studies (Figure 
S5.1).  Heterozygous Lepr-Cre; tdTomato+ mice were subsequently crossed with 
B6;129-Adcy6tm1.1Dek/J to generate animals with a knockout for AC6 in Lepr-Cre; 
tdTomato+ expressing cells resulting in a Lepr-Cre; tdTomato+; AC6fl/fl. Genotyping 
of ear-punch DNA was performed externally by Transnetyx (Cordova, TN, USA). 
All mice used were female. The procedures performed in this study were approved 
by Trinity College Dublin Animal Research Ethics and Health Products Regulatory 
Authority in Ireland.  
5.3.2 Histological analysis 
Embryos, organs, and tibiae from all groups were dissected, fixed for 12 hrs in 
neutral buffered formalin (Sigma-Aldrich), further decalcified in 10% EDTA 
(Sigma-Aldrich), and processed for standard paraffin embedding. Transverse 10µm 
sections were taken from individual samples and multiple sections were used in 
subsequent procedures. Prior to staining, sections were dewaxed and rehydrated. For 
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Haematoxylin and Eosin (H&E) staining, sections were stained with HARRIS 
Hematoxylin solution (Sigma-Aldrich-HHS32) for 4 min before rinsing and staining 
with Eosin Y solution (Sigma-Aldrich- HT110232) for 2 min. Sections were 
subsequently rehydrated and mounted using DPX (Sigma-Aldrich). Slides were 
imaged on an Aperio Scanscope CS2 (Leica biosystems, Germany). For 
immunofluorescence studies, bones tissue was fixed, decalcified and cryoembedded. 
Sections of 20m were sliced with a cryostat. DAPI at 1:2000 in PBS (32670; 
Sigma-Aldrich-Aldrich) was applied to all samples for 5 min prior to sample 
mounting on glass slides using Prolong gold mounting medium (P36934; 
Invitrogen). Imaging was performed on the Leica SP7 (Leica Microsystems, 
Germany) scanning confocal microscope at 20x. 
5.3.3 Flow cytometry  
To quantify the percentage of tdTomato+ cells in a given population, organs 
were harvested, minced and homogenized, and cell suspension filtered through a 70 
µm cell strainer. After centrifugation, cell pellets were resuspended in 1mL red-cell 
lysis buffer 242mg Tris (Sigma-Aldrich, 20mM), 802g NH4Cl (Sigma-Aldrich, 
150mM) and 100mL diH20, sterile filtered for 5 min on ice, then washed and 
resuspended in 1mL flow cytometry buffer composed of PBS (Sigma-Aldrich) with 
0.5% BSA (Sigma-Aldrich) and 2mM EDTA (Sigma-Aldrich, pH7.2).  
Left and right tibia were isolated, and the bone marrow was flushed from the 
marrow cavity with 3mL Dulbecco’s modified Eagle’s medium (DMEM; D6046, 
Sigma-Aldrich). Once flushed, cells were centrifuged at 400g for 5min, and re-
suspended in 1mL red-cell lysis buffer for 5 min on ice. Cells were washed before 
subsequent re-suspension in 2% Phosphate Buffer Saline (PBS)-Foetal Bovine 
Serum (FBS) and incubated on ice for 30 min. Cells were then incubated for 30 min 
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on ice with CD45 (1:100, 563890, BD Biosciences, 50g at 0.2mg/mL) and TER-
119 (1:100, 564760, BD Biosciences, 50g at 0.2mg/mL) antibodies. After washing 
in PBS, cells were re-suspended in 1mL flow cytometry buffer. Flow cytometry 
analysis was performed on a BD LSRFortessa (BD Biosciences) at medium speed 
and gated at 100,000 events of tdTomato+ cells.  
5.3.4 In vivo axial tibia loading 
Mice at 12 weeks of age were anesthetised using 4% isoflurane and 2L oxygen 
and maintained at 1.5-2% isoflurane and 1L oxygen. The right tibia was placed 
between 2 cups attached to an electromagnetic loading system with feedback control 
(ElectroForce 5500, TA Instruments, DE, USA). After an initial 2N load, a peak 
compressive load of 11N was applied, for 40 cycles with 10 seconds of rest between 
each cycle, every second day, for 2 weeks as previously described (De Souza et al., 
2005). Left tibiae served as non-loaded internal controls. As no phenotypical 
difference was found between AC6 WT and KO mice, the same loading protocol 
was used in both studies. Body weight was measured at 12 weeks of age and on 
subsequent loading days. All animals were euthanized on d18 and prepared for either 
dynamic histomorphometric, histological or flow cytometry analysis.  
5.3.5 Micro-computed tomography (microCT) analysis 
Mice were placed under isoflurane anaesthesia as described above. Tibiae were 
imaged by in vivo microCT (Scanco vivaCT 80; Scanco Medical AG, Brüttisellen, 
Switzerland). The trabecular and cortical area were scanned with a voxel size of 10- 
and 25 µm, respectively. Scans were performed using a voltage of 70 kVp, and a 
current of 114 μA. A Gaussian filter (Sigma = 0.8, support = 1) was used to suppress 
noise and a global threshold of 150 was applied for scan analysis. The bone volume, 
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densities and other parameters were then quantified using scripts provided by 
Scanco. 
Whole body scans were taken for phenotypic analysis of Lepr-Cre; tdTomato+; 
AC6fl/fl. mice. Briefly, after euthanasia whole body scans were realised at 15 m 
voxel size.  
5.3.6 Dynamic histomorphometry 
Mice were subcutaneously injected with calcein (15 mg/kg body weight; C0875; 
Sigma-Aldrich-Aldrich) on d7 and alizarin red (30 mg/kg body weight; A5533; 
Sigma-Aldrich-Aldrich) on d14 following initiation of loading. For Lepr-Cre; 
tdTomato+; AC6fl/fl mice, calcein injections were given on both d7 and d14. Left and 
right tibiae were isolated, cleaned of soft tissue, and stored in 70% ethanol for 
histomorphometry. The tibiae were then dehydrated in graded alcohol (70–100%), 
infiltrated with three changes of Technovit 9100 methyl methacrylate (CN Technical 
Services Ltd; UK), and embedded in Technovit 9100 following manufacturer 
recommendation. Transverse sections of the embedded tibia midshaft were imaged 
on a Leica SP7 (Leica Microsystems, Germany) scanning confocal microscope. 
Measurements of bone perimeter, single label perimeter, double label perimeter, and 
double label area were completed with ImageJ and used to calculate mineralizing 
surface/bone surface (MS/BS), mineral apposition rate (MAR), and bone formation 
rate/bone surface (BFR/BS). Measurements were taken at both the endosteum and 
periosteum. 
5.3.7 Immunofluorescence image analysis-LepR/tdTomato cell counting 
A region of interest for cortical bone was calculated and drawn starting 3mm 
from the tibia-fibula junction and continued for 100 slices, therefore was 2500µm 
towards the tibial proximal metaphysis. Using ImageJ, the number of red cells along 
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the bone surface, both endosteal and periosteal surfaces and embedded within bone 
were counted for both regions of interest.  
5.3.8 Statistical Analysis  
For flow cytometry of organs, a one-way ANOVA analysis was performed with 
Tukey correction post-hoc test. For comparison of DHM data between AC6 WT and 
KO a two-way ANOVA was performed with a Tukey correction test. For all other 
studies a paired two tailed student t-test with Wilcoxon correction was employed. All 
data were analysed using Graph Pad Prism 8. In all experiments, p<0.05 was 




5.4 Results  
5.4.1 LepR+ cells arise pre-natally in numerous tissues including bone  
LepR+ cells arose prenatally in bone and brain tissue. Lepr-Cre; tdTomato+ 
expression has been detected in adult mice, however, little is known regarding LepR 
expression during embryonic development, therefore, LepR expression was 
analysed, using the Lepr-Cre; tdTomato+ mouse at day E19.5. Gross anatomy of 
embryos was assessed using H&E staining, where no anatomical abnormalities were 
found (Figure 5.1A-B). Lepr-Cre; tdTomato+ cells were identified by day E19.5, 
primarily in the brain and bone regions, where tdTomato+ cells were found in the 
cerebral cortex, mid brain, cerebellum and choroid plexus (Figure 5.1C-D, I-J). 
tdTomato+ cells were also found in the bone regions such as the cervical spine, ribs 
and nasal bones in the embryos (Figure 5.1E, F, K), however, no Lepr-Cre; 
tdTomato+ cells were found in any other organs, highlighting that Lepr-Cre; 
tdTomato+ is differentially expressed in embryos at day E19.5 (Figure 5.1G-H).  
Fore-and hind-limbs were investigated in further detail as bone is the primary 
focus of this study. Using H&E staining the anatomy of day E19.5 embryonic limbs 
showed no abnormalities (Figure 5.1L-M). Lepr-Cre; tdTomato+ cells were detected 
in the ossification zone of the radius, ulna and tibia (Figure 5.1N-P). No signal was 
found in the hypertrophic zones nor in the skeletal muscle (Figure 5.1N-P).  
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Figure 5.1: Lepr-Cre ;tdTomato+ cells arise pre-natally in numerous tissue including bone. (A-K) To 
assess whether Lepr-Cre ;tdTomato+ was actively expressed in embryo tissues, heterozygous LepR 
embryos were harvested at E19.5 days and processed for histological analyses with Hematoxylin and 
Eosin staining (A-B;L-M) and the nuclear dye DAPI (C-K; N-P). (A-B) Hematoxylin and Eosin 
staining of an embryo in the sagittal plane (A) and embryo head in the transverse plane (B). (C-K) 
Confocal microscopy revealed LepR staining in the cerebral cortex (C), midbrain (D), cervical spine 
(E), ribs (F), cerebellum (I), choroid plexus (J) and nasal bone (K). No staining was found in the liver 
(G) or the intestines (H). (L-M) Hematoxylin and Eosin staining of embryo fore- (L) and hind limbs 
(M). (N-P) Confocal microscopy revealed Lepr-Cre ;tdTomato+ staining in the ossification zone 
regions of the radius (N), ulna (O), and tibia (P). n=4. Scale bar 100µm   
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5.4.2 LepR+ cells expand overtime and are present in all major organs 
The pattern of Lepr-Cre; tdTomato+ expression was further investigated post-
natally. H&E staining was used to investigate the anatomy of the organs, and to 
more accurately identify the location of Lepr-Cre; tdTomato+ cells at 8- and 12-
weeks of age (Figure 5.2A-F). Lepr-Cre; tdTomato+ cells were found in various 
organs including the liver, kidney medulla, lung, spleen, and heart (Figure 5.2A-B, 
D-F). Interestingly, tdTomato+ cells decreased in expression from the medulla region 
to the cortex of the kidney (Figure 5.2C). In general, Lepr-Cre; tdTomato+ cells 
increased over time, from 8- to 12-weeks of age, in all organs (Figure 5.2A-F). 
Quantification of cell number within each organ using flow cytometry in 12-week 
old Lepr-Cre; tdTomato+ mice further highlighted the spatial differences in LepR+ 
cells. The percentage of tdTomato+ was lowest in the heart and highest in the liver, 




Figure 5.2: Lepr-Cre ;tdTomato+ cells expand overtime and are present in all major organs. To assess 
whether Lepr-Cre ;tdTomato+ was actively expressed in adult tissues, organs were harvested from 8 
and 12-week-old Lepr-Cre ;tdTomato+ mice and processed for histological analyses with the nuclear 
dye DAPI. (A-D) Confocal microscopy revealed LepR signal various organs including the liver (A), 
kidney medulla (B), lung (D), spleen (E), and heart (F). LepR signal reduced from the medulla to the 
kidney cortex (C). n=3. Scale bar 100µm. (G) Flow cytometry analyses revealed that in 12-week-old 
mice Lepr-Cre ;tdTomato+ cells vary between organs, where Lepr-Cre ;tdTomato+ expression  is 
lowest in the heart 1.2-2.3% and highest in the liver 23.3-38.4%. Statistical tests employed was a one-




5.4.3 LepR+ bone marrow cells appear around sinusoids and contribute to 
osteoblast and osteocyte populations over time  
Sections from Lepr-Cre; tdTomato+ mice exhibited perivascular Lepr-Cre; 
tdTomato+ staining throughout the bone marrow. The expression of Lepr-Cre; 
tdTomato+ cells of 8- and 12-week old mice were analyzed in greater depth in the 
tibiae. Sagittal sections of tibia were imaged using confocal microscopy and the 
trabecular and cortical bone regions examined for patterns of Lepr-Cre; tdTomato+ 
cell expression (Figure5.3A). Firstly, looking at the trabecular region of the tibiae of 
8-week old Lepr-Cre; tdTomato+ mice, Lepr-Cre; tdTomato+ cells were found within 
the marrow space between trabeculae (Figure 5.3Bi-Cii) where these cells located 
around sinusoids (Figure 5.3Bii). Small populations of Lepr-Cre; tdTomato+ cells 
were also found lining and embedded within trabecular struts (Figure 5.3Bi, Ci & 
Dii). While Lepr-Cre; tdTomato+ cells are expressed perivascularly and along the 
bone surface, no Lepr-Cre; tdTomato+ cells were found in the growth plate, 
indicating that LepR+ cells do not contribute to chondrocytes during normal 
development (Figure 5.3Di). By 12- weeks of age, the prevalence of Lepr-Cre; 
tdTomato+ cells found perivascularly within the trabecular bone marrow increased 
(Figure 5.3Ei-ii), while Lepr-Cre; tdTomato+ cells also increased along and within 
the trabecular bone (Figure 5.3E-Eii). Interestingly, at 12 weeks of age, Lepr-Cre; 
tdTomato+ cells along the surface of trabecular bone morphologically resembled that 
of cuboidal active osteoblasts (Figure 5.3 F; yellow arrows) suggestive of 
osteoblastic differentiation of LepR+ bone marrow stromal cells. Furthermore, the 
population of Lepr-Cre; tdTomato+ cells found embedded within trabecular bone 
(Figure 5.3F; green arrows) is evidence of osteocytic differentiation.  
Examining the cortical bone region of the mid tibia, a small population of Lepr-
Cre; tdTomato+ cells were found along the bone surface at 8-weeks of age (Figure 
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5.3A). Therefore, at 8 weeks of age Lepr-Cre; tdTomato+ cells are largely restricted 
perivascularly and not to more differentiated mesenchymal derived osteogenic 
derivatives in the bone marrow. Flow cytometry revealed that 0.8-0.85% of bone 
marrow cells in the tibia are Lepr-Cre; tdTomato+ positive at 8 weeks of age (Figure 
5.3 F). The pattern of an expansion of this cell population seen in trabecular bone 
held true when the cortical bone was further examined (Figure 5.3 C), where at 12 
weeks, Lepr-Cre; tdTomato+ cells were found perivascularly (Figure 5.3Di), along 
the endosteal surface (Figure 5.3Dii & E; yellow arrow) and embedded within 
cortical bone (Figure 5.3E; green arrows) at this later time point. This observation of 
a histological increase was confirmed using flow cytometry, where the percentage of 
Lepr-Cre; tdTomato+ cells in the tibia increased by 2.6% from week 8 to 3.4% in 12-
week-old mice (Figure 5.3G). Furthermore, LepR+CD45-Ter119- bone marrow 
stromal cells accounted for 0.073-0.348% of enzymatically dissociated bone marrow 
cells within the tibia (Figure 5.3H). Together, this data demonstrates that Lepr-Cre; 
tdTomato+ bone marrow stromal cells appear perivascularly, where over time they 
expand, are recruited to the bone surface of both trabecular and cortical bone and 




Figure 5.3: Lepr-Cre ;tdTomato+ bone marrow cells appear around sinusoids and contribute to 
osteoblast and osteocyte populations over time in cortical bone. To assess whether LepR was actively 
expressed in adult tibia, limbs were harvested from 8- and 12-week-old mice. Lepr-Cre ;tdTomato+ 
mice and processed for histological analyses with and the nuclear dye DAPI. (A) LepR signal was 
found on the endosteal surface of cortical bone at 8-weeks. (B) Representative cross section of Lepr-
Cre ;tdTomato+ tibia, highlighting the presence of LepR:tdTom cells on the periosteal surface. (C) 
Representative image of a 12-week old tibia. (Di-ii). Confocal microscopy revealed LepR signal 
perivascularly in the marrow space (Bi) and along the cortical bone surface (Dii). (E) LepR is 
expressed on the bone surface (yellow arrow) and embedded within bone (green arrow). n=4. Scale 
bar 50µm. (F) Flow cytometry analyses revealed that in 8-week-old mice Lepr-Cre ;tdTomato+ make 
up 0.8-0.85% and 0.5-0.9% of bone marrow cells in the tibia and femur, respectively. (G) Flow 
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cytometry analyses revealed that in 12-week-old mice Lepr-cre ;tdTomato+ make up 1.23-7.65% and 
1.35-6.36% of bone marrow cells in the tibia and femur, respectively. (H) Exclusion of CD45/Ter119+ 
cells reveals 0.07-0.35% and 0.09-0.34% Lepr-Cre ;tdTomato+ cells in the tibia and femur, 
respectively. n=2-3. Statistical tests employed paired two tailed student t-test with Wilcoxon 
correction. Values are percentages ± SEM  
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5.4.4 Tibial compressive loading enhances endosteal and periosteal cortical bone 
formation 
To investigate the contribution to LepR+ cells to loading-induced bone 
formation, a compressive load of 11N was applied to the tibia of 12-week old female 
Lepr-Cre; tdTomato+ mice for 40 cycles, with 10 sec of rest between each cycle, for 
2 weeks ( 
Figure 5.4A-C). Tibia loading led to an anabolic response in cortical bone of 
Lepr-Cre; tdTomato+ mice (Figure 5.5A-G), however no statistical change was found 
in trabecular bone (data not shown). Bone formation was measured on both the 
endosteal and periosteal surface using dynamic histomorphometry, where right 
(loaded) tibiae formed significantly more bone than left (nonloaded) tibia (Figure 
5.5A–G). After 2 weeks of loading, there was a significant increase in mineralised 
surface, mineral apposition rate and bone formation rate at both the endosteal and 
periosteal surfaces (Figure 5.5B-G; P<0.05). Mineralised surface, mineral apposition 
rate and bone formation rate were increased by 30, 20, and 79% on the endosteal 
surface, respectively (Figure 5.5B-D), while on the periosteal surface mineralised 
surface, mineral apposition rate and bone formation rate, increased by 23, 10, and 





Figure 5.4: Axial tibia loading of 12-week-old Lepr-Cre ;tdTomato+ mice. (A) Schematic of the 
experimental plan and tibia loading set up. (B) The right tibiae of 12-week old mice were axially 
loaded at 11N for 40 cycles with 10 sec rest periods per day for a total of 7 days. (C) Image of tibia 




Figure 5.5: Tibial compressive loading enhances endosteal and periosteal cortical bone formation. 
(A-G) Tibia loading induces bone formation on the endosteal and periosteal surface of cortical bone. 
(A) Image of typical loaded tibia. (B-D) Relative mineralizing surface over bone surface (B), mineral 
apposition rate (C), and bone formation rate (D) at the endosteal surface of mechanically loaded tibia. 
(E-G) Relative mineralizing surface over bone surface (E), mineral apposition rate (F), and bone 
formation rate (G) at the periosteal surface of mechanically loaded tibia. n=5. Tibial compressive 
loading dose not increase LepR+ bone marrow stromal cells, norLepR+ osteoblasts or osteocytes. (H-
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I) Flow cytometry analyses following mechanical loading of Lepr-Cre ;tdTomato+ tibia. (H). Flow 
cytometry analyses revealed loading did not alter the % of tdTom+ cells. (I) Exclusion of 
CD45/Ter119+ cells reveals a trend towards an increase in tdTom+ cells following tibia loading. n=4 
(J-L) The % of tdTom+ cells on the endosteal (J) or periosteal surface (K) and embedded with the 
bone (L) was not altered in cortical bone. n=5 Statistical tests employed paired two tailed student t-





5.4.5 Tibial compressive loading increases LepR+ bone marrow stromal cells but 
not LepR+ osteoblasts or osteocytes  
To determine whether this mechanical loading, sufficient to induce bone 
formation, activated and enhanced osteogenesis of Lepr-Cre; tdTomato+ marrow 
cells, bone marrow was flushed from loaded and non-loaded tibia and flow 
cytometry was utilised to assess the percentage Lepr-Cre; tdTomato+ cells. The 
percentage of Lepr-Cre; tdTomato+ cells did not increase following tibia loading 
when no cellular sub-groups were excluded (Figure 5.5H). However, when the 
CD45+ hematopoietic and TER-119+ erythropoietic cells were excluded, a 37% 
increase in the percentage Lepr-Cre; tdTomato+ was found (Figure 5.5I; P=0.2412).  
The effect of loading on Lepr-Cre; tdTomato+ cells lining and embedded within 
bone was furthered assessed using histology. No change in the percentage of Lepr-
Cre; tdTomato+ cells was observed in any region (Figure 5.5J-L). This data 
demonstrates that our loading protocol which increases bone formation, does induce 
an initial proliferation response of Lepr-Cre; tdTomato+ bone marrow cells, however, 
there is no recruitment of this cell type to the bone surface, suggestive of a re-





Table 5.1: Cortical bone midshaft geometry and trabecular bone microarchitecture   
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5.4.6 Adenylyl Cyclase 6 is required for LepR+ cell contribution to loading-induced 
bone formation 
To investigate the role of AC6 within LepR+ cells in loading-induced bone 
formation, AC6fl/fl mice were crossed with mice carrying the Lepr-Cre transgenic 
allele to generate AC6 knockout in Lepr-Cre; tdTomato+ cells (Lepr-Cre; tdTomato+; 
AC6fl/fl). Lepr-Cre; tdTomato+; AC6fl/fl mice are healthy and fertile and appeared 
phenotypically normal (Table 5.1; Figure 5.6 A-B; Figure S5.2A-D; Figure S5.3). 
Body weight of all mice in the study increased over time, with no differences were 
observed between Lepr-Cre; tdTomato+ and Lepr-Cre; tdTomato+;AC6fl/fl mice at 
any timepoint (Figure S5.2B). On average the body weights of Lepr-Cre; tdTomato+ 
and Lepr-Cre; tdTomato+;AC6fl/fl were not significantly different at 8- or 12-weeks of 
age, where Lepr-Cre; tdTomato+  weighed 17±0.1g and 18.85±0.377g at 8- and 12-
weeks, respectively, whereas Lepr-Cre; tdTomato+;AC6fl/fl mice weighed 
17.67±0.35g and 19.02±0.77g at 8- and 12-weeks, respectively (Figure S5.2). In 
addition, µCT analysis was conducted to further examine cortical bone and 
trabecular bone microarchitecture of Lepr-Cre; tdTomato+;AC6fl/fl and Lepr-Cre; 
tdTomato+ tibiae. The total area, cortical area, cortical thickness, Imin, and Imax at the 
ulnar midshaft Lepr-Cre; tdTomato+;AC6fl/fl mice were not significantly different 
from Lepr-Cre; tdTomato+ mice (Table 5.1). The total area, cortical area, Imin, and 
Imax of the tibial midsection, and the trabecular indices bone volume (BV/ TV), 
trabecular number (Tb. N.), trabecular thickness (Tb. Th.), trabecular spacing (Tb. 
Sp.), and connectivity density (Conn. D.) were not significantly different between 
Lepr-Cre; tdTomato+;AC6fl/fl mice and Lepr-Cre; tdTomato+ controls (Table 5.1). 
Collectively, these data indicate that there were no substantial differences in the 
skeletal morphology of young adult Lepr-Cre; tdTomato+ and Lepr-Cre; 
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tdTomato+;AC6fl/fl mice. Thus, these results suggest Lepr-Cre; tdTomato+;AC6fl/fl 
mice do not exhibit a gross morphological or skeletal phenotype. 
Axial compressive tibia loading induced significant bone formation on both the 
endosteal and periosteal surface of cortical bone in Lepr-Cre; tdTomato+ mice 
(Figure 5.6C-J).As there is no skeletal phenotype following AC6 deletion, the same 
loading regime was applied to the Lepr-Cre; tdTomato+; AC6fl/fl mice. DHM was 
used to evaluate the effect of compressive tibia loading on cortical bone formation in 
these animals (Figure 5.6C-J). Interestingly, no change in mineralised surface 
(Figure 5.6E), mineral apposition rate (Figure 5.6F) or bone formation rate (Figure 
5.6G) was found at the endosteal surface of cortical bone in Lepr-Cre; 
tdTomato+;AC6fl/fl following tibia loading. However, on the periosteal surface 
loading of Lepr-Cre; tdTomato+; AC6fl/fl  tibia resulted in a trend towards an increase 
in mineralised surface (Figure 5.6 H; P=0.105) and an increase in bone formation 
rate (Figure 5.6 I; P<0.01), while no effect was seen in mineral apposition rate 
(Figure 5.6 J).  
This effect of loading on Lepr-Cre ;tdTomato+; AC6fl/fl  cells lining and 
embedded within bone was furthered assessed using histology. Mechanical loading 
resulted in no change in the percentage of Lepr-Cre; tdTomato+ cells observed in any 
region of the tibiae (Figure 5.6K-M). The percentage of Lepr-Cre; tdTomato+ cells 
on the endosteum (Figure 5.6K), periosteum (Figure 5.6L) and embedded within 
cortical bone (Figure 5.6M) were investigated, and no effect of compressive tibia 
loading was found. This data demonstrates that Lepr-Cre; tdTomato+; AC6fl/fl 
animals have an attenuated response to compressive tibia loading, where bone is not 
formed on the endosteal surface, nor is there a change in the percentage of Lepr-Cre; 
tdTomato+ cells. This therefore demonstrates that LepR+ cell on the bone surface 
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directly contribute to bone formation and that adenylyl cyclase 6 is required for 




Figure 5.6: Phenotypic analysis of Lepr-Cre ;tdTomato+ and Lepr-Cre ;tdTomato+ ;AC6fl/fl  mice at 8- 
and 12-weeks. (A) Photographs of Lepr-Cre ;tdTomato+ and Lepr-Cre ;tdTomato+ ;AC6fl/fl mice at 8- 
and 12-weeks of age. (B) Full body µCT scans comparing the two genotypes. Skeletally mature Lepr-
Cre ;tdTomato+ and Lepr-Cre ;tdTomato+ ;AC6fl/fl animals were exposed to tibia loading and the 
resulting mineralizing surfaces were labelled with calcein (green) fluorochrome dye (C-D) 
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Representative images of loaded tibias from AC6 WT (C) and AC6 KO (D) mice. (E-G) Relative 
mineralizing surface over bone surface (E), mineral apposition rate (F), and bone formation rate (G) at 
the endosteal surface of mechanically loaded tibia. (H-J) Relative mineralizing surface over bone 
surface (H), mineral apposition rate (I), and bone formation rate (J) at the periosteal surface. n=4 for 
Lepr-Cre ;tdTomato+. n=3 for Lepr-Cre ;tdTomato+ ;AC6fl/fl . (K-M) Tibial compressive loading does 
not increase LepR+ osteoblasts or osteocytes in AC6 knockout mice. (K-M) The % of tdTom+ cells 
on the endosteal (K) or periosteal surface (L) and embedded with the bone (M) was not altered in 
cortical bone. n=4. Statistical tests employed a two-way ANOVA with a Tukey correction test for 
comparison of DHM data between AC6 WT and KO and a paired two tailed student t-test with 
Wilcoxon correction for LepR cell counting. Values are individual animals ± SD *p<0.05, **p<0.01, 




5.5 Discussion  
Bone marrow stem cells represent a quiescent cell population that supply 
osteoblast bone forming cells over time and in response to injury, maintaining bone 
mass and repair. A potent mediator of stem cell differentiation in vitro and bone 
formation in vivo is physical loading, yet it is unclear whether loading-induced bone 
formation requires the differentiation of resident stem cells. Therefore, in this study 
we utilized Leptin Receptor to identify and trace the contribution of bone marrow 
stem cells to bone mechanoadaptation. Lepr-Cre; tdTomato+ cells were tracked from 
E19.5 through to early adulthood, where Lepr-Cre; tdTomato+ cells appear 
perivascularly within the marrow perinatally and increase over time, contributing to 
osteoblast and osteocyte populations, demonstrating osteogenic lineage commitment. 
Compressive loading of Lepr-Cre; tdTomato+ tibiae resulted in increased bone 
formation on the endosteal and periosteal surface of cortical bone. Interestingly, an 
increase in the percentage of Lepr-Cre; tdTomato+ cells within the bone marrow 
approached significance, while no change in the number of Lepr-Cre; tdTomato+ 
osteoblasts or osteocytes were found. AC6 deletion in Lepr-Cre; tdTomato+ cells 
resulted in a reduced cortical bone forming response to loading. In summary, this 
data indicates that mechanical stimulation results in an initial proliferative response 
of Lepr-Cre; tdTomato+ stem cells within the marrow but does not result in the 
recruitment of these cells to the bone surface, highlighting an activation of the 
resident bone lining cells via an AC6 dependent manner as the predominant 
mechanism mediating short term loading-induced bone formation.  
Leptin Receptor is expressed prenatally in bone and brain tissue and becomes 
widely expressed in nearly all major organs postnatally. Using confocal microscopy, 
the expression pattern of Lepr-Cre; tdTomato+ cells was analyzed in E19.5 mice. 
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During this late stage gestation, Lepr-cre; tdTomato+ cells were found to be present 
only in brain and bone tissue and in a limited capacity. This is consistent with 
previous work that demonstrated no Lepr-Cre; tdTomato+ cells in the ossification 
centre of bone at E15.5 (Mizoguchi et al., 2014), and limited LepR positive cells at 
E19.5, indicating little contribution of these cells to bone formation at this stage 
(Zhou et al., 2014). The number of Lepr-Cre; tdTomato+ in the metaphyseal bone 
marrow showed a sharp increase by postnatal day (P) 0.5 (Zhou et al., 2014), and in 
1-week old mice, LepR+ cells were present throughout the bone marrow (Mizoguchi 
et al., 2014). The data presented in this study, in combination with previous work 
suggests that Lepr-Cre; tdTomato+ cells increase in the bone marrow during bone 
maturation. It was also shown that while Lepr-Cre; tdTomato+ cells were not found 
in the major organs prenatally, they were present within the brain at E19.5 and were 
found in the heart, lungs, spleen, liver and the medulla region of the kidney in 8- and 
12-week old animals. The expression of Lepr-Cre; tdTomato+ cells varied 
considerably between organs by 12-weeks of age, as confirmed by flow cytometry. 
Work looking at mRNA expression of LepR in various mouse tissues also found that 
the heart and spleen have the lowest expression of LepR, of the tissues analysed (Fei 
et al., 1997), which is consistent with our findings. The wide expression of Leptin 
Receptor has considerable implications for the use of Leptin Receptor for the study 
of MSC behaviour in bone, particularly when combining with Cre-lox strategies for 
gene deletion. 
Within bone, Lepr-Cre; tdTomato+ cells appear perivascularly in marrow, where 
they are recruited to the bone surface and commit to the osteogenic lineage overtime. 
The percentage of Lepr-Cre; tdTomato+ cells within the tibiae marrow increased by 
2.6% from 8- to 12-weeks of age demonstrating a proliferation of this cell type. This 
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increase in marrow Lepr-Cre; tdTomato+ cells was mirrored by an increase in Lepr-
Cre; tdTomato+ cells on the bone surface and embedded with bone. Similar findings 
were reported by Zhou et al. where the percentage of Lepr-Cre; tdTomato+ cells 
making up Col2.3-GFP+ osteoblast cells increased from 10 to 81% from 6- to 14-
months of age (Zhou et al., 2014). This study also reported that the increase found 
was not due to the induced expression of LepR at this age, but rather the 
differentiation of LepR cells overtime (Zhou et al., 2014). Furthermore, studies at 
15-weeks showed that Lepr-Cre; tdTomato+ cells in the bone tissue were 
osteocalcin- and dentin matrix protein 1 (DMP1)-expressing mature osteoblasts and 
osteocytes, respectively (Mizoguchi et al., 2014). Importantly, LepR mRNA was not 
detectable by quantitative real-time PCR in the osteoblasts, suggesting that Lepr-Cre; 
tdTomato+ mature bone cells do not autonomously express LepR, but are descendant 
of LepR+ precursors (Mizoguchi et al., 2014). Taken together, this data demonstrates 
that Leptin Receptor is a robust marker of MSCs in vivo which can be used to trace 
the osteogenic lineage.  
Compressive tibial loading induces cortical bone formation on the endosteal and 
periosteal surface via activation of bone lining cells. Differences in response to 
mechanical loading was noted between trabecular and cortical bone, where 11N of 
tibia loading did not induce bone formation in trabecular bone. De Souza et al., 
demonstrated similar findings where loading for two weeks produced significant 
load magnitude-dependent increases in cortical bone formation that were similar in 
mice at 8-, 12- and 20-weeks of age, however, the loading protocol increases 
trabecular bone volume only in 8-week old mice (De Souza et al., 2005). Age related 
differences in bone formation have been well characterised previously, where 
loading has no effect in 2-month old mice yet increases in osteoblast/matrix gene 
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expression is observed in 12-month old mice (Silva et al., 2012). It has been 
suggested that this difference in mechanoadaptation between cortical and trabecular 
bone and age is due to the overload of cortical bone during growth, while trabecular 
bone is somewhat underloaded during usual mechanical usage (Iwamoto et al., 
1999). They concluded that cortical bone will therefore be increased by adaptation to 
overload during growth, while trabecular bone will be decreased, which is suggestive 
of trabecular bone being less sensitive to mechanical loading (Iwamoto et al., 1999). 
While the contribution of Lepr-Cre; tdTomato+ cells to adult bone formation has 
been investigated, the contribution of this cell population to loading induced bone 
formation has not been examined to date. Herein, in vivo mechanical loading of 
Lepr-Cre; tdTomato+ mouse tibia resulted in no change in the percentage of Lepr-
Cre; tdTomato+ osteoblasts or osteocytes, suggesting that this tibia loading protocol 
does not initiate a recruitment of Lepr-Cre; tdTomato+ marrow cells, but rather the 
potential activation of resident cells at the bones surface. The loading protocol used 
in this study was short term spanning two weeks in length, therefore, while loading 
induced a trend to an increase in the percentage of Lepr-Cre; tdTomato+ marrow 
stem cells, these LepR+ stem cells do not contribute to short term bone formation. 
This finding is consistent with a study by Chow et al., where loading of the caudal 
vertebrae resulted in reactivation of previously quiescent bone lining cells (Chow et 
al., 1998). As with the present study, the rapidity with which new bone was formed 
following mechanical stimulation raised the potential for this bone formation to 
occur via the reactivation of lining cells, rather than a recruitment from the stem cell 
niche. In addition to rapid bone formation, Chow et al., noted that bone loading 
resulted in an alteration of morphological appearance of the bone lining cells, to 
those consistent with osteoblast differentiation (Chow et al., 1998). More recently, 
169 
 
Matic et al, demonstrated that labelled bone surface cells were observed at time 
points extending beyond the reported lifespan for an osteoblast, suggesting 
continuous reactivation of bone lining cells. Following ablation of osteoblasts, this 
study showed that bone lining cells also make a major contribution to bone 
formation, which includes the ability to proliferate (Matic et al., 2016). Furthermore, 
these bone lining cells were shown to be a major source of osteoblasts and 
proliferating pre-osteoblasts and contribute to osteoblasts during normal bone 
turnover in adults (Matic et al., 2016), therefore opening up the potential that a 
similar response is happening in this study.  
Specific knockout of AC6 in LepR+ cells does not induce a skeletal phenotype 
but results in an inhibited bone forming response on the endosteal surface to 
mechanical loading. The absence of a skeletal phenotype in Lepr-Cre; tdTomato+; 
AC6fl/fl mice suggests that AC6 does not play a role in skeletal development. 
However, the disruption of bone mechanoadaptation in Lepr-Cre; tdTomato+; AC6fl/fl 
mice demonstrates the importance of AC6 in loading-induced bone formation and 
validates in vitro studies in MSCs highlighting the vital role of AC6 in 
mechanotransduction (Johnson et al., 2018).  
Interestingly, loading induced bone formation was completely lost on the 
endosteal surface Lepr-Cre; tdTomato+; AC6fl/fl mice. This clearly demonstrates that 
AC6 is required for bone mechanobiology but also reinforces the finding that LepR+ 
cells on the bone surface are mediating the bone forming response to loading. While 
the response on the periosteal surface was blunted, the bone forming response seen 
here may be attributed to other non-LepR+ cells potentially being recruited from the 
periosteum, however additional work is needed to draw conclusive findings. One 
potential other source of stem cells in the periosteal region maybe PRX-1 expressing 
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cells, which have recently been shown to be required for periosteal bone formation 
(Moore et al., 2018). In general, this diminished mechanoadaptive response is in 
agreement with work examining a global knockout of AC6, where AC6 deletion 
resulted in an inhibited response to ulna loading (Lee et al., 2014). Furthermore, as 
with the Lepr-Cre; tdTomato+ mouse, no change was found in the percentage of 
Lepr-Cre; tdTomato+ cells on the bone surface, nor embedded within bone. The lack 
of bone formation, and the failure of loading to recruit LepR+ cells to the bone 
surface in Lepr-Cre; tdTomato+; AC6fl/fl animals further strengthens the hypothesis 
that loading induces a reactivation of the Lepr-Cre; tdTomato+ bone lining cells, and 
that this requires AC6.  
In conclusion, this study has characterised the contribution of LepR+ bone 
marrow stem cells to bone formation over time and in response to mechanical 
loading. Interestingly, although LepR+ stem cells are the main source of osteoblasts 
and osteocytes over time, they are not recruited to the bone surface in response to 
loading. Rather, mechanical loading of bone activates dormant bone lining cells or 
osteoprogenitors on the bone surface to lay down new matrix in a rapid manner to 
accommodate for increased physical stress. Interestingly, this activation of bone 
lining cells required AC6 which has previously been shown to be an important 





Figure S5.1: Breeding Lepr-Cre ;tdTomato+ to homozygosity results in expression of tdTomato in 
every cell of the organism. Excessive signal in all organs and cell types was found when mice were 




Figure S5.2: Ablation of AC6 in LepR+ cells does not result in a phenotype. (A) Gel electrophoresis 
of genotyping (B) Mean weight progression of both genotypes from 8 to 12 weeks. (C) Mean length 
of both genotypes at 12 weeks. (D) A summary of phenotypes found in Lepr-Cre ;tdTomato+ and 





Figure S5.3: Patterns of LepR expression in adult Lepr-Cre ;tdTomato+ and Lepr-Cre ;tdTomato+ 
;AC6fl/fl mice. To assess whether Lepr-Cre ;tdTomato+ expression differs with the addition of an 
Adenylyl cyclase 6 knockout in adult tissues organs were harvested from 14-week-old Lepr-Cre 
;tdTomato+ and Lepr-Cre ;tdTomato+ ;AC6fl/fl mice and processed for histological analyses and 















6.1 Thesis Summary  
The objective of this thesis is to investigate the role of MSCs in loading-induced 
bone formation and to determine the molecular mechanisms employed in MSC 
mechanotransduction both in vitro and in vivo, with the aim of identifying new 
targets for mechanotherapeutic intervention. Initially in chapter three, it was 
demonstrated that MSC utilise cAMP as a second messenger in 
mechanotransduction. Next, whether MSC primary cilia utilise cAMP as second 
messenger as an alternate to Ca++ was investigated. Additionally, the AC responsible 
for this this action was delineated. It was found that MSC primary cilia are indeed 
cAMP responsive mechanosensors. This was further explored and found that fluid 
shear-induced increases in cAMP is dependant specifically on AC6. These findings 
add to the growing body of evidence detailing the importance of ciliary-based 
signalling in MSCs and highlight a calcium independent mechanism of cilia-based 
mechanotransduction in stem cells. Therefore, this study highlights this pathway, and 
the various components within, as potential targets to enhance MSC osteogenesis 
and bone formation. Importantly, it was demonstrated in a proof of concept study 
that Forskolin activated this novel mechanism eliciting a cAMP and osteogenic 
response mirroring that seen with oscillatory fluid shear, demonstrating 
mechanotherapeutic potential and a new anabolic treatment for bone loss diseases 
such as osteoporosis. The aim of chapter four of this thesis, was to investigate the 
upstream mechano-activator of ACs within the primary cilium mediating cAMP 
dependent MSC mechanotransduction and osteogenesis. It was found that Gpr161 is 
a mechanoresponsive GPCR, that localises to the primary cilium, and is required for 
fluid shear induced increases in cAMP concentration and downstream osteogenesis. 
This Gpr161 mediated mechanotransduction is dependent on the primary cilium but 
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acts upstream of cilia localised AC6, suggesting that Gpr161 may act through AC6 
to regulate cAMP and MSC osteogenesis. Moreover, it was demonstrated that Hh 
signalling is positively correlated with osteogenesis and demonstrate that Hh 
signalling is mechanically regulated and required for loading-induced MSC 
osteogenic differentiation through a primary cilium-Gpr161-AC6-cAMP mechanism. 
Therefore, this study delineated a molecular mechanism of MSC 
mechanotransduction which occurs at the primary cilium, highlighting numerous 
novel therapeutic targets to enhance MSC osteogenesis, mimicking 
mechanotransduction at a molecular level. Finally, in chapter five, the aim was to 
identify the contribution of LepR+ MSCs and their progeny to loading-induced bone 
formation in vivo and to investigate the role of ACs in this process. Using transgenic 
mouse strains combined with histological analysis, it was revealed that LepR is 
expressed from the embryonic stage in various organs including bones. Lepr-Cre; 
tdTomato+ cells are located around blood vessels and on bone surfaces. Mechanical 
loading induces an increase in bone mass and bone parameters, such as mineral 
apposition rate, mineralised surface and bone formation rate. Lepr-Cre; tdTomato+ 
mice were further crossed with Leprtm2(cre)Rck/J::B6;129-Adcy6tm1.1Dek/J  mice to 
generate an LepR specific knockout of adenylyl cyclase 6, in order to investigate the 
role of AC6 in this loading-induced bone formation. This model allows us to track 
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and evaluate the role of LepR positive cells as bone forming cells, and to decipher 
the role of AC6 in these cells during mechanically-induced bone formation. The data 
highlights a novel mechanism, whereby, loading induced-bone formation occurs via 
the reactivation of dormant bone lining cells or osteoprogenitors on the bones surface 
via an AC6 dependent manner, and not the recruitment of MSCs as previously 
hypothesized. 
Figure 6.1: Outline of main results of thesis. An extensive novel mechanism of cilia mediated MSC 
mechanotransduction was identified in vitro (Chapters 3 & 4) and loading induced bone formation 
was found to occur via AC6 regulation of reactivation of resident cells in vivo (Chapter 5). 
 
6.2 Mesenchymal stem cell mechanotransduction is cAMP 
dependent and regulated by Adenylyl Cyclase 6 and the 
Primary Cilium 
The results of this thesis begin in chapter 3, where the primary cilium was 
investigated as a cAMP responsive mechanosensor in MSCs. It has been previously 
shown that fluid shear increases intracellular cAMP not only over time, but also over 
increasing shear magnitudes demonstrating mechanosensitivity of cAMP in 
osteoblasts (Reich et al., 1990), and demonstrates the utilization of cAMP signalling 
as a potential 2nd messenger in the skeleton. In this chapter, mimicking the 
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mechanical environment of the marrow, via the application of OFS, resulted in a 
rapid increase of cAMP following 15 mins stimulation. Importantly, it was shown 
that this cAMP was required for downstream osteogenic signalling. This work 
highlighted that MSCs utilise cAMP as a 2nd messenger to transduce a biophysical 
stimulus into a biochemical osteogenic response, where mechanical loading-induced 
osteogenesis has previously been linked to Ca2+ signalling (Thompson et al., 2012, 
Liu et al., 2015, Reich et al., 1990). However, studies looking at Ca2+ channels 
recently demonstrated that a complete loss of calcium signalling following TRPV4 
inhibition only partially blunted the osteogenic response to fluid shear in MSC 
(Corrigan et al., 2018). Given the complete loss of osteogenesis following cAMP 
inhibition in this study, this may suggest a more dominant role for the increase in 
cAMP as a 2nd messenger in MSC mechanotransduction.  
The results prompted the investigation as to which AC was regulating this 
cAMP dependent mechanotransduction. Using a combination of PCR and ICC, AC6 
was highlighted as one of the ACs expressed in this cell line. This was interesting, as 
AC6 has been previously shown to play an important role in bone 
mechanoadaptation both in vitro and in vivo (Kwon et al., 2010, Lee et al., 2014), 
however, the role of AC6 in MSC mechanotransduction is unknown. Knocking 
down AC6 expression in MSCs did not affect basal cAMP concentrations but 
abolished the increase in cAMP in response to fluid shear, demonstrating a similar 
mechanotransduction specific role as in the AC6 knockout animal (Lee et al., 2014). 
This trend was also evident when examining MSC osteogenesis, suggesting the 
defect in loading induced bone formation in vivo may be attributable to a defect in 
mechanotransduction in many cell types along the osteogenic lineage. Interestingly 
the complete loss of the cAMP and osteogenic responses to OFS following AC6 
179 
 
knock down mirrors that seen following generic AC inhibition, indicating that AC6 
is the dominant AC mediating MSC mechanotransduction. Hence, this chapter 
demonstrates a novel role for AC6 in MSC mechanotransduction, mediating fluid 
shear induced cAMP 2nd messenger abundance and downstream osteogenesis. 
AC6 is localised to the primary cilium in osteocytes (Kwon et al., 2010) and is 
known to be required for fluid shear-induced cAMP signalling (Moore et al., 2016), 
therefore AC6 localization to the cilium was investigated in MSCs. In this chapter, it 
was found that AC6 preferentially localizes to the primary cilium, an area of high 
strain. Remarkably, in MSCs which do not possess primary cilia, fluid shear-induced 
increases in cAMP are lost, which is consistent with that seen with AC6 knockdown. 
This therefore suggests that the localization of AC6 to the cilium is functionally 
significant and demonstrates a potential calcium independent mechanism of cilia-
based mechanotransduction (Malone et al., 2007, Delling et al., 2016). 
The final aim of this chapter was to investigate whether the biochemical 
activation of this novel MSC mechanotransduction mechanism via adenylyl cyclases 
could mimic the responses seen to OFS. Treatment of MSCs with the adenylyl 
cyclase agonist, forskolin, stimulated robust cAMP and osteogenic gene responses 
comparable to that seen following OFS, revealing itself as a potential novel 
therapeutic that mimics the beneficial effect of mechanical loading. It is known that 
Forskolin induced cAMP activation enhanced bone formation of transplanted MSCs 
in vivo, where both 8-bromo-cAMP and forskolin resulted in increased bone 
formation in pretreated MSCs (Doorn et al., 2012). In this chapter, ablation of AC6 
was found to inhibit the forskolin induced increases in osteogenic gene expression, 
suggesting that in MSCs, a knockdown of AC6 is sufficient to inhibit the effect of 
forskolin. Similarly, it was found that the inhibition of primary cilia formation via 
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Ift88 siRNA blocked the forskolin induced increases in osteogenic gene expression. 
This data suggests that the primary cilium, and the ciliary localised AC6 are both 
required for forskolin induced alterations of osteogenic gene expression. This 
consistent lack of a response further points to the importance of primary cilia. This 
makes AC6 a prime candidate for targeting as a mechanotherapeutic as this chapter 
has demonstrated proof of concept whereby forskolin activated this novel 
mechanism eliciting a cAMP and osteogenic response mirroring that seen with 
oscillatory fluid shear, demonstrating therapeutic potential and a new anabolic 
treatment for bone loss diseases such as osteoporosis. For the development of robust 
and realisable therapeutics, targets at the earliest stages of the pathway are sought 
after, therefore leading to the work carried out in chapter 4 of this thesis. 
6.3 Primary cilium-mediated MSC mechanotransduction is 
dependent on Gpr161 regulation of hedgehog signalling 
The aim of chapter four was to identify the upstream mechano-activator of ACs 
within the primary cilium mediating cAMP-dependent MSC mechanotransduction 
and osteogenesis. In the previous chapter, a novel molecular mechanism of MSC 
mechanotransduction was discovered, however the upstream regulator and 
downstream effectors of said pathway were still not understood. Although the cilium 
can be targeted directly to modulate MSC mechanosensitivity and osteogenesis 
(Corrigan et al., 2019), understanding the molecular components of cilium-mediated 
MSC mechanotransduction may reveal new insights to bone pathologies and identify 
more effective therapeutic targets to treat bone loss diseases such as osteoporosis.  
Hedgehog signalling was found to be positively correlated with osteogenic 
signalling, is mechanoresponsive, and required for loading-induced increases in 
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MSC osteogenesis. The correlation between Hh activation and osteogenic gene 
expression demonstrated here is consistent with previous findings in rodent bone 
marrow MSCs, where treatment with N-terminal Shh increases the percentage of 
cells responding positively to BMP2, in terms of alkaline phosphatase production, 
proliferation and osteogenic differentiation (Cai et al., 2012, Kinto et al., 1997, 
Spinella-Jaegle et al., 2001b, Chen et al., 2016c). Fascinatingly, ablation of both AC6 
and Ift88 resulted in a loss of OFS induced Hh signalling, implicating it in the 
pathway highlighted in chapter 3 of this thesis. Moreover, Hh signalling in 
chondrocytes has been shown to be mechanoresponsive to cyclic tensile strain and 
hydrostatic pressure where application of both stimuli increased Hh gene expression, 
and transcription of Ptch1 and Gli1 genes (Thompson et al., 2014, Shao et al., 2012), 
therefore, this chapter adds to the significance of Hh signalling in regulating stem 
cell behaviour and demonstrates the importance of Hh in MSC mechanotransduction 
and loading-induced osteogenesis. 
Herein, Gpr161 was discovered to be a mechanosensitive GPCR, whereby it 
localizes to the primary cilium, and is required for downstream OFS induced 
increases in cAMP and osteogenic gene expression. Removal of Ift88, but not AC6 
had an inhibitory effect on OFS-induced increases in Gpr161, suggesting that 
Gpr161 localizes to the primary cilium, but works upstream of AC6. The localization 
of GPR161 to the primary cilium was confirmed with ICC, further emphasizing its 
potential importance as a Gsα which may be acting through AC6 to coordinate MSC 
osteogenesis in the pathway exposed in chapter three. Intriguingly, this chapter also 
demonstrates that Gpr161 is required for increases in Hh signalling which is 
consistent with a Gsα-AC-cAMP mediated activation of PKA mechanism resulting 
in trafficking of Smo into the cilium and the activation of Hh signalling (Wilson et 
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al., 2009, Bachmann et al., 2016) and osteogenesis. Due to the significance of AC6 
in both this and the previous chapter led to chapter 5 of this thesis, in which an in 
vivo model looking at AC6 mechanotransduction was developed, which we 
previously demonstrated was a critical component of cilium-mediated 
mechanotransduction.  
6.4 Tibia loading reactivates Leptin-receptor expressing bone lining 
cells via Adenylyl Cyclase 6  
The final aim of this thesis was to identify the contribution of LepR+ MSCs and 
their progeny to loading-induced bone formation in vivo and to investigate the role of 
AC6 in this process.  
The first aim of this chapter was to characterize the 
Leprtm2(cre)Rck::(ROSA)26Sortm9(CAG-tdTomato) mouse for the tracking and lineage tracing 
of MSCs over time and following mechanical loading, in order to identify the 
contribution of LepR+ MSCs to bone physiology and specifically mechanobiology. 
LepR+ cells have been highlighted as key players in adult bone formation, where 
they arise perinatally (Zhou et al., 2014). Interestingly, examining E19.5 embryos, it 
was found that Lepr-Cre; tdTomato+ cells are located in the brain and bone regions, 
such as the primary ossification centre in the tibia. Having located tdTomato+ cells 
outside of the bone, a full characterization of the location of these cells was carried 
out. Using histology and flow cytometry, tdTomato+ cells were found to increase 
over time, but interestingly were primarily located perivascularly, a key 
characteristic of MSCs. This finding of Lepr-Cre; tdTomato+ cells is important for 
subsequent knockout studies, in that LepR expression is not as restricted to bone was 
previously believed.  
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Looking specifically at the bone marrow, an area where MSCs are located, Lepr-
Cre; tdTomato+ cells appear perivascularly initially, before expanding and being 
recruited to the bone surface and differentiating overtime. The percentage of 
tdTomato+ cells increased significantly with age demonstrating proliferation and 
differentiation of this cell population. Similar findings were reported where 
tdTomato positive cells increased from 10% to 81% of Col2.3-GFP+ osteoblastic 
cells at 14 months of age (Zhou et al., 2014). This study also reported that the 
increase found was not due to the induced expression of LepR at this age, but rather 
the differentiation of LepR cells overtime (Zhou et al., 2014). Importantly, LepR 
mRNA was not detectable by quantitative real-time PCR in the osteoblasts, 
suggesting that Lepr-Cre; tdTomato+ mature osteolineage committed cells do not 
autonomously express LepR, but are descendant on LepR+ precursors (Mizoguchi et 
al., 2014).  
To investigate the role of LepR in loading-induced bone formation, 11N of load 
was applied every two days for two weeks. Curiously, this loading regime resulted in 
differences in response to mechanical loading between cancellous and cortical bone, 
where 11N of tibia loading did not induce bone formation in cancellous bone but 
generated a robust cortical bone response. De Souza et al., showed similar findings 
where loading for two weeks produced significant load magnitude-related increases 
in cortical bone formation that were similar in mice at 8, 12 and 20 weeks of age, 
however, the loading protocol increases trabecular bone volume in 8 week old mice, 
but modifies trabecular organization with decreases in trabecular bone volume in 12 
and 20 week old mice (De Souza et al., 2005). This validation of the loading regime 
to form bone allowed for the investigation of the contribution of Lepr-cre ;tdTomato+ 
cells in this response. Surprisingly, the in vivo mechanical loading of transgenic 
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mouse tibia increased bone formation parameters, however no change in the 
percentage of Lepr-Cre; tdTomato+ osteoblasts and osteocytes were found, 
suggesting that this tibia loading protocol is not playing a role in the immediate 
recruitment of LepR+ MSCs, but rather the reactivation of resident cells at the bones 
surface.  
This result was highly intriguing. Therefore, based on the role of AC6 shown in 
chapters 3 and 4, this thesis next sought to investigate the role of AC6 in the LepR+ 
cells during loading-induced bone formation. What was fascinating here was that 
compressive tibia loading did not induce cortical bone formation on the endosteal 
surface and had only a limited effect on the periosteal surface of Lepr-Cre; 
tdTomato+; AC6fl/fl mice. The blunted response at the periosteal surface, may be as a 
result of a recruitment osteoprogenitors from the surrounding periosteum. Studies 
have shown that PRX-1 positive cells contribute to loading induced bone formation 
on the periosteal surface (Moore et al., 2018).  This diminished response is in 
agreement with work looking at the global knockout of AC6, where the knockout of 
global AC6 resulted in an inhibited response to ulna loading (Lee et al., 2014). The 
lack of bone formation on the endosteal surface, and the failure of loading to recruit 
LepR+ cells to the bone surface in Lepr-Cre; tdTomato+; AC6fl/fl animals further 
strengthens the hypothesis that loading induces a reactivation of the Lepr-Cre; 
tdTomato+ bone lining cells, and that this requires AC6. As with the Lepr-Cre; 
tdTomato+ mice, no increase in the percentage of tdTomato+ cells was found on the 
endosteal, periosteal or embedded within the cortical bone in the Lepr-Cre; 
tdTomato+; AC6fl/fl mice, highlighting a novel mechanism, whereby, loading induced 
bone formation occurs via the reactivation of dormant bone lining cells or 
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osteoprogenitors on the bones surface via an AC6 dependent manner, and not the 
recruitment of MSCs as previously hypothesized. 
6.5 Limitations and future directions 
In chapters three and four, exploring the molecular mechanism of primary cilia 
mediated MSC mechanotransduction, an MSC model represented by C3H10T1/2 
mouse embryonic mesenchymal stem cell line derived from C3H mice were used. 
Although, this cell line has been shown to be responsive to fluid flow stimuli 
(Arnsdorf et al., 2009) and has been consistently used as a model of mesenchymal 
stem cells, it has also been shown to have limited mineralization ability (Zhao et al., 
2009, Hu et al., 2013). This cell line was chosen as it was cost effective, easy to use, 
provide an unlimited supply of material. Attempts at isolating primary bone marrow 
cells were made using the mice from chapter 5, however cells were unable to be 
maintained as homogeneous cultures of MSCs, and became senescent and apoptotic 
after approximately 3 days of culture. To verify translation of these effects in human 
species, human mesenchymal stem cells should be used in the future.  
In chapters 3 and 4, studies were performed using short term fluid flow. The 
parallel plate flow chambers utilized in these chapters take a considerable amount of 
time to set up and to conduct experiments for low n numbers. Future studies 
exploring a protocol whereby intermittent mechanical stimulation over 2-3 weeks is 
applied to MSC to induce full osteogenic lineage commitment and bone extracellular 
matrix deposition should be considered. Furthermore, all mechanical studies 
employed only 2D systems therefore a more physiological approach of 3D spatial 
distribution on various extracellular matrices are worth exploring.  
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In chapter five, the Lepr-Cre mouse model was used with the tdTomato reporter 
and subsequently used to specifically delete AC6. This model is not optimal for 
looking at contributions to adult or loading-induced bone formation as the tdTomato 
reported remains fluorescent for a cell’s lifespan, therefore a cell which is 
fluorescing red at the time of analysis may not be actively expression LepR but may 
have expressed LepR at some point previously. Additionally, breeding of the mouse 
lines was very time consuming and this also found that LepR is expressed in 
multiple tissues, therefore when it comes to knockout models, such as AC6 in this 
thesis, the gene is not only knocked out in the tissue of interest, but also in the 
variety of other tissues. Ideally, an inducible Cre would have been more appropriate 
for this thesis, however, the model did not exist at the time of commencement of 
work. To be more aware of which organs were affected by the knockout of the AC6 
gene, full phenotypic characterization was performed.  
In chapter five strain gauge measurements were not taken due to time restraints. 
This resulted in uncertainty of the difference in strain being applied to the tibiae of 
Lepr-Cre; tdTomato+; AC6fl/fl mice when compared to Lepr-Cre; tdTomato+ mice. 
Studies using mice of same sex and age have managed to strain gauge and found that 
the local micro-strain is in the region of 2083.5 ± 259.1 µε and 2083.5 ± 259.1 µε for 
AC6 WT and KO mice, respectively (Kwon et al., 2013). Although in further studies 
strain gauging should be performed, to alleviate this concern, CT scans were taken, 
and the bone parameters were compared across the two genotypes. No phenotypic 
difference was found which would indicate similar strain fields in response to 11N 
compressive load.    
As highlighted throughout this thesis, multiple potential targets for therapeutics 
have been identified. Further work from this thesis could involve further experiments 
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looking at the effect of these therapeutics in vitro, and also expanding and looking at 
their roles in vivo. For example, FSK treatment could be applied to AC6 KO mice to 
validate this therapeutic in vivo.  
6.6 Thesis conclusions 
• MSCs were shown to utilize cAMP as an important 2nd messenger to initiate an 
osteogenic response post fluid shear stimulation. 
• Fluid shear-induced increases in cAMP concentration was shown to be mediated 
by AC6 and the primary cilium. These findings add to the growing body of 
evidence detailing the importance of ciliary-based signalling in MSCs and 
highlight a calcium independent mechanism of cilia-based mechanotransduction 
in stem cells.   
• This thesis demonstrated a proof of concept whereby forskolin activated this 
novel mechanism eliciting a cAMP and osteogenic response mirroring that seen 
with oscillatory fluid shear, demonstrating mechanotherapeutic potential and a 
new anabolic treatment for bone loss diseases such as osteoporosis. 
• It was demonstrated that Hh signalling is mechano-responsive in MSCs and the 
regulation of mechanically-induced Hh signalling occurs via the primary cilium 
and is dependent on AC6 in MSCs.  
• GPR161 was found to be mechanoresponsive and localise to the primary cilium, 
where it is upstream of AC6 and is required for stem cell mechanotransduction. 
• This thesis delineated a novel molecular mechanism of MSC 
mechanotransduction which occurs at the primary cilium, whereby a biophysical 
stimulus triggers a Gpr161-AC6-cAMP-Hh pathway leading to osteogenesis. 
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• Lepr-Cre; tdTomato+ cells were found to arise during embryonic development 
and expand into adulthood in various organs, including bones, where tdTomato+ 
cells are found primarily perivascularly. 
• It was shown that Lepr-Cre; tdTomato+ cells are present in brain and bone 
regions prenatally, where they appear perivascularly in various major organs and 
bones by 8-weeks of age and are recruited to the bone surface and differentiate 
overtime. 
• It was shown that loading increases bone formation parameters in the tibiae and 
the percentage of Lepr-Cre; tdTomato+ cells within the marrow. No changes in 
the percentage of tdTomato+ osteoblasts or osteocytes were found, suggesting 
that tibia loading is not playing a role in the recruitment of LepR+ BMSCs, but 
rather the reactivation of resident cells at the bones surface over the initial 2 
weeks of loading. 
• AC6 deletion within Lepr-Cre ;tdTomato+ cells resulted in a loss of endo-
cortical bone formation further highlighting that a reactivation of LepR+ lining 
cells contributes to loading-induced bone formation and AC6 plays a critical 
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